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ABSTRACT
(2S)- and (2R)-Serine O-suIphate have been synthesised and shown to inactivate 
glutamate decarboxylase (GAD) from E. Coli. Novel methodology was developed to 
enable the stereospecific synthesis of (2S) and (2R)-a-deuteriated serine in order to 
probe the mechanism of inactivation. The rates of inactivation of glutamate 
decarboxylase by (2S)-, (2S)-[2-^H]-, (2R)- and (2R)-[2-^H]-serine 0-sulphate have 
been measured for each of the isotopomers at a range of concentrations. From the 
data obtained the deuterium isotope effects were determined for each enantiomer. The 
inactivation by the (2S)-enantiomer was shown to involve C“-H bond cleavage while 
inactivation by the (2R)-isomer involves C“-decarboxylation. Both processes were 
shown to occur on the 4 ’-re-face of the coenzyme, the opposite face to that utilised in 
the physiological decarboxylation reaction.
The methodology developed for the synthesis of the deuteriated serines involved the 
regiospecific introduction of deuterium to the C-6 centre of (3R)- and (3S)-2,5- 
dimethoxy-3-isopropyl“3,6-dihydropyrazine. Schollkopf chemistry was then exploited 
for the stereospecific alkylation at C-6 of the dihydropyrazines. This chemistry was 
versatile and enabled the synthesis of other a-deuteriated a-amino acids. For example 
(2S)-[2-^H]-phenylalanine, (2S)-[2-^H]-allylglycine and (2S)-[2-^H]-aspartic acid were 
synthesised using this chemistry.
The decarboxylation of 2-aminomalonic acid by cytosolic serine 
hydroxymethyltransferase (SHMT) was studied. Contrary to previous reports, the 
reaction was found to be stereospecific and the newly Introduced hydrogen was shown 
to occupy the 2-pro-S position of the glycine product.
I
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CHAPTER ONE
INTRODUCTION TO 
PYRIDOXAL 5-PHOSPHATE ENZYMES
1OHG
CH
H
OH
OHHO
CH
H
1.0 Pyridoxal 5’-phosphate dependent enzymes
Enzymes requiring pyridoxal 5’-phosphate (PLP) (1) as acoenzyme are ubiquitous in 
nature, and have been isolated from bacterial and mammalian sources. PLP, the 
biologicaiiy active form of vitamin Be (pyridoxol) (2), serves as a cofactor for a myriad of 
enzyme catalysed reactions, many of which are essential for amino acid metabolism. In 
the mid 1940's, SnelP identified PLP as the coenzyme for transaminases, and since 
then PLP has been established as the coenzyme for over 20 different types of enzyme 
catalysed reactions inciuding decarboxylases.
0
1O— P-IIo
(1) (2)
1.1 The metabolic role of PLP dependent enzymes
The mechanisms of action of the PLP dependent enzymes are of great scientific 
interest. The PLP dependent enzymes play a major role in the regulation of 
physiological processes. Some of the more important processes are detailed below.
Two important transaminases are y-aminobutyric acid transaminase (GABA-T) and co­
ornithine transaminase. GABA-T is a key enzyme involved in the reguiation of the 
GABA-ergic system (Scheme 1.1) in the mammalian central nervous system.
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NHc
COgH 
(2S)-glutamic acid
glutamate 
decaitKJxylase  ^
NHc
COgH H
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a-ketoglutarate O
via
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in the citric 
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H ' ^  "COgH
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COgH reduction
HO^ "COgH
4-hydroxy butanoic acid
Scheme 1.1. The GABA-ergic system.
Y-Aminobutyric acid (GABA) is a major inhibitory neurotransmitter and there is much 
evidence to suggest that high cerebral concentrations prevent convulsions.^ m- 
Ornithine transaminase not only interconnects the citric acid cycle and the urea cycle 
but also couples ornithine to proline metabolism (Scheme 1.2).
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NHc
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Y+NH,NHc COgH
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cycle NK
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NHr
H
COgH 
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Yo NHc O NHcHOgC
a-ketoglutarate, 
an Intermediate 
in the citric 
acid cycle
COgH H' J "COgH
,H
Glutamic acid
Scheme 1.2. The metabolic significance of ornithine transaminase.
The decarboxylases are one of the most important classes of PLP dependent 
enzymes. The physiological role of the amino acid decarboxylases in bacteria is not 
fully understood, but inducible decarboxylases for glutamate, arginine and lysine have 
been purified to homogeneity.^ One of the most important physiological roles of the 
decarboxylases in mammals is the conversion of amino acids to pharmacologically 
active amines. The formation of dopamine, histamine, GABA, and putrescine all 
depend on PLP-dependent decarboxylation of their respective parent amino acids. 
The biosynthesis of the higher polyamines, spermine and spermidine, from putrescine 
involves the pyruvate-dependent decarboxylation of S-adenosylmethionine (SAM) 
(Scheme 1.3).
Mammalian brain glutamate decarboxylase is directly responsible for the biosynthesis
3
1
«
of GABA in the GABA-ergic system (Scheme 1.1). Knowledge of the mechanism of 
action will enable the synthesis of inhibitors to control the level of GABA in the brain. 
Ornithine decarboxylase (ODC) is the first and rate-limiting enzyme in the biosynthetic 
pathway leading to putrescine and higher polyamines (Scheme 1.3)."^  The activity of 
the enzyme in vivo increases dramatically in response to cellular stimulation which 
promotes regeneration and replication. Cellular levels of the enzyme are high during 
growth, and low at other stages.® The association of high polyamine levels with rapid 
cellular proliferation, and protein biosynthesis, led to the idea that polyamines may be 
required for RNA/DNA biosynthesis.® The enzyme has been identified as a target for 
cancer chemotherapy."^
NHc
ornithine
decarboxylase,
PLP
Huw^
COgH
ornithine
NHo
NHc
putrescine
SIAd
yCHgH\^
COgH 
S-adenosylmethionine
SAM NHg
decaitKDxylase S'IAd
S-adenosyl-(methylthio)
-propylamine
Higher polyamines
spermidine
Scheme 1,3. The synthesis of higher polyamines.
Histidine decarboxylase (HOC) catalyses the decarboxylation of histidine to give 
histamine. In mammals, histidine is important as the major receptor agonist.^ 
Overproduction of histamine is associated with many biological responses including 
gastric secretion, allergic and hypersensitivity reactions.® The development of
4
antihistamines, antagonists for the receptors, has been an important area in medicinal 
chemistry. Histamine is also active as a regulator of peripheral blood circulation.^
The aromatic amino acid decarboxylases catalyse the formation of many 
pharmacologically important amines. For example, DOPA decarboxylase (DDC) is 
able to convert many aromatic substrates to the corresponding amines including, 
phenylalanine to phenyethylamine, tyrosine to tyramlne, tryptophan to tryptamine, 
histidine to histamine, 3,4-dlhydroxyphenylalanine (3) to 3,4-dihydroxy- 
phenylethylamine (dopamine) and 5-hydroxytryptophan (4) to serotonin.® Dopamine 
and serotonin act on smooth muscles and the cardiovascular system. Dopamine is a 
precursor in the biosynthesis of adrenaline, and serotonin is itself neuroactive.®
"{?
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(3)
OH
OH
NH
H
H
NH
OH(4)
Serine hydroxymethyltransferase (SHMT) catalyses the formation of 5,10- 
methylenetetrahydrofolic acid and glycine from tetrahydrofolic acid and (2S)-serine. 
The enzyme is a key enzyme in single carbon (0^) metabolism at all oxidation levels 
and will be discussed further in Chapter 3.
Another important class of PLP dependent enzymes, the racemases, catalyse the 
interconversion of (2R)- and (2S)-amino acids. These enzymes are common in 
prokaryotes and several are involved in the biosynthesis of peptidoglycan in bacterial 
cell walls.® Alanine racemase is an important enzyme In peptidoglycan biosynthesis
5
and as such the enzyme Is a target for the action of many antibacterial agents, 
including (2R)-cyc/oserine (5),^  ^ 0-carbamyl-{2R)-serine (6)^  ^ and phosphoalanine 
(7)JG
NH
NHH
(6)
NH
CHc
PO 2-
(7)
1.2 Structure and mechanism of PLP dependent enzymes
The coenzyme, PLP, is bound at the enzyme active site as a Schiff's base complex 
with the e-amino group of an active site lysine residue (Scheme 1.4, 8).^^'^'*The nature 
of the coenzyme binding at the active site has been shown by chemical and X-ray 
crystallographic studies. Introduction of the substrate leads to a transaldimination 
reaction which frees the active-site lysine residue and leads to the formation of another 
Schiff's base (Scheme 1.4, (9)). When the Schiff’s base is bound at an enzyme active 
site it can undergo a range of reactions as a result of labilisation of the C“ bonds.
For some enzymic systems the transaldimination reaction causes a large 
conformational change. After the formation of the substrate aldimine (9) specific 
cleavage of one of the C“ bonds of the amino acid occurs.
Dunathan^^ proposed that the bond to be cleaved is orientated perpendicularly to the 
plane of the conjugated pyridinium ring system by the apoenzyme, so that the maximal 
orbital overlap is achieved between the developing negative charge at C “ and the
6
extended 7c-electron system. 
Lys
PO
CH
(8)
^  Transaldimination
R
H,
PO
CH.
(9)
Products
eg. 0 - H cleavage
.OHPO
CH.
Scheme 1.4. PLP and substrate at the enzyme active site.
1.2.1 Transamination
Transaminases {or aminotransferases) are the best studied of the PLP-dependent 
enzymes. They catalyse the reversible interconversion of amino acids and a-ketoacids 
using the coenzyme as an ammonia carrier. In the first half-reaction the proton of 
the aldimine (10) is transferred to the ketimine (11) on the C-4’-s/-face of the 
coenzyme giving pyridoxamine 5'-phosphate (PMP) (12) and an a-ketoacid (Scheme 
1.5a). When a new a-ketoacid is added to the solution it condenses with the PMP (12) 
to give a second ketimine (13). 1,3-suprafacial proton transfer from C-4’ to C*on the 4’- 
s/-face of the coenzyme gives the aldimine (14) which undergoes transaldimination to 
yield a new (2S)-amino acid and the internal PLP-aldimine (8) (Scheme 1.5b).
■i
1
s
Enz NH
â^V^Oo
(10)
HO2C
CO2H
o
NH
,OHPO
CH
PMP. (12)
Enz -NH2
H
PO
CH
Enz NH
PO
CH
(11)
1
i
Scheme 1.5a. The first haif-reaction catalysed by aspartate 
aminotransferase.
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Enz— NHg
HOgC^ ^COgH
OpC
NH. NH.Enz
.OH POPC
CH
EnzI
-ly":
H
(13)
Enz— NH.
H
CH.
PC PC
CH.
H
(8) (14)
HOpC. i COgH
Scheme 1.5b. The second half-reaction catalysed by aspartate aminotransferase.
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%Of all the PLP-dependent enzymes, aspartate aminotransferase (AAT) has been 
studied the most i n t e n s e l y X - r a y  structures of the active holoenzyme-substrate 
complex have been published for chicken mitochondrial AAT,^° pig cytosolic AAT,^
and chicken heart cytosolic AAT^  ^at 2.8Â. More recently a crystal structure of £  coli i
AAT has been elucidated,and the overall structure was found to be similar to that of 
higher animals.
Arigoni and Besmer,^® and Dunathan et have independently studied the 4
aminotransferase reaction. It was discovered that pyridoxal was a coenzyme for the 
reaction, but that It did not bind to the apoenzyme as tightly as PLP. Both groups of 
researchers demonstrated that the removal of the proton from C-4' occurs from the 4*-s/- 
face of the pyridoxamine. For the transamination catalysed by pyridoxamine pyruvate 
transaminase it was shown that direct internal hydrogen transfer occurred between 0 “ 
of (2S)-alanine and 0-4' of the coenzyme suggesting that the protonation and 
deprotonation are suprafacial processes mediated by a single base.
X-ray crystallographic studies of mitochondrial chicken heart AAT has allowed the 
identification of the active-site residues that are important for binding PLP and the 
substrate (Scheme 1.6). The protonated nitrogen of the pyridinium ring forms a 
hydrogen bond with Asp222, whilst the deprotonated phenolic hydroxyl is hydrogen |
bonded to Tyr225. The 2-methyl group lies in a pocket defined by eight amino acids. ]
The 5’-phosphate ester is hydrogen bonded within a hydrophilic pocket to six amino 
acids, including Ser255 and Arg266. Arg266 neutralises the dianionic phosphate. The 
proximal and distal carboxylate groups of the physiological substrates are bound by 
Arg386 and Arg292 respectively. These studies have improved the understanding of 
the conformational changes which occur in the protein binding.
11
The protein consists of two identical subunits each consisting of two domains. The 
coenzyme is bound to the larger domain and is situated in an open pocket near the 
subunit interface which is made up of residues from both subunits. The two carboxylate 
groups of the dicarboxylic acid substrates are bound to Arg386 and Arg292 from 
adjacent subunits, and the substrate specificity is determined by these interactions. 
The charge stabilisation provided by these interactions not only positions the substrate 
correctly for efficient catalysis but also shifts the conformational equilibrium to the 
closed form which brings Arg386 3Â closer to the coenzyme which is rigidly positioned 
in the smaller domain. Transaldimination of the e-amino group of Lys258 by the a- 
amino group of the substrate to form the external aldimine is accompanied by a tilting 
of the coenzyme by «30°, Scheme 1.6 . The released e-amino group of Lys258 then 
serves as a proton donor/acceptor in the 1,3-prototropic shifts accompanying 
transamination. At this stage or after formation and hydrolysis of the Initial ketimine the 
coenzyme rotates back by «20°. Throughout this process, the pyridinium ring is 
hydrogen bonded to the p-carboxylate group of Asp222.
Two genetically distinct isoenzymes exist in animal tissue, cytosolic (cAAT) and 
mitochondrial (mAAT).^® The primary structures of a number of a number of AAT's have 
been completely or partly elucidated.^® The amino acid sequence of mAAT's from 
chicken, pig, rat,^ mouse,^ horse,® and human® and of cAAT from chicken, pig,® 
mouse, ^  and horse^® are known as well as those from £  coli and £  coli K12.®  ^ In 
general the mAATs from different sources show «85% sequence homology.
12
TyrTO
Ser255
Ser107
Arg266 ' ' /  }
+ * I
Thr109 /  
GlylOS
^g292 Arg386
Lys258 -Q  Q + QQ -
.  I W - H
NHg
Ù  O ' His193I Asn194
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O ^ A sp 222
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'H  HO
N X H 3
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Scheme 1.6. The active site of chicken mitochondrial aspartate aminotransferase.
Similar homology is also found between cAAT’s. However the sequence homology 
between two isozymes of the same species is only about 45% .^ It should be noted that 
in all the above examples there is almost 100% homology for the regions of the protein 
corresponding to substrate or coenzyme binding sites. The active enzyme, as stated 
above is a dimer of two identical sub-units (Mr 45 000 Daltons)^^ and contains two 
independent active sites.^*^® A comparison of the amino acid sequence for selected 
regions of AAT isoenzymes^ and the amino acid sequences for the Schiff’s base 
forming region of several AATs^^are shown in Tables 1.1. and 1 .2 .
13
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Table 1.1. Comparison of the amino acid sequences for selected regions of AAT isozymes.
Isoenzyme Amino acid residue number
Source 7 0 10 8 14 0 190 222
* * * * *
Human (mit.) EYL SGTG TWGNH LHACAHNPTG FFDMAYQGF
Chicken (mit.) EYL SGTG SWGNH LHACAHNPTG YFDMAYQGF
Pig (mit.) EYL SGTG SWGNH LHACAHNPTG FFDMAYQGF
Rat (mit.) EYL SGTG SGGNH LHACAHNPTG FFDMAYQGF
Chicken (cyt.) EYL GGTG TWENH LHACAHNPTG FFDSAYQGF
Pig (cyt.) EYL GGTG TWENH LHACAHNPTG FFDSAYQGF
E. coli NYL GGTG SWPNH FHGCCHNPTG LFDFAYQGF
Isoenzyme
Source 258 266 292 360 38 6
* * * * *
Human (mit.) QSYAKN ERV IRP MFC GRI
Chicken (mit.) QSYAKN ERA IRP MFC GRI
Pig (mit.) QSYAKN ERV IRP MFC GRI
Rat (mit.) QSYAKN ERV IRP MFC GRI
Chicken (cyt.) QSFSKN ERV VRT MFS GRI
Pig (cyt.) QSFSKN ERV VRV MFS GRI
E. coli SSYSKN ERV IRA DFS GRV
* Corresponds to the numbered residue, the residues are numbered according to the sequence 
for cytsolic pig AAT.
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Table 1.2. The Schiff’s base forming regions of several AAT isozymes.
Isoenzyme 
Source
Amino acid sequence 1
E. coli
Chicken (mitochondrial) 
Turkey (mitochondrial) 
Pig (mitochondrial)
Rat (mitochondrial) 
Human (mitochondrial) 
Chicken (cytosolic)
Pig (cytosolic)
I V A S S Y S K N F G L Y
V L S Q S Y A K N M G L Y
V L S Q S Y A K N M G L Y
C L C Q S Y A K N M G L Y
C L C Q S Y A K N M G L Y
C L C Q S Y A K N M G L Y
F C A Q S P S K N F G L Y
F C A Q S F S K N F G L Y
i
1.2.2 Decarboxylation
Specific a-decarboxylases are known for more than ten amino acids. For example 
glutamate, histidine, tyrosine, lysine, ornithine, arginine, methionine, valine, DOPA and 
phenylalanine decarboxylase. In each case the a-carboxyl group is cleaved to give 
CO2 and an amine as the products (Scheme 1.7). All of the above decarboxylases 
require PLP as a coenzyme. (For the physiological roles of the decarboxylase 
enzymes see section 1.1).
15
Enz— Enz
NH
RH-"
PLP-Holoenzyme POPO
CH
H
H
H A
Enz— B: H
H ^  =
R R
NHc
PO
CH
PLP-Holoenzyme
Scheme 1.7. Mechanism of decarboxylation.
However only one ^-decarboxylase is known. Aspartate p-decarboxylase catalyses the 
a-decarboxylation of amlnomalonic acid^ and the p-decarboxylatlon of (2S)-aspartic 
acid to give (2S)-alanine and carbon dioxide.®® Enzymes also exist which catalyse the 
condensation of an amino acid with an electrophile and subsequent decarboxylation of 
the product. Almost all of these enzymes require PLP as a coenzyme. Two exceptions 
are Lactobacillus histidine decarboxylase"*®’^^  and E. coll S-adenosylmethionine 
decarboxylase,®’^ ® as these require pyruvate as a prosthetic group.
;
All of the a-amino acid decarboxylases studied to date, except two, show retention of 
stereochemistry at 0®. These include glutamate,^® "*® lysine,"*^ "*® tryptophan,®®-®* 
tyrosine,®® phenylalanine,®® histidine,®* methyldopa,®® a-methylglutamic acid,"*®
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ornithine/®*®®'^® and arginine/^'^^'^^ The two decarboxylases which show Inversion of 
configuration are wheat®® and bacterial®  ^ meso-a.co-diaminopimeiic acid f
decarboxylases which decarboxylate at the (R)-amino acid centre of the substrate (15) 
to give (2S)-lysine (16) with inversion of stereochemistry at C“, Scheme 1.8.
jecarooxyiase, i  ^ i ^
— --------------------- H H
COgH  ^ COgH COgH H'
(15) (16)
Scheme 1,6. The decarboxylation of a,co-diaminoplmelic acid (15).
Meso-a,m-diaminopimelic acid decarboxylase is the only known a-amino acid 
decarboxylase which acts on a D-amino acid. However only the (2R,6S)-isomer is a 
substrate for the enzyme from Bacillus sphaericus, the (2R,6R)- and (2S,6S)-isomers 
are not substrates or inhibitors.®  ^ There is evidence that the conformation of the 
coenzyme-substrate complex in L-specific decarboxylases is controlled by binding of 
distal groups in the extended side chain of the substrates.®® For the decarboxylases 
studied it has been shown that PLP binds to the protein in the presence of the 
substrate with the C-4'-sHace of the coenzyme exposed to the solvent.
It was reported in the literature®"^  that aminomalonate decarboxylase [an activity of 
serine hydroxymethyltransferase (SHMT)] catalysed the non-stereospecific 
decarboxylation of aminomalonate. We have shown®® that the glycine formed in the 
earlier experiments®^ was racemic, however the racemic nature of the glycine was not 
due the enzyme catalysed reaction but due to a non-enzymic exchange of the a - 
hydrogen which occurred prior to the decarboxylation reaction (see Chapter 3 for more 
details).
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In addition to the a-decarboxylation of aminomalonic acid^ and the p-decarboxylation 
of (2S)-aspartic acid,® the enzyme aspartate p-decarboxylase also catalyses the 
desulphination of (2S)-cysteine sulphinate, p-elimination of {2S)-3-chloroalanine, and 
a variety of transaminations between several (2S)-amino acids and a-ketoglutarate, 
pyruvate and oxaloacetate.®® The decarboxylation of aminomalonate occurs with 
retention of configuration.^®-®^ However the stereochemical course of p- 
decarboxylation of (2S)-aspartate occurred with inversion of configuration at C-3,®® A 
single base mechanism seems unlikely due to the fact that when the enzyme was 
incubated with C“ -tritiated (2S)-aspartic acid 17% of the from the a  position of 
aspartate was incorporated at the C-4' pro-S position of the PMP, whereas less than 
1% was found in the alanine, A two base mechanism® has now been proposed for the 
enzyme (Figure 1.1). The two base mechanism would explain the stereochemistry of 
the aminomalonate decarboxylation, and the unusual observation that aspartate-p- 
decarboxylase, modified by the use of N-methyl-PLP, can decarboxylate (2R)- 
aspartate at a significant rate to give (2S)-alanine.^®
BH
PO
HN +
Figure 1.1. The two base mechanism for aspartate p- 
decartx)xylase.
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1.3 Mechanism-based inhibitors of PLP enzymes
Many mechanism-based or suicide inhibitors have been prepared and tested for 
specific time-dependent inhibition of PLP-dependent enzymes. There has been a wide 
interest in such inactivators as potential drug candidates, because of the 
pharmacological and therapeutic utility of inhibiting specific PLP enzymes (Table 1.3), 
The suicide inhibitors are substrate analogues and as such are useful tools for 
investigating the mechanism of specific enzymes because they act at the active site of 
the enzyme.
Table 1.3. Some therapeutically important target enzymes dependent on PLP.
Enzyme Potential Effect
bacterial alanine racemase 
brain GABA transaminase 
mammalian ornithine decarbo^q^'lase 
mammalian DOPA decarboxylase
antibacterial 
antiepileptic 
antineoplastic 
ant ihypertensive
In general, enzymes that require PLP, catalyse some chemical change at the a-, p-, or 
y-carbon of the common a - or y-amino acids. In every case the role of the PLP moiety is 
to stabilise the carbanionic intermediates that develop during the catalytic process. The 
suicide inhibitors all have latent functional groups that become activated by their 
proximity to the site of an enzyme-generated carbanion. Such an intermediate can 
breakdown to yield a reactive species that may react with an active-site amino acid 
side chain, or with tightly bound PLP coenzyme. Each of these processes leads to the 
inactivation of the enzyme, in the first case the active site is blocked by an unreactive
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species and in the second the coenzyme is no longer available to bind to the substrate. i
Mechanism-based inactivating functional groups in substrates that inhibit PLP 
enzymes include, acetylenic, olefinic, p-halo substituents and other leaving groups, 
nitriles, aryl sulphoxides, dihydroaromatics and phosphonoamino a c id s .T h e  most 
common functional groups used for suicide inhibitors, and the mechanisms of 
inactivation are presented in the next three sections.
1.3.1 Transaminase inhibitors
In the catalysis of transamination reactions, there are two half-reactions for each 
complete catalytic cycle (see Section 1.2). In the first half-reaction catalysis proceeds 
through the substrate-PLP anion and the product a-imino acid-PMP enzyme complex 
(Scheme 1.5a, (11)). Both of these intermediates are species allowing for activation of 
latent functional groups in suicide substrates. Activation by net oxidation to the 
ketoacid equivalent is observed in both olefinic and acetylenic amino acid analogues.
The olefin analogues include vinyl glycine ( 1 7 ) , (E)-methoxy-vinyl glycine (18),^'* 
and p-methylene aspartate (19).^® The generally accepted inactivation mechanism is 
as outlined in Scheme 1.9.
NHg
COgH
(18)
The acetylenic analogues include the natural product (2S)-propargyl glycine,^ and the 
mechanism of inactivation is depicted in Scheme 1.10.
2 0
COgH
COgH
Enz-NHg
H
â ^COgH
NH.
(17)
HA^COc
PO
CH
Enz tNH
NHC
W r
PO
CH
wi
'=1
Enz-Lys-NH 
HOgC,
O
+
PLP
Enz-Lys-NH Enz-Lys-NH;
Scheme 1.9. The mechanism of inactivation of AAT by vinyigiycine (17).
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Enz EnzEnz
Enz
COo-
PO POPO
CHCHCH
Enz— B
Scheme 1.10. Mechanism of Inactivation of AAT by (2S)-propargylglycine.
Some of the more common types of inhibitor contain good leaving groups at QP. These 
compounds are able to undergo facile elimination to generate olefinic intermediates. 
These include, 3-chloro-(2S)-alanine (2 0 )^ *^^ ® an inhibitor of alanine 
aminotransferase, and {2S)-serine O-sulphate (2 1 ) ^  which inhibits aspartate 
aminotransferase and glutamate decarboxylase (see Chapter 2 for more details).
NHg NHg
COgH
(20)
COgH
(21)
2 2
...I
The accepted mechanism had been that the killing species was the aminoacryi-PLP 
intermediate, which undergoes a putative Michael reaction with an enzymic 
nucleophile. Although a Michael reaction does occur with some enzymes (aspartate-p- 
decarboxylase, serine hydroxymethyl-transferase(SHMT)), Metzier and coworkers® 
have shown that the inactivation of aspartate aminotransferase is not due to the 
occurrence of a Michael reaction. Bright and coworkers®  ^ have used the nitro group of
3-nitroalanine as an inactivator of aspartate aminotransferase and alanine 
aminotransferase.® The nitroalanine undergoes a-proton abstraction followed by p- 
nitro elimination. Alanine aminotransferase is also inhibited by cyc/oserine (5),® while 
aspartate aminotransferase is inhibited to varying extents by a - and y-cyciog\u\am\c 
acids.®"^ '®® a-Cyc/oglutamate®" '^®® (Scheme 1.11, (22)) is believed to acylate an active- 
site bound nucleophile to give a stable inactivated complex. y-Cyc/ogiutamate is 
thought to form an oxime of p-aminooxyglutamate with PLP by ring opening of the 
isoxazolidone ring. Various analogues of GABA inhibit GABA-transaminase. These 
include p-chloro, 3-phenyl, y-acetylenic and y-vlnyi GABA and ethanolamine O  
sulphate.® Finally the mammalian GABA transaminase is inhibited by the naturally 
occurring product gabaculine (23) via an interesting aromatisation mechanism to give 
an aromatic PMP adduct®®*®® (Scheme 1.12, (24)).
1
1
23
O -N
—EnzHOgC
+ PLP
O NHg O— N —Enz
Scheme 1.11. Mechanism of inactivation of AAT by a-cyc/oglutamate.
,COp-EnzCOgH
GABA-T
PLP
NHNH
(23)
POPO
CHCH.
(24)
Scheme 1.12. Mechanism of inactivation of GABA-T by gabaculine (23).
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1.3.2 Decarboxylase Inhibitors
These inhibitors are particularly important because of the role of the decarboxylases in 
the biosynthesis of many pharmacologically active amines (see section 1.1). Many 
examples with alkynyl, olefinic, and mono-, di-, or trihalomethyl groups have been 
reported. Decarboxylases bind C-2 alkylated a-amino acids in the active-site pocket 
and the decarboxylation step occurs as for the natural substrate. When the alkyl groups 
are a-ethynyl, a-vinyl, a-fluoromethyl, and a,a-difluoromethyl amino acids, loss of CO2 
generates a reactive intermediate which can react with an active-site nucleophile or 
remain bound to the PLP and so these compounds act as suicide substrates. The 
inactivation of DOPA decarboxylase by a-vinyl DOPA (25)®®*®^  and a,a-difluoromethy! 
DOPA (26)^  are shown in Scheme 1.13.
5-Hexyne-1,4-diamine (2  7 ) , a putrescine analogue, inactivates ornithine 
decarboxylase;®® in view of the microscopic reversibility principle, presumably via a 
similar mechanism to that for a-ethynylornithine.
(27)
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Enz
a)
COgH
(25)
b)
NHg
FgHG 
COgH 
(26)
OH
OH
PO
I  A
inactivation
FgHC>^
inactivation
Scheme 1.13. The Inactivation of DORA decarboxylase by a) a-vlnyl DORA (25) and b) a,a-
dlfluoromethyl DORA (26).
1
Inhibitors of ornithine decarboxylase include p.y-dehydroornithine (28),^  a -  
fluoromethylputrescine (29)® and a,a-difiuoromethylornithine (30).® Haiomethyl and 
olefinic groups have been incorporated into a single molecule by Bey and collègues.®® 
a-Fluoromethyldehydroornithine (31) and a,a-difluoromethyldehydroputrescine (32) 
have been tested as ornithine decarboxylase inhibitors. The dehydroornithine is more 
effective as an inhibitor than the saturated analogues and its Kj is 30 times lower.
1
4'%
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CO2H H CO2H
(28) (29) (30)
NH. NH.
NH. NHFCH
(32)
NH2 NHg NHg
%
1.3.3 Other PLP inhibitors
Other types of PLP Inhibitors include those for racemases, and for enzymes that f
catalyse reactions at the p-carbon.
PLP-dependent racemase enzymes, in particular alanine and glutamate racemase are #
important because they are involved in the biosynthetic pathway leading to 
peptidoglycan (see section 1 ,1). Several suicide substrates, both natural and synthetic 
are known, including p-substituted alanines®^®® (for alanine racemase) and 
phosphoalanine (for gram-positive alanine racemase only). In the latter case the 
inactivation mechanism is thought to involve the initial reversible formation of a weak 
complex (competitive inhibition) which slowly isomerises to a stoichiometric complex 
which then dissociates extremely slowly. The complex is not reducible by 
borohydride and shows a non-perturbed fluorescence spectrum for the bound 
coenzyme.
Enzymes that catalyse a,p-elimination are not susceptible to inhibition initiated by 
many of the typical suicide substrates containing halogens, acetylenic or olefinic 
functionalities. However, occasionally an abortive reaction occurs with a physiological
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substrate. For example, threonine deaminase is very slowly inactivated by (2S)-serine 
(and also by 3-choroalanine^°^) about once in every 10"^  turnovers.^However  
(2S,3R)-threonine does not cause inactivation, presumably because the intermediate 
is less reactive to Michael addition or enamine condensation (which gives the inhibited 
Schnackerz-type p r o d u c t (S c h e m e  1,14).
£  coli tryptophanase is irreversibly inactivated by trifluoroalanine.^°® The hypothesis is 
that the difluoroaminoacrylyl-PLP-aldimine adduct is more susceptible to nucleophilic 
attack at C-3 by an enzyme bound base than hydrolysis at the aldimine carbon atom.
The enzyme p-cystathionase is irreversibly inactivated by the fungal toxin 
rhizobiotoxin *^^® (Scheme 1.15, (33)). The alkoxyvinylglyclne analogue, rhizobiotoxin, 
may undergo initial C“-H abstraction, and then an addition and elimination sequence, 
similar to that for (E)-methoxyvinylglycine with aspartate transaminase, p- j
Cystathionase is also irreversibly inhibited by trifluoroalanine.^®^ Tryptophan synthase 
is also irreversibly inhibited by trifluoroalanine, trichloro- and dichloroalanine.^®^ £  coll 
tryptophan synthase also reacts with cyanoglycine, causing reversible inactivation on |
dialysis or gel-fiitration. The inactivated coenzyme is presumed to be a stable a- 
aminomalomononitrile anion.
âI
H-N Enz
HJ
+
H^N-
-HX
PO PO
CHCH
Enz
Enz NH
Enz— NH
PO PO
CH CH
COpH
Enz
OHPO PO
CH CH
•Enz
Schnackerz adduct
Scheme 1.14. Possible mechanisms for the inactivation of enzymes that catalyse a,p-
elimination reactions.
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1) p"Cystathionase
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+ PLP 
(33)
Enz— Nu
Enz— Nu
inactive enzyme
J
Scheme 1.15. The inactivation of p-cystathionase by rhizobiotoxin.
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1.4 Research objectives
The aim of our work was to clarify two reports in the literature. These reports were 
inconsistent with the current models for reactions catalysed by PLP dependent 
enzymes.
The first report^^ concerned the inactivation of GAD by (2S)-serine O-sulphate (21 ). 
The mechanism of which did not involve the loss of CO2 from the serine O-sulphate 
(Chapter 2).
NH2
COgH
(21)
The second^ reported that the decarboxylation of 2-aminomalonic acid (34) catalysed 
by SHMT appeared to be non-stereospecific (Chapter 3).
NHo
COgH 
(34)
31 •f
CHAPTER TWO
GLUTAMATE DECARBOXYLASE
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2.0 Glutamate Decarboxylase
Glutamate decarboxylase (GAD) (EC 4.1.1,15) is one of the most widely studied of the 
PLP-dependent decarboxylases. The enzyme catalyses the conversion of (2S)- 
glutamic acid to y-aminobutyric acid (GABA) (35) (Scheme 2.1).
(35)
NHg NHg
COgH H
Scheme 2.1. The physiological reaction catalysed by glutamate 
decait>oxylase (GAD).
2.1 Properties and Structure of GAD
2.1.1 Properties and Structure of mammalian GAD
Mammalian GAD is of considerable physiological importance. The enzyme has been 
isolated from several species, Including mouse,rat,^^^ h u m a n a n d  p i g . T h e  
most common source of mammalian GAD is from brain tissue. The enzyme has also 
been cloned from fruit-fly  ^ and cat.^^ ®
The mouse enzyme was found to be unstable with respect to the conditions used for 
the purification processes that were originally developed. Stabilisation of the enzyme 
preparation with PLP and aminoethylisothiuronium bromide (AET) enabled the 
completion of a 200-fold purification process in 1966.^^® In 1973 a 700-fold purification 
of the mouse enzyme was achieved using a combination of ammonium sulphate $
fractionation, size exclusion, calcium phosphate gel and DEAE-Sephadex 
chromatography.^^® The pure mouse GAD is stable for 1-2 hours at 30-40 °C, but at
32
higher temperatures a rapid loss of activity occurs. 117
1
The determination of the molecular weight of the various mammalian glutamate 
decarboxylases has been a contentious issue as there are multiple forms of the 
enzyme in several species including rat^ ®^ and pig.^ ^® The apparent molecular weight 
of native rat brain GAD has been determined to be 110 000 ±  10 000 Daltons by size 
exclusion chromatography. SDS-polyacrylamide gel electrophoresis of the purified 
enzyme indicated a subunit molecular weight of 60 000 D a l t o n s a n d  SDS- 
polyacrylamide gel electrophoresis of the purified enzyme after cross linking with 
dimethylsuberimidate indicated a dimeric subunit structure. ^ ®^ The omission of #
mercaptoethanol from the SDS cocktail enabled the molecular weight to be 
determined using SDS-polyacrylamide gel electrophoresis under non reducing 
conditions. The molecular weight of the enzyme determined in this manner was found 
to be 120 000 Daltons. The results of all three studies suggested that the enzyme is 
dimeric. The results from parallel studies indicated that human and pig brain GAD are 
also dimeric. Human brain GAD has a subunit molecular weight of 67 000 ±  5 000 
Daltons.^Pig brain GAD has a subunit molecular weight of 60 000 Daltons, and the 
native enzyme molecular weight is 120 000 Daltons.
Due to the problems encountered during the purification of the mammalian enzymes, I
the amount of kinetic data available is limited. The Michaelis constant, Km, for the 
natural substrate, (2S)-glutamic acid, has been determined for the three forms of pig 
brain GAD.^^^ The relative rates of the abortive décarboxylation-transamination 
reaction (see section 2 .1 .6 ) leading to the formation of inactive enzyme catalysed by 
the three forms of porcine brain GAD have also been determined. The value of V^ax 
for the three forms of pig brain GAD have been determined to be 0.337, 0.73 and 0.7
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unit/mg for the a-, (3- and 7 -forms respectively. The effect of pH on the value of Vmax of 
the three forms of enzyme was found to be quite similar. In each case the highest 
relative value occurred at pH 6.2-6.5. The rates of the abortive decarboxylation- 
transamination reaction of the three forms of porcine enzyme with the pseudo substrate 
(2S)-aspartic acid have also been studied.^^®
2.1.2 Properties and Structure of plant GAD
GAD activity has been detected in various plants including s q u a s h , t e a  leaves,^®® 
potato tubers,^®® barley/®^ radish leaves,^®® wheat^®® and lupin s e e d s .H o w e v e r ,  
there are only a few reports of the purification of the enzyme from higher plants, for 
example, from radish,^®® w h e a t a n d  lupin seeds.^®® Efficient purification has not 
been achieved largely due to instability and the resulting loss of enzyme activity during |
the purification process. Prior to 1985 the only report of homogeneous GAD from a 
higher plant, a 2 2 0 -fold purification in 10% yield from squash tissue came from the 
laboratory of Melius.^®'* However the subunit structure and the PLP content of the 
enzyme were not determined. At that time the first molecular weight for a plant GAD 
was determined, 310 000 Daltons for barley root GAD. ^ ®® The molecular weight of the 
potato tuber isozyme^®® was found to be 91 000  Daltons where SDS-polyacrylamide 
gel electrophoresis gave a single band of 43 000 Daltons, consistent with a dimeric 
structure. More recent work with squash GAD^ ®® indicates that the enzyme is 
homohexameric with subunits of 58 000 Daltons. Apparently, at pH 7.2, the enzyme 
dissociates to active dimers which appear to be less stable than the hexamer isolated 
at pH 5.8.
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2.1.3 Properties and Structure of Bacterial GAD
35
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The discovery of the bacterial protein enabled the first detailed study of the enzyme 4
m e c h a n i s m G A D  has been isolated from E  co//^ ®® and Clostridium perfringens}^ f
The Clostridium perfringens enzyme has a H  of 290 000 Daltons, an unknown subunit J
structure and contains 2 molecules of PLP. The E  coli enzyme has been extensively 
studied and is a hexameric species of H  300 000 Daltons which is readily purified, 
and contains one molecule of PLP per subunit, ft shows a high degree of stability and 
has a relatively high turnover number (kcat ~ 1-875 x 10® s'^  at pH 4.6),^®  ^ In several 
cases the mechanistic and stereochemical features of some suicide inactivation 
processes have been difficult to rationalise within the context of the known properties 
of pyridoxai dependent systems. In certain cases bonds connected to C“ were 
apparently cleaved on the wrong and unexpected 4’- re-face of the coenzyme.®® Some :i
of these observations have now been rationalised (see section 2.1.7).
?
2.1.4 Glutamate Decarboxylase as a chemotherapeutic target
The mammalian brain enzyme is directly responsible for the biosynthesis of GABA in 
the GABA-ergic system (section 1.1).^®® GABA, the product of the decarboxylase 
reaction is a major neurotransmitter and there is much evidence to suggest that high 
cerebral concentrations prevent convulsions.® Reduced levels of GABA not only trigger 
convulsive attacks but are also associated with a variety of maladies including
Parkinson’s Disease, Alzheimer's Disease and Huntington’s Chorea.
»■
2.1.5 Substrate and Reaction Specificity
{2S)-Glutamic acid is the only naturally occurring amino acid that Is decarboxylated by 
GAD at a significant rate. The Michaelis constant (Km) for E  coli GAD was determined 
to be 0.5-1.0 mM at pH 4.6 by Shukuya and Schwert in 1960.^®®
Several pseudo substrates, for example glutaric acid, (2 S)-aspartic acid, a-methyl- 
(2RS)-glutamic acid and (2S)-serine O-sulphate, have been incubated with the 
enzyme. They were all found to inhibit the enzyme. (2S)-Aspartic acid and a-methyl- 
(2RS)-aspartic acid were decarboxylated but at 10® times and 10"^  times more slowly 
than the natural substrate. GAD is substrate and reaction specific unlike SHMT (see 
Chapter 3).
2.1.6 Mechanistic features of decarboxylation
During decarboxylation there are two competing reactions that occur (Scheme 2.2). 
Following the transaldimination of the internal aldimine by the enzyme-bound 
substrate, the protein orients the substrate so that the C^-COgH bond is orthogonal to 
the plane of the pyridlnium ring, the optimal geometry for the delocalisation of the 
developing negative charge. "^*® Loss of the carboxylate group leads to the formation of 
the quinoid intermediate (36), which is reprotonated at C® on the 4’-s/-face of the 
coenzyme to give the corresponding amine (37) and PLP (Scheme 2.2, a). The 
second reaction occurs when the quinoid (36) is occasionally reprotonated a tC -4 ’, 
GAD is one of the few enzymes that catalyse this unusual r e a c t i o n . T h i s  second 
reaction leads to the formation of an aldehyde (38) and PMP (1 2) (Scheme 2.2, b). 
The second reaction pathway is called an abortive decarboxylative-transamination.
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The abortive reaction results in the inactivation of the enzyme as the PLP is converted 
to PMP. T i l l e y h a s  studied the pH dependence of the abortive reaction and found 
that at pH 4.6 approximately 1 in every 30 000 turnovers leads to an abortive reaction.
It is known that when substrate analogues, for example, (2S)-aspartic acid, are 
decarboxylated, pyridoxamine phosphate (PMP) (12) is produced as a result of the
abortive décarboxylation-transamination reaction (see above). The process leads to 1
■f
inactivation of the enzyme. I
The mechanism of inactivation by (2S)-serine O-sulphate (2 1 ) is more complex and is 
discussed in detail below (Section 2.2). •Ï
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Scheme 2 .2 . The mechanism of GAD showing a) the normal reaction pathway and b) the
abortive reaction pathway.
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2.1.7 Stereochemical Studies
The decarboxylation of {2S)-g!utamic acid has been shown’^ ®'"^ ®*^ '^  ^ to occur with 
retention of configuration at C“ Indeed this stereochemical outcome has been noted :f
for the reactions of most other decarboxylases that have been studied.
One exception is a,m-diaminopimelic acid (16) decarboxylase which decarboxylates 
the (2R)-centre of the substrate with an inversion of configuration at C®. The inversion 
can be rationalised by the following hypothesis. In the external aldimine form of the 
enzyme the Schiff's base binds to the protein with the C-4'-s/ face exposed to the 
solvent and the active-site lysine. The (2R)-amino acid a-centre of a,o)-diaminopimelic 
acid binds to the active site of the enzyme with the C^-H and the side chain occupying 
similar positions to those in (2S)-amino acid decarboxylases (Scheme 2.3, (39)). This 
binding mode disposes the a-carboxylate group on the C-4'-re-face of the coenzyme 
(Scheme 2,3). The a-carboxylate group Is perpendicular to the 7c-electron system and 
so decarboxylation is stereoelectronlcally assisted. "^*® The resulting ketimine (40) is 
identical to that produced by (2S)-amino acid decarboxylation and can be protonated 
from the C-4'-s/face of the coenzyme in the normal fashion. Hence (2S)-lysine (42) is 
formed via a mechanism involving decarboxylation with inversion at 0 - 6  of the 
substrate (15).
ÎS.ÎÎ.;
(43)
COgH
The bacterial enzyme is inhibited by the {4R)-enantiomer^'^ while the rat brain enzyme 
is inhibited by the (4S)-enantiomerJ'^® In the physiological reaction both enzymes 
catalyse decarboxylation In a retention mode and thus inhibition must be initiated via 
different mechanisms. Tilley et have carried out stereochemical investigations to 
define the conformations of substrates and inhibitors and hence, the positions of the
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1 COoHCOpH
(2S)-amino acid 
-CO2
COpH Y CH3 reprotonated on 
^ C-4'-s/-face of
(4 1 ) coenzyme (4 ^)
Scheme 2.3. The decarboxylation of a,o)-diaminopimeiic acid (15).
4-Aminohex-5-ynoic acid (acetyienic GABA) (43) inactivates both E. coli and
mammalian
-I'- ''".'"I
distal binding groups at the active site of GAD from E  coli.
The stereospecificity of the protonation of the quinoid intermediate (36) (in the abortive 
transamination reaction) at C-4’ was determined using the natural substrate, (2S)- |
glutamic acid. An earlier study had employed racemic 2-methyiglutamic acid. This 
substrate was unsuitable for use in simple stereochemical correlations in view of its 
very low V^ax value and racemic nature. In Tilley’s work [4’-^H]-PLP was incubated t!
with the enzyme in the presence of (2S)-glutamic acid. The abortive transamination 
product, [4’-®H]-PMP, was separated and treated with alkaline phosphatase to give 4'- 
tritiated pyridoxamine. The absolute configuration at 0 -4 ’ was determined by i
incubation with apoaspartate aminotransferase which is known to exchange the 4'-pro- 
S hydrogen of pyridoxamine with the solvent. None of the tritium was exchanged while #
Î50% of the label in a synthetic racemic sample was lost to the solvent. The retention of
The stereospecificity and fidelity of the decarboxylation and reprotonation at 0 “ of the 
quinoid intermediate derived from a “loose-fit” substrate, (2S)-aspartic acid, was 
investigated.^"^® The results indicated that the decarboxylation reaction occurred 
stereospecifically and with retention of configuration at C“ of the substrate. The high 
chiral integrity of the decarboxylation products is in keeping with the notion that either a 
single acid or two acids operate on the 4’-s/-face of the coenzyme. This result mirrors 
those obtained for methionine decarboxylase.
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the tritium indicated that the sample was (4’R)-[4’-®H]-PMP and that a proton is 
transferred to the 4’-s/-face of the coenzyme during the transamination catalysed by the 
decarboxylase. This result is in accord with the results obtained for methionine 
decarboxylase^®® and aspartate aminotransferase.^®’^ ^
.. . . . . .  . I
The regeneration of active holoenzyme from apoenzyme and N"^-(2-phosphoethyi)- 
pyridoxamine 5' phosphate (44) had not been reported for E. coli GAD, but it had been 
demonstrated for the porcine brain enzyme.
OP
NH
OHPO
CH.
H
N “(2-phosphoethyl)-pyridoxamine 5'-phosphate
(44)
Tilley et prepared N'^ ’-(2-phosphoethyl)-pyridoxamine 5’-phosphate (44) by 
reduction with NaBH4 of the imine formed by the condensation of PLP and 
ethanolamine phosphate. The N' ’^-(2-phosphoethyl)"pyridoxamine 5' phosphate (44) 
was incubated with £  coli apoGAD and active holoenzyme was regenerated. In order 
to study the mechanism of the regeneration, the 0-2 deuteriated isotopomers of (44) 
were prepared and were incubated with the apoenzyme. Incubation of (2S)-[2-^H]-N'*'- 
(2-phosphoethyl)-pyrldoxamine 5’-phosphate with E. coli apoGAD gave reactivation 
rates identical to those obtained for the unlabelled compound. The (2R)-antipode gave 
rates close to those obtained for the dideuteriated compound which revealed that the 
enzyme removes the 2-pro-R hydrogen from the phosphoethyl group of N" '^-(2- 
phosphoethyl)-pyridoxamine 5’-phosphate during the reactivation process.
The collective results of Tilley's work indicate that enzyme catalysed proton transfers 
occur on the 4 ’-s/-face of the coenzyme at C-4’ and 0 “ and that the distal binding 
groups of substrates and analogues occupy similar positions on the 3'-0H side of the 
coenzyme. As a result of these findings it is postulated that the unexpected reactions
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observed for GAD with the suicide substrates do not result from alternative binding
modes, but may be promoted by the enhanced acidity of the methylene protons in the #1
derived aldimines due to the flanking multiply bonded moieties, and in actual fact, the |
enzymes may not provide a base on the 4’- re-face of the coenzyme at all.
A recent review by Smith et compares PLP dependent decarboxylases and ^
transaminases at a molecular level. The amount of stereochemical, mechanistic and 
structural information available for the decarboxylases at the start of the work was very 
limited. However the active-site peptide sequences for some decarboxylases were 
known, and the stereochemical courses of decarboxylation had been reported for 
some system s.^ -F rom  these studies it was evident that, in general, PLP dependent 
decarboxylases catalyse the decarboxylation of (2S)-amino acid substrates with 
retention of configuration at C“. Transaminases appear to catalyse proton transfers on 
the C-4'-s/ face of the coenzyme only. Other PLP dependent enzymes also utilise the 0- 
4'-s/ face of the coenzyme, including SHMT. (2S)-Methionine decarboxylase from 
Dryopteris fHix-mas^^  ^ and Streptomyces sp.^^ were used for chemical studies due to 
their wide substrate structure tolerance and stabilities. It was demonstrated that both 
enzymes catalysed the decarboxylation of methionine with retention of configuration at 
Qtt 150,153,154 -|-p@ enzymes also decarboxylated other straight chain and branched 
chain hydrophobic amino acids with retention of configuration even at extreme pH. For 
the fern enzyme, Stevenson et al. demonstrated that the coenzyme was protonated 
from the C-4’-s/-face of the coenzyme during an essentially irreversible abortive 
decarboxylatlve reaction .S tevenson et al. carried out stereochemical and kinetic 
analysis of the fern enzyme, and observed that a proton was transferred to the C-4’-sA 
face of the coenzyme during the abortive transamination.^®® In order to determine the 
identity of the proton donor for the C-4’ and of the quinoid intermediate, Stevenson
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et al. determined the deuterium solvent isotope effects on V^ax and V/K for (2S)- 
methionine, valine and leucine over the pH range 4.0-7.5. The results indicated that 
the proton donors for C“ and C-4' of the quinoid intermediate are distinct. For the fern 
enzyme, Akhtar et al. established that the proton donor for the quinoid intermediate at 
C“ is probably the imidazolium side chain of a histidine residue, and the proton donor 
at C-4’ is probably the e-ammonium group of the active-site lysine residue. Tilley 
performed a similar stereochemical and kinetic analysis with E. coll GAD using (2S)- 
glutamic acid as the substrate. A proton was transferred to the C-4'-s/ face of the 
coenzyme during the abortive transamination reaction In the same way as for the fern 
enzyme.^®® Strausbauch^®® had previously established that borohydride reduction of 
the holoenzyme gave a pyridoxy I lysine peptide, and so it appeared that the proton 
donor was the e-ammonium group of the lysine residue. For the E. coli enzyme, 4
T illeydem onstrated  that the large isotope effect of 5.0 observed for was due, in 
part, to partially rate limiting protonatibn of the quinoid intermediate at C“ . These 
findings were in accord with the operation of a monoprotic conjugate acid. Thus it 
appeared that for fern methionine decarboxylase and E. coli GAD, the lysyl e- 
ammonium and the histidyl imidazolium groups are disposed on the C-4'-s/-face of the 
coenzyme. It appears that these conjugate acids are responsible for the specific 
protonation of the quinoid intermediate at C-4’ and C “, respectively.
2.1.8 Active-site structures of PLP-dependent decarboxylases
In view of the similarities discussed above, the reported active-site peptide sequences 
for the PLP-dependent decarboxylases were examined and aligned with regions of the 
active-site sequence of chicken mitochondrial AAT. Each residue deemed to be 
functionally important was completely conserved (Table 2.1).
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Tablé 2.1. Active-site residues of several AAT Isozymes
Tfie decarboxylases were examined In tfie light of the findings for the AAT's, in many 
the equivalent residue to AAT Ser255 was a Ser, Asn, or Thr residue, all of which are 
hydrogen bond donors (Table 2.2). In particular the active-site tetrapeptides for the 
decarboxylases were well conserved, and contained the sequence -S(N,T)-X-H-K-, 
unless there were rationalisable mechanistic reasons for why they should not be 
conserved.
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Isoenzyme Amino acid sequence
Source
E- coli^O I V A S S Y S K N F G L Y
Chicken (mitochondrial) V L S Q S Y  A K N M G L Y
Turkey (mitochondrial) V L S Q S Y A K N M G L Y  1
Pig (mitochondrial) 158 C L C Q S Y A K N M G L Y
Rat (mitochondrial) 159 C L C Q S Y A K N M G L Y
Human (mitochondrial)29 C L C Q S Y A K N M G L Y
Chicken (cytosolic) i^ ® F C A Q S F S K N F G L Y
Pig (cytosolic) 151 F C A Q S F S K N F G L Y
Analysis of the regions of AAT which interact with the coenzyme indicated that a 
tetrapeptide unit -S-X-X-K- contained tvyo completely conserved residues, a serine f
(S255) which forms a side-chain hydrogen bond with the 5’-phosphate ester group of 
PLP, and the active-site lysine (K258) which forms the Internal aldimine with the |
coenzyme and also serves to shuttle protons between C® and C-4’.
J
.■:4_ ■ ■ .0-—1-— -Liv.-::/ iv- - i'- - ...... .. «...
Table 2.2. Schiff's base forming region of PLP-dependent decarboxylase enzymes.
Enzyme Source Amino acid residues
Arginine {E. coli)^^^ A T H S T H K L L N A L
Glutamate (E. coli)^^^ S I S A S G H K F
Histidine
{Morganella morganii)^^^ S I G V S G H K M I G S P
Lysine (E. coii)i54 Y E T E S T H K L L A A F
Lysine {Hafnia alvei)i55 Y E T Q S T H K L L A A F
Ornithine (E. coli)^^^ V H K Q Q A G Q
Dopa {Drosophila) 15? S F N F N P H K W M L V N
Dopa (Pig) 158 N F N P H K w
Glutamate (Feline) H5 S V T W N P H K M M G V L
Glycine (Chicken) 159 V S H L N L H K T F C I P
SHMT (E. coIi)l'^ 5 V V T T T T H K T L A G P
SHMT (Rabbit, Cyt. ) l^ i V V T T T T H K T L R G C
SHMT (Rabbit, mit.) 1^ 1 V V T T T T H K T L R
2.1.9 The optical properties of bacterial glutamate decarboxylase
The electronic absorption spectrum of E. coli glutamate decarboxylase has been 
widely studied. The solution was found to be yellow in acid solution, but colourless at 
neutral pH values. These properties are similar to those exhibited by several PLP 
enzymes and by Schiff’s bases which are formed from PLP and peptides and some 
proteins.
The catalytically active form of the enzyme existing in solution at pH <5.0 has a spectral 
absorption maximum at 415 nm. As the pH is increased to 6.5, the intensity of the peak
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In the presence of an excess of substrate, {2S)-glutamic acid, at pH 4.6 a spectral 
change was observed. There is an instantaneous reduction of absorbance at 420 nm 
and an increase at 330 nm. As the substrate is exhausted, the spectrum returns to the 
original position within several seconds. Shukuya and Schwert^®® made no attempt to 
suggest the nature of the species responsible for the absorption at 340 nm. In an 
attempt to discover the nature of the intermediates responsible for the above spectral
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at 415 nm reduces and a new absorption maximum appears at pH 340 nm. The form of 
the enzyme exhibiting the absorption maximum at 340 nm is no longer active. The 
spectra at pH 5.1 and 4.6 are experimentally identical, so it is presumed that the 
structure which gives rise to the changes in the spectrum is fully protonated at pH 5.1.
Anderson and C h a n g c o n c lu d e d , on the basis of experiments with sodium 
borohydride, that the absorption maximum at 415 nm arises from the formation of a 
Schiff’s base between the PLP and an active-site lysine residue (in common with many 
other PLP dependent enzymes), in which the hydrogen of the phenolic hydroxyl of 
pyridoxai is hydrogen bonded to the imino nitrogen of the Schiff base. The identity of 
the structure responsible for the absorption at 340 nm has not been clearly 
established. However there are a number of compounds formally derived from Schiff 
bases of PLP and pyridoxai in which various groups or molecules are added across |
the imine double bond resulting in saturation. These include the reduced aldimines, |
the addition compounds with cysteine, histidine, 3,4-dihydroxyphenylalanine and I
related substances, and aminoacetal and carbinolamine derivatives. ^  These 
materials characteristically show an absorption band around 330 nm in neutral 
solution. Christensen^^® suggests that the unknown compound is more likely to be a 
zwitterionic aldimine, where the phenolic hydroxyl group has lost its proton and the 
pyridlnium nitrogen has remained protonated.
shifts, Sukhareva and Torchinsky^®"* employed a-methyl glutamate, a substrate 
analogue that acts as an inhibitor of the enzymeJ®^ The changes observed in the 
spectrum were similar to those that had been seen to occur with the natural substrate 
but at a considerably slower rate. The drop in absorbance at 415 nm required at least 
30 min for completion, but was not reversed on further incubation. The enzyme- 
quasisubstrate complex was found to be inactive. Activity was not restored with the 
addition of (2S)-glutamic acid, but the addition of PLP (4 mM) restored the activity to 
73% of the initial value. During later work with a-methyl glutamate, Sukhareva and 
Braunstein^"*  ^ detected and characterised successive intermediate forms and 
complexes of the enzyme which were formed during the inactivation reaction. The 
inactive form with the absorption maximum at 340 nm was found to be the PMP form of 
the enzyme. However the identities of the short-lived intermediates with an absorption 
maximum at 340 nm, for both the natural substrate and a-methyl glutamate, were not 
discovered.
2.1.10 Pyrroloquinolfne quinone (PQQ)
The electronic absorption spectra of the PLP enzymes are well documented (section 
2.1.9). However in some cases there is an unidentifiable chromophore in the spectrum 
of active enzyme in the 330-340 nm range. Enzyme samples have been treated to 
remove the excess PLP, but the chromophore is not removed, it has been suggested 
that the chromophore is due to the presence of covalently bound pyrroloquinoiine 
quinone (PQQ) (45).
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On the basis of such data it was suggested that rat liver ornithine aminotransferase, 
(2S)-lysine 6 -aminotransferase and mammalian GABA-T contain PQQj®® Since then 
evidence has been provided to show that mammalian DOPA decarboxylase, 
methylamine d e h y d ro g en ase ,£  coli (2S)-glutamate decarboxylase^®® and soybean 
lipoxygenase-1^®^ contain tightly bound PQQ. However, more recently it has been 
reported that dopamine p-hydroxylase^®® and soybean lipoxygenase-1 ®^® are not PQQ 
dependent enzymes.
Recent work has been published for £  coli glutamate decarboxylase^®® demonstrating 
that the only cofactor present Is PLP and describing the origins of the unidentifiable 
chromophore. The spectrum of E. coli GAD prepared in the absence of added PLP 
shows only one chromophore absorbing at wavelengths above those expected for the 
aromatic amino acids. The absorption maximum of the band at 417 nm is consistent 
with it being an imine of PLP with the e-amino group of lysine. The conversion to a 330 
nm absorbing species by treatment with a-methylglutamate confirms that the enzyme 
has undergone a decarboxylation dependent transamination to the PMP form. In this 
form the cofactor can be completely removed from the enzyme to leave a protein with 
no trace of any chromophore above 280 nm. Choi and Churchich^®  ^ have studied pig 
brain GAD and concluded that the holoenzyme is not a PQQ protein, and that the 
catalytic mechanism of action involves the participation of only one cofactor i.e. PLP. 
However, free PQQ is a strong inhibitor of GAD (Kj 13 p,M) and the reaction with the
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protein results in spectral changes resembling those of polylysine treated with POO. It 
is suggested that if the concentration of free POO in some regions of the brain reaches 
the micromolar level, then PQQ may play a role in the regulation of GAD activity. In the 
light of this recent information the status of many proteins that have previously been 
Identified as containing PQQ should be reconsidered.
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2.2 inhibition of Glutamate Decarboxylase by (2S)-serine O- 
sulphate
2.2.1 Introduction
In the late 1960's Sukhareva and Braunstein '^^  ^ discovered that (2S)-serine O-sulphate 
(21 ) inactivates glutamate decarboxylase. It was established that at 10 mM 
concentrations the inhibition suppressed activity by 54% after 1 hour. Incubation of the 
enzyme with (2S)-serine O-sulphate lowered the PLP content from 6 to 2.4 moles/mole 
of enzyme. The decrease in PLP content was concomitant with a decrease in the 
absorption at 420 nm and the appearance of a new band at 330 nm due to the 
conversion of PLP to a new unknown product.
More recently Ueno, Likos and Metzler®® discovered that (2S)-serine O-sulphate 
caused the irreversible inactivation of cytosolic aspartate aminotransferase (AAT) from |
pig heart. The enzyme was inactivated over a 10 minute period, and the absorption 
maximum at pH 5.4 shifted from 430 to 338 nm (46). On prolonged standing (20 h), the 
peak shifts again to 455 nm (47). Morino^® reported the same behaviour for the 
inactivation of AAT by p-chloroalanine in the presence of 3 M formate.
When the pH of the AAT enzyme solution was raised to pH >11, a yellow diffusible 
compound (48 ) was released from the protein. Compound (48), as well as its 
dephosphorylation and reduction products (49-52), was isolated and studied by ultra­
violet and proton NMR spectroscopy (Scheme 2.4).
Compound (48) was found to be identical with a compound formed from (2S)-serine O- 
sulphate and glutamate decarboxylase by a similar reaction sequence.^®® The uv data
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obtained on the compound (48) and its dephosphorylation and reduction products (5 4 -  
57 ) are shown in Scheme 2.5.
The compound (48) isolated from the inactive enzyme is the product of an aldoi 
condensation between pyruvate and pyridoxai 5-phosphate. The compound (48) has 
been previously synthesised by SchnackerzJ®'^ and can also be synthesised from 
oxalacetic acid and PLP via a Knoevagel condensation reaction. Compound (48) is 
often called the Schnackerz adduct.
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OHPO
CH
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OHPO
CH
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NaOH
heat, NaOH
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HO
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phosphatase OHPO
CHCH
(48) 411 nm 
NaBH^
(50) 342 nm, broad
(49) 410, 313 nm 
NaBH4
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H
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(52)311 nm(51) 342 nm, broad
Scheme 2.4. The compounds isolated from the inactivation of AAT by (2S)-serine O-
sulphate.
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Scheme 2.5. The compounds isolated from the Inactivation of GAD by (2S)-serine O-
sulphate.
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Mechanisms for the formation of the Schnackerz adduct have been proposed for both 
enzymes (Scheme 2.6, 2.7). The proposed mechanism In the AAT case is 
straightfonward (Scheme 2.6). However for glutamate decarboxylase, if the inactivation 
occurs by a similar mechanism to give the adduct (48), the first step in the reaction 
sequence would be a transaldimination reaction (Scheme 2.7). The second chemical 
step would be the removal of a proton from the C-4’-re-face of the coenzyme and not 
the loss of carbon dioxide from the C-4’-sAface. Loss of CO2 from the C-4’-s/-face of the 
coenzyme would lead to the formation of a different PLP adduct (Scheme 2.8, (58)). If 
the pseudo substrate binds in the expected m a n n e r t h e  sulphate group would 
occupy the same site as the (3-acid group of the natural substrate, (2S)-glutamic acid 
(Figure 2.1).
NH.
ENZ—NH.
0 ,8 0
H
ENZ— NHo \ H
.CO.
AAT------------------------- I*  I
CO2H
N CH3 N CH3
.COoH
"H
OHPO PO
CH CH
ENZ— NHg
N" 'CH
Scheme 2.6. The mechanism of inactivation of AAT by (2S)-serine O-sulphate.
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CH CH
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CH.CH CH.
Scheme 2.7. The proposed mechanism of inactivation of GAD by (2S)-
serine O-sulphate.
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Scheme 2.8. The expected mechanism of inactivation of GAD by (23)-
serine O-sulphate.
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Figure 2.1. The PLP-Schiff’s base ot {2S)-glutamtc acid 
and (2S)-serine O-sulphate.
Initially we wanted to prepare (2S)-serlne O-sulphate (21), and other p-hydroxy- 
a-amino acid sulphate esters and incubate them with the enzyme to verify that the 
inactivation occurred for (2S)-serine O-sulphate and discover if any inactivation 
occurred with (2R)-serine O-sulphate (59), (2S,3R)-threonine O-sulphate (60) and 
(2S,3S)-threonine O-sulphate (61 ). Metzler’s theory was based on comparing the 
proton NMR spectrum of products isolated from the active site of the inactivated 
enzyme with the proton NMR spectrum of the synthetic Schnackerz adduct (35).^®® 
However the proton NMR spectrum of the product (58) of the condensation reaction 
between acetaldehyde and PLP would be expected to be quite similar to that of the 
Schnackerz adduct (48), although the carbon NMR spectrum of the decarboxylated 
compound (58) contains one less carbon and so the carbon NMR spectra should be 
distinguishable. The carbon NMR spectrum published by Metzler^^® for the product 
(48) from the inactivation of GAD by (2S)-serine O-sulphate clearly shows a signal at 
«165 ppm which has been assigned to the carboxylic acid. Attempts to prepare the 
products of the two condensation reactions were largely unsuccessful due to problems 
in separating the products. The synthetic approach (Scheme 2.9) to solving the 
mechanism of inactivation was discontinued. We envisaged the possibility of 
determining whether COg was being given off during the inactivation process by the 
use of labelled (2S)-serine O-sulphate.
57
I
*■
,OHPO
KOH (aq)
OHCOgH PO
CH
(48)
" Y °
P O ' Y f * | r ^ ° ' ^  ^ H a C ^ H
H
Scheme 2.9. The attempted synthesis of PLP condensation products.
2.2.2 Synthesis of O-sulphate esters
KOH (aq)
OHPO
CH.
(58)
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At the start of the project, the preparation of the O-sulphate esters (21, 59-61) was 
attempted according to the method of Tudball.^®  ^This method was successful, but time 
consuming. The amino acid was added to concentrated sulphuric acid and the mixture 
stirred in vacuo until the amino acid had completely dissolved. The solution was 
diluted by the addition of ice, and the excess sulphuric acid destroyed by the addition 
of saturated barium hydroxide. The precipitated barium sulphate was removed by 
centrifugation, and the aqueous solution concentrated to dryness. The product was 
purified using an ion exchange column. The maximum yield achieved was 50%. For 
(2S)-serine O-sulphate, the proton NMR spectrum contained a triplet at 3.53 ppm for 
the a-proton and a multiplet at 4.18 ppm for the methylene protons. The carbon NMR 
signals at 178.4, 71.5, 47.7 ppm correspond to the acid carbonyl, 2CH and 3 CH2 
respectively. Both the proton and the carbon NMR spectra were run in DaO/NaOD. The
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M o  was found to be -10.25® (c. 1 in H2O) compared to the literature value of -9.5® (c. 
5.0 in H20).^®2 a  more recent paper by Previero and coworkers^®^ described an 
alternative method. Accordingly, the amino acid was dissolved in trifluoroacetic acid 
and chlorosulphonic acid was added dropwise using a syringe. The O-sulphate ester 
precipitated as the reaction occurred. When the addition was complete, the mixture 
was allowed to stand for 20 min to allow for further precipitation. The excess 
chlorosulphonic acid was destroyed by the addition of ethanol, and ether was added to 
complete the precipitation. The solid was filtered, washed with diethyl ether, and 
recrystallised from water/ethanol.
In our hands we did not obtain the high yields quoted in the paper (92%) but the yields 
of pure product were 60-65%, slightly better than those using the method of Tudball.^®^ 
The method was however much faster than Tudball's synthesis and for this reason the 
method was adopted for all the large scale synthesis. Previero found that the isolated 
product was the hydrochloride salt, however when the product was isolated in our 
laboratories, microanalysis indicated that the product was the free base (or zwitterion). 
The proton and carbon NMR spectra and optical rotation measurements were in 
agreement with those obtained for the product using Tudball’s method.
The O-sulphate esters of (2R)-serine, (2S,3R)- and (2S,3S)-threonine were prepared 
in an identical manner to (2S)-serine O-sulphate using the method of TudbalP^^ in 30- 
50% yield. The proton NMR spectrum of (2R)-serine O-sulphate contained a triplet at 
3.55 ppm for the a-proton and a multiplet at 4.2 ppm for the 0-3  methylene protons. 
The optical rotation was found to be +6.3® (c. 1 in H2O). The proton NMR spectrum of 
(2S,3R)-threonine O-sulphate exhibited a doublet at 1.38 ppm for the 0-4  protons, a 
doublet at 3.22 and a double quartet at 4.55 ppm for the a-proton and 0-3 proton
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1respectively. The optical rotation was determined as -20® (c. 9.7 in H2O). The proton 
NMR spectrum of (2S,3S)-threonine O-sulphate exhibited a doublet at 1.1 ppm for the 
C-4 protons, a doublet at 3.32 and a double quartet at 4.05 ppm for the a-proton and C- 
3 proton respectively. The optical rotation was determined as +0.8° (c. 0.56 in H2O). All 
of the above proton NMR were obtained in basic D2O.
2.2.3 Preliminary studies with giutamate decarboxylase
t
1
In previous studies the inactivation reaction of GAD and AAT^*^°^ by (2S)-serine O- 
sulphate had been followed by electronic absorption spectroscopy. On addition of (28)- 
serine O-sulphate to the enzyme the absorption maximum at 420 nm was reduced in 
intensity and a new band at 336 nm appeared. Although this method is easy to 
perform, it requires large quantities of GAD to detect the spectral bands and the activity |
of the enzyme is not measured directly. We have also had difficulty obtaining good 
uv/vis spectra of the glutamate decarboxylase purchased from Sigma.
Since we wanted to measure the enzyme activity directly we chose to incubate the 
inhibitor with a known amount of enzyme and measure the enzyme activity at various 
time Intervals using a radiochemical method (Chapter 4).
Experiments in our laboratory showed that (2S)-serine O-sulphate (2 1 ) inactivated 
GAD over several hours at 2-10 mM concentrations. The values of the kinetic 
parameters, Kj and kinact, were not determined at this stage. (2R)-Serine O-sulphate 
(59 ) was also found to inhibit the enzyme albeit at a slower rate than the (2S)- 
antipode, this was very interesting and merited further investigation. The O-sulphate 
esters of (2S,3R)-threonine (60) and (2S,3S)-threonine (61) were incubated with the
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%enzyme at concentrations up to 50 mM, no inactivation of the enzyme was observed.
The inactivation of GAD by {2R)-serine O-sulphate (59) was an unexpected result, l
however it was possible that the (2R)-serine O-sulphate was contaminated with (2S)- 
serine O-sulphate and that the inactivation was due to the contaminant. The optical 
rotations of the (2S)- and (2R)- enantiomers suggested that the (2R)-isomer was pure, 
but the purity was further verified through the synthesis of the (TS,4’R)- 
camphanamides of each enantiomer of serine O-sulphate (62,63). Each enantiomer 
of serine O-sulphate was reacted with freshly prepared camphanoyl chloride under 
Schotten-Bauman conditions."'®'  ^ Due to the highly polar nature of the serine O- 
sulphate, it was not possible to extract the camphanamide into the organic layer (even 
at low pH), so the aqueous layer was concentrated to dryness in vacuo to yield the 
serine O-sulphate camphanamide contaminated with inorganic salts. Inspection of the 
proton NMR spectrum in DaO/NaOD at 200 MHz clearly showed that the signal 
corresponding to the a-proton in the (2S)-serine O-sulphate (1’S,4’R)-camphanamide |
(62) occurs at 4.55 ppm. In the proton NMR spectrum for the (1’S,4’R)-camphanamide 
of (2 R)-serine O-sulphate (63), the equivalent signal occurred at 4.47 ppm. 
Comparison of the two proton NMR spectra Indicated that there was no contamination.
A proton NMR spectrum of a mixture of the two samples clearly showed two |
independent signals (Figure 2.2).
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Figure 2.2. The 200 MHz proton NMR spectra in DaO/NaOD of I) <2S)>serine O-sulphate
(1'S,4’R)-camphanamide (49), il) (2R)-serine O-sulphate {1’S,4’R)-camphanamide (50) and iii)a 
mixture of (2S)-serine O-sulphate (1'S,4'R)-camphanamide and (2R)-serine O-sulphate (1’S,4’R)- 
camphanamide.
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%2.2.4 Studies with (2S)-serine O-sulphate
In order to probe the mechanism of the inactivation further we needed to discover 
whether any carbon dioxide was liberated during the inactivation process. Carbon 
dioxide is known to react with barium hydroxide to form insoluble barium carbonate as 
a white precipitate. Initially the inactivation experiment was carried out so that any gas 
liberated was passed through barium hydroxide solution. No cloudiness was seen, but a
the quantity of gas liberated may not have been enough to form a precipitate visible to 
the naked eye. To circumvent the problem, radiolabelled carbon dioxide could be 
used. The radioactive carbon dioxide could be trapped in barium hydroxide and the 
amount of radioactivity measured using a scintillation counter. (2S)-[U-^'^C]-Serine was 
available commercially, and was converted to (2S)-[U-^'^C]-serine O-sulphate (64) 
using methods described in section 2.2.2. Before the inactivation experiment was 
performed it was necessary to verify that the (2S)-[U-^'^C]-serine was uniformly 
labelled. The (2S)-[U-^^C]-serine was degraded following the method of Gani,^^  ^ by 
heating It with 4-methoxyacetophenone (65) (Scheme 2.10) in a stream of nitrogen.
The 4-methoxyacetophenone reacts with the (2S)-serine to form an imine which 
decarboxylates to yield a second imine (6 6 ). Refluxing with conc. HCI hydrolyses the 
decarboxylated imine to yield ethanolamine.HCI (67 ) and regenerate the 4- 
methoxyacetophenone (52). The effluent gas was passed through barium hydroxide.
The amount of radioactivity in the carbon dioxide and ethanolamine was detected 
using a scintillation counter. It was found that the amount of radioactivity in the 
ethanolamine corresponded to twice that found in the carbon dioxide proving that the 
serine was indeed uniformly labelled.
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NHg HgC^O +
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^^ 2^ OCH, H*
(67)
OOH.
OH
2.3 Deuteriated (2S)-serine O-sulphate as a mechanistic probe
if Metzler's^'^ mechanistic theory and the structure for the inactivated product were 
correct, the inactivation reaction would proceed via the elimination of H2SO4 . It is 
possible that the proton abstraction would be the rate-limiting step in the inactivation 
process. As the activation energy required to break a C-H bond is lower than that for C- 
D bond cleavage this possibility could be tested using kinetic isotope effect techniques. 
A synthesis of (2S)-[2-^H]-serine O-sulphate (6 8 ) was, therefore, required. The 
conversion of (2S)-serine to (2S)-serine O-sulphate had already been achieved and
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Reagents: i) N2, 160-190 
ii) HCI (aq), reflux, 2 h.
Scheme 2.10. The chemical decarboxylation of (2S)-serine.
(2S)-[U-^'^C]-Serine O-sulphate (64) was incubated with a solution of the enzyme in a 
Warburg apparatus in such a way that any gas liberated was passed through a 
solution of barium hydroxide. It was found that there was no increase in the level of |
radioactivity in the barium hydroxide solution. There was also no detectable decrease 
in the radioactivity level of the enzyme incubation solution. As no carbon dioxide was 
liberated, the C “-0 0 2 H bond is not broken during the inactivation reaction. Therefore a 
different group must be lost, most plausibly a proton, thus adding weight to Metzler’s 
theory.
îso we needed to prepare (2S)-[2-^H]-serine (69) for conversion to the required O- 
sulphate ester.
2.3.1 Synthesis of (2S)-[2-^H]-serine O-sulphate from (2S)-aspartic 
acid
(2S)-Serine had been prepared from (2S)-aspartic acid by Young^ ®^ -^®^  in the 1980's. 
This route (Scheme 2.11) could be used for the synthesis of deuteriated (2S)-serlne as 
the deuterium could be introduced into the a-centre of the (2S)-aspartic acid by an 
enzymic exchange reaction.^®® Incubation of (2S)-aspartic acid with the enzyme 
aspartate aminotransferase in deuterium oxide with pyridoxal 5’-phosphate at 37 °C for 
3 days caused the exchange of the a-proton for deuterium with retention of 
configuration and «90% incorporation of deuterium. The reaction progress was 
followed by proton NMR spectroscopy, where integration of the signal corresponding to 
the a-proton (4.4 ppm in acidic D2O) decreased with respect to time. The mechanism 
involves the simple deprotonation-deuteriation of the position of (2S)-aspartic acid 
within the chiral environment provided by the protein, see section 1 .2 .1 .
The important step in the reaction pathway (step v, scheme 2 .1 1 ) published by 
Young^®  ^ is the formation of a diacyl peroxide (peroxy-anhydride) (70). Heating this 
compound causes a radical cage rearrangement to occur, with loss of carbon dioxide 
from the peroxy-anhydride (7 0) to form (2S)-methyl N-trifluoroacetyl-0-(m- 
chlorobenzoyl)-serinate (71 ).
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COgH
(81) Ha
CFXON H CFXON H
CO2H
CF3CONH
COgH
COgR'
(82) Ha
CF3CONH
COgR'
O
(72) Ha = H 
(83) Ha = ^H
(73)Ha «H, R' = Me 
(77) HA = H.R’ = 'Pr
(84) Ha = ^H, R '-M e
(85) HA = H^, R’ = 'Pr
COgH 
R’ = Me
CO2R’
IV
CFXON H C F X O N  H
Ha- *^ |( \^ C O C I + H A ^ lL ^ C O g R '
(70)Ha = H. R’ = Me 
(79)Ha = H, R’ = 'Pr
(89)HA = ^H,R’ = Me
(90)HA = ^H,R' = 'Pr
CO2R'
(74) Ha = H. R' = Me 
(78)Ha = H, R = ‘Pr
(87) Ha = ^H, R' = Me
(88)Ha = ^H, R' = 'Pr
COCI 
(75) Ha = H  R' = Me 
(86)Ha = ^H. R' = Me
CF3CONH
NH3CI
COgR'
(71)H a = H. R' = Me 
(80)Ha = H, R' = 'Pr
(91)Ha = ^H R' = Me
(92)Ha = ^H, R’ = 'Pr
COgH
(76a) Ha = H from methyl ester 
(76b) Ha = H from /sopropyl ester 
(69a) Ha = ^H from methyl ester 
(69b) Ha = ^H from /sopropyl ester
Reagents: I) "^ HgO, PLP, AAT, pH 7.25, 37 X .  3 days, 72%; ii) TFAA (10 eq),
THF, 0 X  to room temp, 2 h; ill) a) MeOH, 0 X  to room temp, 20 min,
85% of mixture of a and p esters over 2 steps or b) 'PrOH, 37 X ,  12 h,
55% of a ester over 2 steps; iv) SOCI2, reflux, 2 h, 10-99%; v) mCPBA, 
pyridine (1.5 eq), ether. 0 X ,  4 h, 40%; vi) CCI4 ,6 days, 20%; 
vil) 5 M HCI, 2 h, 90%.
Scheme 2.11. The synthesis of (2S)-[2-2Hj-serine from (2S)-aspartic acid (81).
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The initial part of the synthesis was repeated successfully. (2S)-Aspartic acid was 
treated with trifluoroacetic anhydride, and the intermediate cyclic anhydride (72) was 
treated with methanol. The cyclic anhydride was not fully characterised- The infrared 
spectrum showed an absorption at 1780 cnr  ^corresponding to the anhydride carbonyl 
stretching frequency. The proton NMR spectrum in DMSO showed an ABX system with 4
the signal for the methylene protons centred at 3.25 ppm and the a-proton signal |
centred at 5.05 ppm. The methylene protons of (2S)-aspartic acid in basic deuterium 
oxide were at 3.48 ppm in the proton NMR spectrum. The proton NMR spectrum of the 
product (73) of the reaction of the anhydride (72) with methanol showed two distinct 
methoxy singlets (the a-signal at 3.85 ppm and the p-signal at 3.7 ppm), and the signal 
for the methylene protons at 3.02 ppm. The a-ester accounted for about 60% of the 
total mixture. The monoesters (73) were converted into a mixture of the corresponding 
acid chlorides (74,75) which could be separated by fractional recrystallisation from 
diethyl ether, although this was not a reliable process. At this stage a sample of the 
pure a-methyl ester was obtained by hydrolysis of the pure p-acid chloride.
Young’s published work for the later part of the synthesis used the ethyl ester.^®  ^ it was 
decided not to use the ethyl esters as they are much harder to crystallise than the 
methyl esters.^^ As the methyl ester had been successfully crystallised it was decided 
to continue the synthesis with the methyl esters. The next step was the formation of the 
diacyl peroxide (70). The acid chloride (74) from (2S)-a-methyl N-trifiuoroacetyl- 
aspartate (73 ) was reacted with mCPBA to yield the diacyl peroxide (70). The proton 
NMR spectrum of the product (70) contained a multiplet in the aromatic region 
corresponding to the m-chlorobenzoyl fragment. The signals for the hydrogen atoms 
on C-3 which are part of an ABX system can be differentiated.
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The published rearrangement step was complete after reflux in toluene for 3 hours, 
however this was not found to be the case for the methyl ester. In attempts to overcome 
the problem, several other solvents with varying boiling points were tried, and also 
varying the length of the reaction time. We found that for the methyl ester diacyl 
peroxide (70), the rearrangement reaction occurred smoothly on refluxing in 
tetrachloromethane for 6  days. The product ( 71 )  was purified by column 
chromatography on silica (to remove a small amount of rearranged product that had 
been hydrolysed). Hydrolysis of (2S)-methyl N-trifluoroacetyl-O-(m-chlorobenzoyl)- |
serinate (71) in hydrochloric acid yielded (2S)-serine (76a). Studies carried out by 
Young and coworkers^®  ^ concluded that this was the first reported decarboxylative 
rearrangement of a diacyl peroxide in which a chiral primary carbon centre migrates 
non-stereospecifically. This supports a radical cage mechanism for the process and is 
in keeping with previous studies using It is evident that chirality cannot be
maintained within the cage whereas, in the ionic mechanism, secondary diacyl 1
peroxides rearrange with retention of stereochemistry.
The difficult step of separating the mixture of acid chlorides (74,75) needed to be }
overcome as acid chlorides are inherently unstable. They are easily hydrolysed in 
traces of acid and so any recrystallisation step could be difficult. One possible 
approach was to open the cyclic anhydride (72) regioselectively. teopropanol was tried 
and the reaction was found to be regiospecific as only one set of signals for the 
/sopropyl group were seen in the proton NMR spectrum, at 1.27 ppm for the methyl 
protons and at 5.11 ppm for the /sopropyl C-2 proton. The a-carbonyl group is more 
susceptible to nucleophilic attack due to the electron withdrawing effect of the 
trifluoroacetyl protecting group and the extra bulk of the /sopropanol makes it a more 
selective nucleophile. The a-/sopropyl ester N-trifluoroacetyl p-aspartic acid (77) was
6 8
converted to the acid chloride (78) by refluxing in excess thionyl chloride for one hour. 
However, this step was not reliable as the presence of traces of acid in the thionyl 
chloride caused the reformation of the cyclic anhydride (72) (Scheme 2.12). Several 
other methods were tried to improve this step. Attempts to form the acid chloride using, 
for example, phosphorus pentachloride, phosphorus trichloride, oxalyl chloride, 
triphenyl phosphine in carbon tetrachloride, shorter reaction times, lower temperatures, 
reaction in an inert atmosphere, higher purity thionyl chloride, and smaller equivalents 
of thionyl chloride in other solvents, gave mixed results. The most successful of these 
was using 1.1 equivalents of thionyl chloride in toluene at reflux for 6  hours. This gave 
a mixture of products, but yields of 70% of the required acid chloride were deemed to 
be sufficient as the product could be purified after the next step. Since this work was 
finished another member of the group has discovered a reliable route for the synthesis 
of the acid chloride (78).^ a-/sopropyl N-trifluoroacetyl p-(2S)-aspartlc acid (77) was 
dissolved in dry ether, and the solution cooled to 0 X .  One equivalent of phosphorous 
pentachloride was added to the solution. After 2 hours, the product was precipitated by 
the addition of petroleum ether. Recrystallisation from diethyl ether and petroleum 
ether gave the pure acid chloride (78) in 80% yield. The infrared spectrum of the acid 
chloride contained a band at 1810 cm'  ^ which was assigned as the acid chloride 
carbonyl stretching frequency. The methylene signal in the proton NMR spectrum had 
shifted to 3.5-3.73 ppm, compared with 2.93-3.25 ppm for the same protons in the acid 
(77).
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Scheme 2.12. The formation of the cyclic anhydride (72) from the ester (77) in the
presence of traces of acid.
The diacyl peroxide (79) was formed by stirring the acid chloride with one equivalent 
of pyridine and mCPBA in dry ether at 0 ""C for 4 hours. The signal for the methylene 
protons in the NMR spectrum occurs as a multiplet at 3.1-3.4 ppm, and the aromatic 
protons occur as a multiplet at 7.4-8.05 ppm. The rearrangement step was not 
straightforward, as the reaction was slower than for the methyl ester (70). A mixture of 
products was formed and only a small amount was the required (2S)-a-/sopropyl-N- 
trifluoroacetyl (m-chlorobenzoyl)-serinate (80), the rest of the mixture being 
a-/sopropyl-N"trifluoroacetyl-(2S)-serine, and unreacted starting material. The extra 
bulk of the /sopropyl group compared to the methyl group may cause the 
rearrangement reaction (Scheme 2.13) to occur at a slower rate. As some hydrolysed 
product is formed It would appear that under the reaction conditions the small amount 
of rearranged product (80) is hydrolysed.
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Scheme 2.13. The rearrangement of the diacyl peroxide (79).
A small amount of the required product (80 ) was isolated by column chromatography 
(7:3 petroleum ether: ethyl acetate), and hydrolysed with 5 M hydrochloric acid to yield 
(2S)-serine hydrochloride (76b). The free base was obtained by refluxing the 
hydrochloride salt in ethanol and propylene oxide for 15 min. The product co-ran with 
authentic serine by tic. The proton NMR spectrum in DaO/NaOD showed the presence 
of an ABX system with the signal for the methylene protons centred at 3.65 ppm and 
the a-proton signal centred at 3.32 ppm.
A small amount of (2S)-[2-^H]-serine (69a) was prepared via the methyl esters of (2S)- 
aspartic acid (81 ) but the problems encountered and the low yields prevented us from 
using this route for the large scale synthesis of (2S)-[2-^H]-serine (69).
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2.3.2 An alternative route to deuteriated serines via cyclic 
sulphamldates
Baldwin et have prepared cyclic sulphamidates from serine as new synthetic
precursors for p-functionalised a-amino acids. It was hoped that we could make use of 
these cyclic sulphamidates to prepare a-deuteriated serines in a stereoselective 
synthesis.
Baldwin^^® prepared N-benzyl-2,2-dioxo-1,2,3-oxathiazolidine-(4S)-carboxylic acid tert- 
butyl ester (93) from (2S)-serine in 6 steps with 32% overall yield (Scheme 2.14). in 
the synthesis described, N-benzyl serine (94) was prepared according to the method 
of Ohfune et by a one pot reaction with benzaldehyde followed by sodium
cyanoborohydride reduction of the intermediate imine in 73% yield. Protection of the 
alcohol with TBDMSCI, followed by reabtion with CCl3C(=NH)0 *Bu and removal of the 
protecting group with tetrabutyl ammonium fluoride yielded (2S)-N-benzyl serine tert- 
butyl ester (95) in 62% yield from N-benzyl-(2S)-serine. The cyclisation of (95) was 
effected by reaction with thionyl chloride (1 eq) and triethylamine (2 eq) in toluene in 
82% yield. The mixture of oxo-oxathiazolidines (9 6 ) was oxidised to the dloxo- 
oxathiazolidine (93) with sodium periodate and RuClg as a catalyst in 91% yield. The 
key signals in the proton NMR spectrum of the sulphamidate (93) are a double doublet 
at 3.94 ppm for the C-4 proton (the a-proton in the serine moiety), and a double 
doublet at 4.59 and 4.64 ppm, one for each of the 0-5 protons (the methylene group 
from the serine moiety).
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NHg PhCHgNH PhCHgNH
H
COgH COgH COg'Bu
(94)
0 “ IV
OH
vi / + \  VPhCHgN O ------— PhCHoN O  PhCHgNH
COj'Bu COa'Bu COg'Bu
(93) (96) (95)
Reagents: i) Benzaldehyde (1.1 eq), NaBHgCN (0.7 eq), MeOH, rt, 18 h, 73%;
ii) %uMe2SiCI (1.1 eq), imidazole (2.2 eq), DMF, rt, 4 days;
ill) {CCI3C(=NH)0 ‘Bu} (10 eq), BF3.Et2 0  (cat.), DCM:cyclohexane (2:1), rt,
18 h, 76%; iv) "Bu4N+F (1.0 M in THF, 1.5 eq), THF, O "C, 1 h, 82%; 
v) SOCI2 (1.0 eq), EtsN (2.0 eq), toluene, 0 °C, 92%; vi) NalO  ^(1.0 eq),
RUCI3.H2O (cat.), MeCN:H2 0  (1:1), rt, 91%.
Scheme 2.14. Baldwins synthesis of the sulphamidate (93).
It was hoped that the deuteriated serine could be formed from the N-protected dioxo- 
oxathiazolidine carboxylic acid ester (97) by the following sequence of reactions 
(Scheme 2.15). First, the removal of the N-protecting group from (97 ) without 
disruption of the ring structure to yield (98). Second, the deprotonation of (98) at the 
nitrogen giving (99 ) followed by an electrophilic reaction at one of the sulphur oxygens 
with a suitable electrophile introducing a second chiral centre to the system forming 
(100). Third, removal of the a-proton from (100) resulting in the formation of a planar 
trigonal centre at C-4 (101). Fourth, stereoselective reprotonation/deuteriation on the 
opposite face to the alkylated oxygen forming (102). Removal of the oxygen protecting 
group yielding (103) followed by ring opening to yield the required serine (104).
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Scheme 2.15. Theoretical synthesis of (2R)-[2-^H]-sehne from a cyclic sulphamidate (97).
We wanted to be able to remove the N-protecting group from N-protected dioxo- 
oxathiazolidine carboxylic acid ester (97) easily. We decided to prepare /sopropyl 
esters, by direct reaction with /sopropanol and thionyl chloride, and avoid the need to 
protect the -OH group. To this end N-benzyloxycarbonyl-(2S)-serine /sopropyl ester 
(105), N-(9-fIuorenylmethyloxycarbonyl)-(2S)-serine /sopropyl ester (106) and N- 
benzyl-(2S)-serine /sopropyl ester (107) were prepared from (2S)-serine. N-BOC-(2S)- 
Serine /sopropyl ester (105) and N-FMOC-(2S)-serine /sopropyl ester (106) were 
prepared from (2S)-serine /sopropyl ester (108) by reaction with triethylamine and 
benzylchloroformate, and 9-fluorenylmethyloxycarbonylchloride respectively. N-Benzyl- 
(2 S)-serine /sopropyl ester (107) was prepared from N-benzyl-(2S)-serine (94) by 
reaction in /sopropanol with 5 equivalents of thionyl chloride under reflux for 3 days. An 
easier method was found for the preparation of N-benzyl-(2S)-serine ( 9 4 ) ,^  in which 
the reduction step was carried out with sodium borohydride instead of sodium 
cyanoborohydride. The reaction was complete after 4 hours and the product was
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isolated in 75% yield. The proton NMR spectrum contained a triplet at 3.61 ppm for the 
a-proton, a double doublet at 3.86 ppm for the serine methylene protons, a singlet at 
4.18 and 4,20 ppm for the benzyl methylene protons, and a singlet at 7.38 ppm for the 
aromatic protons.
O
A CHgO
^  I iN n  r n L /M 2 N M
COg'Pr COg'Pr COg'Pr
(105) (106) (107)
Attempts to cyclise the BOC and F-MOC derivatives (105,106) under the conditions of 
Baldwin resulted In the formation of bis sulphite esters (1 0 9 ,1 1 0 ) (dimers of the 
starting materials). These compounds exhibited peaks for [M+H] + at 609 and 785 
respectively.
O o
ArCHgO ^'^NH ?  HN^'^O CHgAr
T "COg'Pr COg'Pr
(109) Ar = CeHs
(110) Ar = C13H9
The N-benzyl-(2S)-serine /sopropyl ester (107) was converted to N-benzyl-2,2-dioxo- 
1,2,3-oxathiazolidine-(4S)-carboxylic add /sopropyl ester (1 1 1 ) via the diastereomeric 
mixture of oxo-oxathiazolidines (112) following the method of Baldwin^®® in 60% yield
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(Scheme 2.16). The key signals in the proton NMR spectrum are for an ABX system 
with the signal for the C-4 proton centred at 4.02 ppm and the signal for the 0-5  
methylene protons centred at 4.65 ppm.
NHc
H
PhCHgNH
OH H ..»»w OH
PhCHgNH
IH OH
COgH COgH
(94)
V °/ XPhOHpN O
COg'Pr
(111)
IV
COg'Pr
(107)
O"
%
PhCHpN O
COg'Pr
(112)
Reagents: i) 2M NaOH, benzaldehyde (2.0 eq), NaBH  ^(0.6 eq), 4 X ,  3 h, 75%;
ii) SOCI2 (5eq), 0 °C for 30 mins then reflux 3 days, 40%; iil) SOCI2 (1.0 eq),
EtaN (2.0 eq), toluene, 0 X .  74%; iv) NalO  ^(1.0 eq), RUCI3.H2O (cat.),
MeCN:H2 0 (1:1), rt. 81%.
Scheme 2.16. The synthesis of N-benzyl-2,2-dioxo-1,2,3-oxathiazolidine- 
(4S)-carboxylic acid /sopropyl ester (111).
This methodology was not developed any further after the discovery that the work by 
Schollkopf, described below (Section 2.3.3), could be exploited to give the required 
deuteriated serines.
-i
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2.3.3 Synthesis of (2S)-[2-^H]-serine O-sulphate using Schollkopf 
methodology
Schollkopf had discovered that chiral 2,5-dimethoxy-3-/sopropyl-3,6-dihydropyrazines 
can be stereospecifically alkylated at C-6 on the opposite face to the bulky /sopropyl 
group at A stereospecific synthesis of (2R)-serine had been published
(Scheme 2.17 shows the same synthesis of (2S)-serine).^ The bis-lactim ether (113) 
formed from (2R)-valine and glycine can be deprotonated at C-6  using n-butyl lithium 
at -80 ""C and the anion stereospecifically alkylated by the addition of 
benzylchloromethyiether on the opposite face to the bulky /sopropyl side chain of the 
(2R)-valine leading to (S)-stereochemistry at the C-6 centre of the product (114). Acid 
hydrolysis of the alkylated dihydropyrazine (114) results in the regeneration of (2R)- 
valine as the methyl ester (115) and the formation of (2S)-0-benzyl serine methyl ester 
(116). Separation of the methyl esters (115,116) was effected by flash column 
chromatography on silica gel. Acid hydrolysis of the (2S)-0-benzyl serine methyl ester
(116) resulted in the formation of (2S)-serine.HCI. The free base (76c) was obtained 
by refluxing the HCI salt in ethanol and propylene oxide.
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C^gH (76c )H a = H  (116)H a = H
(69c)H a =^H (125)H a =^H
Reagents: I) /tBuLI (1 eq), THF, -90°C to -60°C, then PhCH2 0 CH2CI 
(1.5 eq), THF, -90^C. stir, 16 h, 60%; ii) 0.2 M HCI (2 eq), rt. stir,
16 h then separation on flash silica 19:1 Et2 0 :EtOH, 70%; iil) 5 M HCI, 
reflux, 3 h then EtOH, propylene oxide, reflux, 15 min, 55%.
Scheme 2.17. The synthesis of (2S)- and (28)-[2-^H]-serine using Schollkopf chemistry. 1
Although the methodology had been developed for the stereoselective synthesis of 
serine, a method was required for the introduction of deuterium at C-6 . The 
dideuteriated dihydropyrazine (117) could be synthesised from dideuteriated glycine |
and valine. Initially (3R)-2,5-dimethoxy-3-/sopropyl-3,6-dihydropyrazine (1 1 3 ) was 
prepared from glycine and (2R)-valine in up to a maximum overall yield of 62% (from 
glycine) (Scheme 2.18). Glycine was converted to the methyl ester (118) by reflux in 
methanol with thionyl chloride in dry methanol In 100% yield, the proton NMR spectrum 
contained a singlet for the methyl ester at 3.76 ppm and a singlet for the methylene 
protons at 3.86 ppm. (2R)-valine was N-protected with benzyl chloroformate in 8 8 % 
yield, and the resulting N-carbobenzoxy-(2R)-valine (119) was reacted with glycine 
methyl ester (118) to form the dipeptide N-carbobenzoxy-(2R)-valine-glycine methyl 
ester (120) in 87% yield. This compound exhibited the required proton NMR spectrum 
and had Infrared absorptions at 1645 and 1535 cm'  ^ indicative of the presence of an 
amide bond. The mass spectrum of the compound gave the [M+Hf at 323. Removal of 
the nitrogen protecting group was effected by hydrogenation with 10% Pd/C in dry
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methanol:dichloromethane 1:3, this caused partial cyclisation to cyc/o-((2R)-valine- 
glycine) (1 2 1 ) (a diketopiperazine). The cyclisation was completed by refluxing the 
mixture of products from the hydrogenation step for 12  hours in dry toluene, the 
precipitated product was obtained by filtration and dried thoroughly. The proton NMR 
spectrum showed a doublet at 0.87 and 0.96 ppm with J 7 Hz for the valine methyl 
groups, a double septet at 2.2  ppm for the proton adjacent to the valine methyl groups, 
a doublet at 3.88 ppm, J 3  Hz for the ring C-3 proton and a double doublet at 3.9 and 
4.09 ppm for the C-6 protons. The conversion of the diketopiperazine (1 2 1 ) to the 
bis-lactim ether (113) with trimethyloxonium tetrafluoroborate in dry dichloromethane 
gave the most variable yields (66-89%) and was wasteful of trimethyloxonium 
tetrafluoroborate. It was impractical to synthesise large quantities of the bis-lactim 
ethers and so they were purchased commercially. Synthesis of the deuteriated 
analogues in this manner would require large quantities of deuteriated glycine, and 
would be very costly.
Several methods for introducing deuterium at C-6 of the commercially purchased bis- 
lactim ethers were considered using the known kinetic preference for C -6 proton 
a b s t r a c t i o n . M e t h o d s  based upon repeatedly quenching the nBuLI generated 
anion of the dihydropyrazine (113) with ^HaOor CHaO^H were quickly abandoned due 
to the formation of an array of by-products after the first cycle. This method also 
suffered from the potential problem of low selectivity for removing protium from the 
singly deuteriated compound in the second cycle of anion formation.
Stirring compound (113) in ^HzO in the presence of KOH under a variety of conditions 
also proved to be of little or no utility. At room temperature, the exchange of the C -6 
protons was almost undetectable after 3 hours, and at higher temperatures, several
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by-products were formed. However, under optimised conditions, CH3 0 ^H:^H2 0  (10:1, 
v/v), refluxing in the presence of 1 equivalent of KO^H, the C-6  deuteriatlon of a 1 M 
solution of compound (113)  proceeded smoothly, without the formation of side 
products or 0-3 deuteriated material, and was complete within 3 h, (Scheme 2.19, 
Figure 2.3).
PhCH
Hb COoH COpM©
NHCOpCHpPh
(113, Ha=Hb=H)
(117, Ha=Hb=^H) (121)
Reagents: i) SOCI2 (1.2 eq), MeOH, 0°O, then reflux 30 min, 100%;
ii) PhCH2 0 COCI (1.1 eq), NaHC0 3 (3.5 eq), HgO, rt, 18 hours, 88%;
iii) isobutylchloroformate (1 eq), N-methylmorpholine (2 eq),
EtOAc/DMF, stir, rt, 16 h, 87%; iv) H2, Pd/C, DGM/MeOH (3:1); v) PhMe, 
reflux, 16 h, 45% over 2 steps; vi) [MesO] BF^  ^(3.5 eq), DOM, 66%.
Scheme 2.18. The synthesis of (3R)-2,5-dimethoxy-3-/sopropyl-3,6-dihydropyrazine .
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Figure 2.3. i)The 200 MHz proton NMR spectra in CD3OD ot (3R)-2,5-dimethoxy-3-/sopropyl- 
3 ,6 -dihydropyrazine (113). The signais at 4.02 ppm are due to the C-3 proton (1H. d, J3.8 Hz) 
and the 6-0 protons (2H, s), at 3.7 for the 2 and 5 methyloxy protons (6H, 2s), 2.15 for the 
/sopropyl C-H proton and at 1.0 and 0.75 for the /sopropyl CHa’s (6H, 2d, J 6.8 Hz), ii) The 200 
MHz proton NMR spectra in C D 3OD of (3R)-|"6-2H2]-2 ,5 -dimethoxy-3-/sopropyl-3 ,6 - 
dihydropyrazine (117). The signal at 4.02 ppm Is due to the C-3 proton (1H, d, J3.8 Hz).
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(117) (3R)-(113) (3R)-
(126) (3S)- (127) (3S)-
Reagents: i) CH30^H-^H20  (10:1 v/v). KOH (1 eq), reflux, 3 h, 80%.
Scheme 2.19. The synthesis of C6 dideuteriated 
dihydropyrazines.
This pleasing selectivity for C-6  anion formation over C-3 anion formation was further 
probed by refluxing compound (113) under the optimised exchange conditions for 6  h, 
twice as long as that required for exchange at C-6 . Very little deuterium (<10 atom %) 
was incorporated at 0-3  as judged by proton NMR spectroscopy and mass 
spectrometry. It was noted that 0-6 alkylated derivatives of the dihydropyrazine (113) 
were resistant to base catalysed deuteriation at 0 - 6  under the same conditions.
To confirm that the chiral centre at 0-3 of the dideuteriated material (117) was intact, I
the dihydropyrazine ring was cleaved (0.1 M HOI, 16 h) to give the valine and glycine 
methyl esters. These were separated, the valine methyl ester was hydrolysed (5 M HOI, 
reflux, 3 h) and converted to its free base form with propylene oxide. The optical 
rotation of the recrystallised valine was -24.2° (c. 1.01, 5 M HOI) which compared 
favourably to that of an authentic sample of (2R)-va!ine [-24.95° (c. 1.09, 5 M HOI)], 
indicative of an enantiomeric excess of >97%. Thus, the deuteriation had proceeded 
highly selectively and without disturbing the stereogenic centre at 0-3.
2.4 (2R)-Serine O-sulphate as a mechanistic probe
(2R)-Serine O-sulphate (59) was also found to be an inhibitor of GAD (section 2.2.3), 
however the mechanism of inactivation was not known. Initially we wanted to 
determine whether CO2 was being liberated from the enzyme during the inactivation 
process. (2R)-[U-^^C]-Serine was not commercially available so we decided to 
investigate the mechanism by determining whether there was a kinetic isotope effect 
on the rate of inactivation.
2.4.1 Synthesis of (2R)-[2-^H]-serine 0-suIphate
The synthesis of (2R)-[2-^H]-serine (122) would not have been possible using the 
route from aspartic acid (section 2.3.1) as (2R)-aspartic acid is not a substrate for the 
enzyme AAT. Therefore (2R)-(2-^H]-serine O-sulphate (123) was synthesised from 
(3S)-2,5-dimethoxy-3-/sopropyl-3,6-dihydropyrazine (126) in an identical manner to 
the (2 S)-antipode in 5% overall yield (Scheme 2 .2 0 ).
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   ^
OCH3 , N OCH3  ^ I
H3C0 ' ^ N ^ - '  H , C O ^
(126) Ha = Hb = H (128) Ha= H
(127) Ha = Hb = (129) Ha =
NH2 ill o ^ O C H a
OH =  '^A ;iflT * ^  ^
^ COpH ^C H gO H  ^sN ^^cH gO C H sP h
2 (132) Ha= H (130) Ha= H
(122)Ha = ^H (131)H a = ^H
Reagents: i) nBuLi (1 e q ), THF, -90°C to -60°C, then PhCH2 ÛCH2 Br 
(1.5 eq), THF, -90<^ C, stir, 16 h, 56%; 11} 0.2 M HCI (2 eq), rt, stir,
16 h then separation on flash silica 19:1 Et20:Et0H, 70%; Hi) 5 M HCI, 
reflux, 3 h then EtOH, propylene oxide, reflux, 15 min, 89%.
Scheme 2.20. The synthesis of (2R)- and (2R)-[2-^H]-serine using Schollkopf chemistry.
2.5 Synthesis of other deuteriated a-amino acids
The availability of labelled amino acids in enantiomerically pure form is of prime 
importance in many biosynthetic and metabolic studies and also in the delineation of 
enzyme mechanism. Access to some C“-deuteriated and tritiated (2S)-ot-amino acids, 
for example, chiral glycines, (2S)-aspartic acid and (2S)-glutamic acid, has been 
facilitated through the use of enzymes in appropriately labelled buffer s o l u t i o n . ï 
The preparation of labelled (2R)-amino acids, however, has been much more difficult.
Some (2R)-a-amino acids (as well as the (2S)-antipodes) have been prepared through 
the acylase catalysed kinetic resolution of racemic mixtures of N-acetylated amino 
acids.^^  ^ Here, deuterium or tritium can be introduced by exchanging the acidic 
hydrogen of the aziactone Intermediates during acétylation.^®"* Unfortunately, the 
differential rates for the déacylation vary considerably for the two antipodes of different 
amino acids, so the enantiomeric excesses are variable. Furthermore, the technique is 
not applicable in several instances.
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Schollkopf’s bis-lactim ether methodology has proved to be of enormous utility in the 
preparation of a wide range of (2R)- and (2S)-a-amino acids^ °®-^ ^® and the chiral 
dihydropyrazine precursors are now commercially available as discussed In section
2.3.3. The chemistry developed in the synthesis of the deuteriated serines can be |
applied to other amino acids (Scheme 2 .2 1 ).
The anion of the dideuteriated dihydropyrazine (117) can be alkylated with a wide 
variety of alkylating agents, e.g. benzyl bromide, ally! bromide, ethyl bromoacetate, 
yielding (133-138) .  It was found that the alkylation proceeded smoothly in most cases, 
long straight chain halides required longer reaction times (up to 24 hours) than 
benzylchloromethylether (16 hours) whereas ethyl bromoacetate only needed 5 hours.
Acid hydrolysis (0.2 M HCI) to the mixture of methyl esters (115 ,139 -144)  did not 
present any problems. The limiting step in this route to a wide variety of amino acids is 
the separation of the methyl esters. There must be a significant difference in the side 
chains to allow the complete separation of the esters, either by chromatography or 
distillation. This methodology Is probably not suitable for the synthesis of leucine or 
/soleucine. (2S)-[2-^H]-Phenylalanine (145), (2S)-[2-^H]-allylgiycine (146), and (2 S)- 3
[2-^H]-aspartic acid (147) were all prepared successfully from (3R)-2,5-dimethoxy-3- 
/sopropyl-3,6-dihydropyrazine (113) using this method. Inspection of the proton NMR 
spectra of the alkylated (3R)-2,5-dimethoxy-3-/sopropyl-3,6-dihydropyrazines showed 
that the signal for the remaining 0-3 proton had become coupled to another proton and 
shifted from 4 ppm to 4.1-4.4 ppm dependent on the alkylating agent. The proton NMR 
spectrum also contained new signals due to the protons from the new side chain at 0 - 
6 . Full details are described in the experimental section (Chapter 4), overall yields and 
optical rotations of each of the obtained amino acids are as shown in Table 2.3.
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< ^ 0 CH3
Hb ■
A . N  OC
H _Hb=H)  (133) R = CHgPh, Hb=H; (134) Hg^^H
’ Ha=Hr=^H) _ J  ' (135) R = CHgCH^CHg, Hb=H; (136) H g A  
(137) R = CHgCOgEt, HB=H; (138) Hb=^H
(113, Ha=Hb=H) 
(117
^  I (115) 
H g C O ^ O
HoNJe"'R
HB=Hor^H
^OH
HgN
IV
R'
(139) R = CHaPh, Hb=H; (140) Hb=^H 
(141) R = CH2CH=CH2. Hb=H; (142) Hb=^H 
(143) R = CH2C02Et, Hb-H ; (144) Hb=^H
(148) R'= CH2Ph, Hb=H;
(149) R' = CH2CH=CH2, Hb=H;
(150) R' = CH2CO2H. Hb=H;
(145) Hb= H
(146) Hb=^H
(147) Hb=^H
Reagents: I) CH3 0 ^H-^H2 0  (10:1, v/v), KOH (1 eq), reflux, 3 h; 
ii) atBuU (1 eq), THF, -90^0 to -60°C, then RBr (1.5 eq), THF,
-90®C, stir, 5-20 h; III) 0.2 M HCI (2 eq), rt, stir,16 h; then separation 
(chromatography for R=CH2CH=CH2, CH2C02Et, distillation for R=CH2Ph);
iv) 5 M HCI, reflux, 3 h then ethanol, propylene oxide, reflux, 15 min.
Scheme 2.21. Synthesis of a-deuteriated amino acids using Schollkopf chemistry.
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Table 2.3. Amino acids synthesised using Schollkopf chemistry.
Compound*^
(Stereochemistry 
and Label at C*)
Yield (%)b [a]D° [ a 3 D Theory
Serine
76c (S-, H) 25 +13.2* (c. 1.00, 1 M HCI) +14.5* (c. 1.0, 1 M HCI) 212,213
69c (S-, 2h ) 20 +12,7* (c. 1.01, 1 M HCI)
132 (R-, H) 20 -13.6* (c. 1.02, 1 M HCI) -14.3* (c. 1.0,1 M HCI) 212,213
122 (R-, 2h ) 35 -13.5* (c. 1.03, 1 M HCI)
Phenylalanine
148 (S-, H) 30 -30.9° {c. 2.04, H2O) -32.5* (c. 2.0, 
H20)214
145 (S-, 2h ) 35 -28.2* (c. 1.50, H2O)
Allylglycine
149 (S-, H) 15 -5.7* (c. 2.00, 5 M HCI) +5.7* (c. 2.0,
5 M HCI)
for R -(24)215
146 {S-, 2h ) 20 -4.2* (c. 1.87, 5 M HCI)
Aspartic Acid
150 (S-, H) 15 +21.8* (C. 0.495 , 5 M HCI) +25.2* (c 2.0, 
5 M HCI) 213
147 (S-, 2h ) 15 +19.5* (c. 0.495, 5 M HCI)
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^All compounds and intermediates gave the expected spectral and analytical data. 
•^ Yield from R- or S- (110) or (123).
^Values determined at 23-25 ®C.
•• i A 14' J'.*. 4 L..- ..... .. -i'"
2.6 Mathematical analysis of the data from the inactivation of GAD 
by serine O-suiphates
For an enzyme-substrate reaction, the substrate binds to the enzyme to form the 
complex ES. The reaction then occurs and ES breaks down to give enzyme and 
products. This can be written as shown below.
E + S ----   E S ------ E + P
At a particular time each of E, S and ES are present at the following concentrations 
et -X, s and x respectively and where et is the total concentration of free enzyme.
The rate of change of the concentration of ES is dx/dt and this can be written as;-
^ = k i  (et-x)s - kgx - ksx = ki ets - (ki s+k2+k3)x (1 )
dt
If steady state conditions are assumed i.e. that the concentration of ES remains 
constant, then dx/dt = 0. Equation (1) can then be solved forx, giving
x= ki6ts (2)
k-jS+k2*fk3
The rate of reaction of the enzyme is first order with respect to the concentration of ES. 
Hence we have that;-
rate, v = k3X (3)
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Substituting equation (2) in equation (3) gives:-
V = kskiStS 
kiS+kg+kg
kgOtS (4)
s+(k2+k3)/k
If the substrate is present in large quantities compared to the enzyme, then s ~ constant 
and the enzyme is said to be saturated. The rate v, is then directly proportional to et. 
We can then write
kapp = kgS (5)
s+(k2+k3)/ki
where kapp is the apparent first order rate constant for the enzyme reaction.
Taking reciprocals of both sides of the rate equation (4) yields:-
1 = 1 + l^+kg (6 }
V kgOt kikgOtS
Equation (6 ) can be written in the more general form:-
1 = 1 + Km (7)
V V Vs
where V=kget and KM={k2+kg)/ki. From equation (7) it can be seen that a plot of iN
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in the analysis of the enzyme-substrate reaction data the numerical values of the rate 
(v) and substrate concentration (s) are fitted to Michaelis-Menten kinetics using the 
computer program Enzfitter^^® which carries out a direct non linear fit and so avoids the 
over emphasis of small v and s, this yields the parameters Km and kcat (kcat=Vmax/et)-
against 1/s will result in a straight line graph that intercepts the x-axis at -1/Km and the y- 
axis at 1/V. The slope of the line equal to Km/V. One problem with this method of 
graphical analysis is that points of small v and s become over emphasised.
I
In the above analysis it was assumed that the steady state assumption was valid. For 
an inactivation reaction dx/dt ^ 0 and so the mathematics become more complicated. If J
we model the inactivation reaction on the same system as for the enzyme-substrate 
reaction, the equation can be written as shown below.
ki kqE + 1 El  ► E’ (inactive enzyme)
At a particular time each of E, I and El are present at the following concentrations et - x, 
i and x respectively and where et is the total concentration of free enzyme.
The rate of change of the concentration of El is dx/dt and this can be written as:-
dx =ki (et-x)i - kgx - kgx = kieti - (ki i+k24k 3)x (8 )
dt
This expression can be integrated by the method of separation of variables (as dx/dt ^ 
0 ) and after evaluating the constant of integration, the following expression Is obtained.
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t = [-1/(ki l+k2+k3)] In {1 -[(ki i+k2-F4<3)x/kieti]} (9)
Dividing both sides by -1/(kii+k2 4 <3) gives:-
-{kii+k2+k3)t = In {1 -[{kii+k2+k3)x/kieti]} (10)
Taking the exponential of both sides gives the expression (11) which can then be 
solved forx to give equation (12).
exp [-(kii+k2+k3)g = 1 -[(kii+k2+k3)x/ki eti] (1 1 ) 1
X = ki6ti{1 -exp[-(kii+k2-+k3)t]} (12)
kii-fk2+k3
The rate of inactivation of the enzyme is first order with respect to the concentration of 
El. Hence we have that:-
rate of inactivation, Vinact = ksx (13)
Equation (12) can be substituted into equation (13) to give an expression for the rate of 
inactivation of the enzyme (14), The following expressions can then be obtained for 
kapp and 1/kapp.
Vinact = k3kieti{1 -exp[-(kii+k24k 3)t]} (14)
k-ji+k2+k3
At saturating i, Vjnact is first order with respect to et, i.e. Vinact=kappet and kapp is as shown 
overleaf.
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kapp = ka{1-exp[-(ki i+kgika)!]} (15)
1 +(k2+k3)/kti
Taking reciprocals of both sides gives equation (16).
1 = 1  + (k2+kg) (16)
kapp ksU -exp[-(ki i+k2-fk3)t]} kik3i{1 -exp[-(kii+k2+k3)t]}
= 1 + Ki
i^nact kinacti
kapp is measured as the enzyme activity decreases, it is an apparent rate constant, but 
is effectively the same as a reaction velocity, v. Plots of In (GAD activity) versus time 
yield straight lines with a gradient equal to -kapp and an intercept on the y axis equal to 
the enzyme activity at t=0. Thus plots of In (GAD activity) versus time at different 
inhibitor concentrations will give different slopes, but they will intercept at the same 
point on the y axis when the initial activity is the same, kjnact and K; can then t>e 
determined graphically by plotting the negative of the gradient obtained (kapp) against 
the inhibitor concentrations, kjnact is the number of moles of inhibitor turned over per 
mole of enzyme per minute and Ki is the inhibitor concentration at which the enzyme is 
inactivated at half the theoretically maximum rate (Vmax/2). These points can be fitted to 
Michaelis-Menten kinetics using Enzfitter^^® or transformed into straight lines by 
plotting the reciprocal of the gradient against the reciprocal of the inhibitor 
concentration.
Accordingly a number of incubations were prepared with a variety of different serine O- 
sulphate concentrations (1, 2, 3.5 and 7 mM for the (2S)-isomers and 2 , 3.5, 5 and 7
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mM for the (2R)-isomers). Aliquots were removed after various time intervals (15 
seconds to 7 hours) and the GAD activity determined using a radiochemical assay and 
the results analysed as above.
2.7 Results and interpretation of the inactivation experiments 
2.7.1 (2S)-Serine O-sulphates
Once the experiments had been completed for the (2 S)-serine O-sulphate inhibitors 
the information was depicted in two ways. The first was to plot the apparent first order 
rate constant (kapp) against the concentration of inhibitor [1] and fit to the Michaelis- 
Menten curve (Figure 2.4) (see section 2.6). The second was to transform the Michaelis- 
Menten fit to a straight line, 1/kapp against 1/[l] (Figure 2.5) (see section 2.6). Kj and kjnact 
can be obtained from these graphs, the intercept of the 1/[l] axis is equal to -1/K; and 
the intercept of the 1/kgpp axis is equal to kjnact - The values obtained for the direct non 
linear fit of the data using Enzfittei^^® are shown in Table 2.4:-
Table 2.4. Values of K| and kjnact for the Inactivation of GAD by (2S)- and (2S)-[2-2H]-serine O- 
sulphate.
Inhibitor Ki (mM) kinact (min-^)
(2S)-serine O-sulphate
(2S)-[2-2h ]-serine O-sulphate
2-57 ± 0.519 
7.59 ± 2.225
0.01076
0.01368
± 0.00098 
± 0.00264
The graphs obtained from the data for the inactivation of GAD by (2S)- and (2S)-[2-^H]- 
serine O-sulphate are shown in Figures 2.4 and 2.5.
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Figure 2.4. kapp against [I] for the Inhibition of GAD by + (2S)-serine O-sulphate 
and X (2S)-[2-2H]-serine O-sulphate.
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Figure 2 .5 .1/kapn against 1/[l] for + {2S)-serine O-sulphate 
and X (2S)-[2-^H]-serine O-sulphate inhibition of GAD.
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From the data in Table 2.4, it can be seen that kjnact is approximately equal for both of 
the inhibitors, and so at constant enzyme concentration (or VhA/q) was about 1 .
However the values for Kj are significantly different and °(V/K) [or (VhA/d)/(Kh/Kd)] was
2.3, The value ^(V/K) indicates that C“ -H bond cleavage does, indeed, occur during 
the inactivation of GAD. The large size of ^(V/K) indicates that the reaction 
commitments to C-H bond cleavage are not large and that C-H bond cleavage is not 
the most significant transition state in the inactivation process.^^^ If the C-H bond 
cleavage was the rate determining step then there would also be a significant isotope 
effect on V as Vmax would be decreased for the deuteriated inhibitor and this is clearly 
not the case. After the C® bond has broken, the intermediates are identical and 
therefore have identical reaction rates. Hence the rate determining step is prior to the 
first irreversible step (the C-H bond breakage). Binding to the enzyme active site and 
transaldimination of the inhibitor with the active-site lysine bound to the PLP have both 
occurred before the C-H bond breaks. It is possible that either of these two processes 
is rate determining.
For (2S)-serine O-sulphate we have shown that a kinetically significant step in the 
inactivation process is the breakage of the C“-H bond which supports the mechanism 
proposed by Metzler.''®® An incubation of (2S)-serine O-sulphate with GAD in 0.1 M 
pyridine/DCI buffer at pH 4.6 was studied by proton NMR spectroscopy. No exchange 
of the a-proton occurred after several days. This observation implies that the anion 
formed on the loss of the a-proton is not stabilised, and almost Immediately the C-C 4
double bond is formed and HO3SO' is eliminated from the enzyme active site. Hence, 
the inactivation process has been shown to occur via the removal of a proton from the 
C-4'-re-face of the coenzyme and the data is most consistent with an E2 type 
elimination reaction.
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2.7.2 (2 R)-Serlne O -sulphates
At all concentrations studied for (2R)-serine O-sulphate, the deuteriated (2R)-serine O- #
sulphate inactivated the enzyme faster than the unlabelled isotopomer, so there is an 
inverse isotope effect. The averaged apparent values rates of inactivation for the two 
inhibitors (Vh and Vp) and the ratio of rates {VhA/q) are shown in Table 2.5.
Table 2.5. The average rates of inactivation of GAD by (2R)- and (2R)-[2-2H]-serine O-sulphate,
Concentration (mM) Vh (X 10-3) Vd (X 10-3) Vh /Vd
2.0 0.921 1.419 0.649
3.5 1.321 2.598 0.509
5.0 1.560 3.891 0.411
7.0 1.861 5.821 0 .320
Î
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The isotope effect is clearly inverse, but could not be determined accurately from 
the narrow range of inhibitor concentrations amenable to kinetic analysis, as the rate of 
Inactivation at points near V^ax was too fast to be measured using the radiochemical 
method. Nevertheless, the existence of an inverse isotope effect indicates thatC“-C0 2 ‘ 
bond cleavage occurs. The C“-C0 2 ‘ bond must be disposed on the 4 ’- re-face of the 
coenzyme as the binding position of the distal sulphate group is identical for all 
substrates and inh ib i tors ,and so the reaction occurs on the C-4’-re-face of the 
coenzyme. The bond cleavage step is rate-limiting, and the observed isotope effect 
values could represent secondary a-isotope effects where the bond is stiffer in 
the transition state than in the product external aldimine.^^® However, the magnitude of 
the measured inverse isotope effect is too large to be due a secondary a-isotope effect 
and a more likely explanation is that there are alternative reaction pathways which do 1
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not lead to inactivation of the enzyme which are suppressed on the addition of 
deuterium. This would make the rate of inactivation faster for the deuteriated inhibitor 
than the non deuteriated one, this is an induced isotope effect. ‘^ (V/K) for the 
inactivation reaction was 1.0  indicating that there is a large reaction commitment to the 
first isotopically sensitive step and that the suicide substrate is extremely stick y , 
contrast to the (2S)-enantiomer. The data is consistent with an early C-OSO3 bond 
ionisation.
In order to verify our conclusion we wanted to inactivate GAD with (2R)-[U-^^G]-serine 
O-sulphate. This study had not been carried out previously due to the lack of 
availability of (2R)-[U-i'^C]-serine (section 2.4). In order to obtain a sample of (2R)-[U- 
^^C]-serine O-sulphate, (2S)-[U-^^C]-serine would need to be racemised, followed by 
the resolution of the racemate to yield (2R)-[U-^^C]-serine. The (2R)-[U-^^C]-serine 
could then be converted into (2R)-[U-^^C]-serine O-sulphate. The synthesis of (2R)-[U-
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A proton NMR experiment with (2R)-serine O-sulphate (0.226 mmol) and GAD (8.467 
nmoles) in 1 ml of 0.1 M pyridine/DCI buffer at pD 4.2 was carried out. No new signals 
were detected for times up to 113 hours. However, the maximum amount of ‘I
Schnackerz adduct produced would only be about 1% of the amount of (2R)-serine O- 
sulphate present at t=0, and so would not be seen. The rate of the alternative reaction 
pathway cannot be slower than the inactivation or the introduction of deuterium would 
not result in the Increased rate of the pathway leading to inactivation. It is likely that the 
two rates are similar and, therefore, It is hardly surprising that no new signals were 
seen in the proton NMR spectrum. It was impractical to attempt to isolate the products 
of the inactivation reaction as a very large amount of enzyme would be required to form 
a realistic amount of the Schnackerz adduct.
1
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'^^Cj-serine O-sulphate in this manner would be time consuming due to the resolution 
step. The possibility of incubating (2RS)-[U-^'^C]-serine O-sulphate (151) with the 
enzyme was therefore investigated. Any ^"^002 evolved would be from the (2R)-[U-^'^C]- 
serine O-sulphate as (2S)-[U-^'^C]-serine O-sulphate does not liberate ^"^002 during the 
inactivation process (section 2.2.4).
N-Acetyl-(2RS)-serine (152) was prepared by reaction of (2S)-serine with acetic 
anhydride and pyridine in w a t e r . Racémisation occurs when the acidic hydrogen of 
the aziactone intermediate exchanges with the solvent (Scheme 2.22). Hydrolysis of 
the N-acetyi-(2RS)-sehne (152) in 2 M HCI, followed by treatment with propylene 
oxide in ethanol gave the required (2RS)-serine (153) in 54% yield with an [a]pof 
+0.15° compared to 11.41° for pure (2S)-serine (c. 2.0 in 1 M HCI). (2RS)-[U-^'^C]- 
Serine (154) was prepared in an identical manner to the non labelled racemate (153) 
in 77% yield {[a]o+3°, (c. 2.0 in 1 M HCI)}.
The (2RS)-[U-^^C]-serine (1 5 4 ) was converted to (2RS)-[U-^'^C]-serine O-sulphate
(155) using the method of Tudball.^®  ^Incubation of a 10 mM solution of (2RS)-[U-^'*C]- 
serlne 0-suiphate (155) (400 pi, 20.956 nCi) in 0.1 M pyridine/HCI buffer with the 
enzyme (1 mg) at pH 4.6 and 37 °C was carried out, so that any "^^ C0 2  liberated would 
be trapped in barium hydroxide solution (10 ml). The amount of radioactivity remaining
in the solutions, after the inactivation, was determined using a scintillation counter. |
1Radioactivity («400 molar equivalents) was lost from the serine O-sulphate solution t
,lïalthough an increase was not detected in the barium hydroxide solutions. The j
inactivation experiment was repeated using larger quantities of enzyme (3.5 mg) i
attempting to trap the CO2 in a smaller volume (2 ml) of barium hydroxide. Again the j
. If
radioactivity of the incubation solution decreased but much lower quantities of "^^ C0 2  !
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were detected in the barium hydroxide solution.
NHc
COoH
OA
NH
.OHOH
O
HoC^ NH
COgH
u
NHg
COgH
H.C
.OH.OH
a
OH
O
Scheme 2.22. Racémisation of {2S)-serine.
To verify that this effect was due to the (2R)-[U-^'^G]-serlne O-sulphate, we decided to 
attempt to resolve the racemate. Resolution of the racemate Involved the preparation of 
N-acetyl-{2RS)-serine (152) which was then incubated with pig liver acylase for 24 
hours. The acylase catalyses the hydrolysis of N-acety!-(2S)-serine at a much faster 
rate than hydrolysis of the (2R)-antipode. The (2S)-serine and N-acetyl-(2R)-serine
(1 5 6 ) can be separated by ion exchange chromatography and the resolution is 
achieved. The optical rotation of the (2R)-serine (157) from the resolution process was 
1.75 ° compared to +7.87 ° for an authentic sample (c. 2.0 in H2O). The (1 ’S, 4’R)- 
camphanamides of authentic (2R)- and (2S)- serine (158,159) were synthesised and
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the chemical shifts for the three serine protons were indistinguishable. These 
camphanamides (158,159) were converted to methyl esters (160,161) by reaction 
with diazomethane, and proton (Figure 2.6 i and ii) and carbon NMR spectra obtained 
at 400 and 100 MHz respectively. The proton NMR spectrum of the (TS ,4 ’R)- 
camphanamide methyl ester of (2R)-serine (162) isolated from the resolution process 
was obtained (Figure 2 .6 . iii) and the enzymically derived (2R)-serine found to be a 
mixture of 58 % (2R)-serine and 42 % (2S)-serine. The resolution step was therefore 
not viable and so this route was not explored with the radioactive material.
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Figure 2.6. The 400 MHz proton NMR spectra in CeOgN of i) (2S)-serine camphanamide methyl
ester (160), «) (2R)-serlne camphanamide methyl ester (161) and iii) the camphanamide methyl
ester of (2R)-serine after resolution of N-acetyi-(2RS)-serine with acylase (162).
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2.7.3 Incubations of (2S)- and (2R)-homocysteic acid with GAD
Homocysteic acid {2-aminobutanoic acid-4-sulphonic acid) (163) is isosteric with 
glutamic acid and serine O-sulphate. The side chains of glutamic acid, homocysteic 
acid and serine O-sulphate are - CH2CH2CO2H, -GH2CH2SO3H and -CH2OSO3H 
respectively. The conformations adopted by each of the side chains in the presence of 
GAD are therefore expected to be similar. Both enantiomers of homocysteic acid were 
incubated with the enzyme. The (2S)-antipode was found to form a GABA analogue, 3- 
aminopropane sulphonic acid, whereas the (2R)-antipode was unchanged after the 
same incubation period. As (2R)-glutamic acid and (2R)-homocysteic acid do not react 
with GAD, the inactivation reaction with (2R)-serine O-sulphate must be due to the 
presence of the sulphate group as a good leaving group.
NH
H
(163)
Equivalent amounts of 10 mM (2S)-glutamic acid and (2S)-homocysteic acid (0.5 ml of 
each) in 0.1 M pyridine/DCI buffer at pH 4.6 were mixed together and glutamate 
decarboxylase (0.2 mg) was added. The reaction was followed by proton NMR 
spectroscopy; after 40 minutes all of the glutamic acid had been converted to GABA, 
but It was several days before there was any appreciable conversion of the (2S)- 
homocystelc acid to Its GABA analogue. From the large difference In reaction rates we 
can deduce that V/K for the a-decarboxylation of (2S)-homocystelc acid Is «1/250 of 
V/K for (2S)-glutamic acid.
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2.7.4 Uv/vis measurements on the inactivation mixture
No experiments to trap Intermediates in the inactivation path for the {2S)- and (2R)- 
serine O-sulphate have been carried out. It was discovered that the amount of 
given off during the inactivation of the GAD by (2R)-serine O-sulphate (59) was 
equivalent to «500 turnover events. We wanted to determine whether any pyruvic acid 
or acetaldehyde was released during the inactivation process. Alcohol dehydrogenase 
and lactate dehydrogenase reduce acetaldehyde and pyruvic acid to ethanol and 
lactate respectively. These enzymes require p-nicotinamide adenine dinucleotide, 
reduced form (NADH), for their activity. On reduction of a substrate the cofactor is 
oxidised. NADH has an absorption maximum at 340 nm (e6220 dm  ^mol'  ^ cm )^. As the 
NADH is oxidised to NAD+ the magnitude of the absorption at 340 nm is reduced. This 
property of NADH allows the reactions of alcohol dehydrogenase and lactate 
dehydrogenase to be studied by uv/visible spectroscopy. An aliquot (10 pi) of each 
inactivation mixture was added to 1 ml of a 100 mM potassium phosphate buffer 
solution at pH 7.0 containing NADH (150 mM) and alcohol dehydrogenase (0.1-0.2 
mg) or lactate dehydrogenase (0 .1 -0 .2  mg). Control experiments showed that the 
presence of acetaldehyde or pyruvic acid in the inactivation solution would be detected 
by a decrease in the absorption maximum at 340 nm. However acetaldehyde and 
pyruvic acid were not detected in the inactivation solution of either (2 S)- or (2R)-serine 
O-sulphate (21,59).
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2.8 Conclusions
E. coli GAD is inactivated by both enantiomers of the suicide inhibitor serine O- 
suiphate; inactivation by the (2S)-antipode appears to involve C “-H bond cleavage 
while inactivation by the (2 R)-isomer involves C^-decarboxylation. If the distal -OSO3 
binding group occupies the same position in each of the external aldimines of the two 
suicide substrates then both of the inactivation events involve the loss of electrofuges 
from the 4'-re-face of the coenzyme. The fact that {2S)-homocysteic acid is a 
decarboxylation substrate for GAD whereas the {2R)-antipode is not is in accord with 
this analysis. The torsional geometry of the distal -OSO3' group which leaves during 
each reaction should be anti- to the 4’- re-face electrofuge. In these conformations the 
activation energies for the concerted processes could be lower than those for the 
alternative stepwise (stabilised carbanion) 4'-sMace processes which are expected for 
pyridoxal systems^^ but which are not observed here.
Tilley's work^"^ has indicated that the distal binding groups of substrates and inhibitors 
of GAD occupy similar positions at the active site on the 3’-phenolic group side of the 
coenzyme.
Marquet^^  ^ has studied the interaction of (2R,3R)- and (2R,3S)-3-fluoroglutamate 
(164 ,165) with E. co//GAD. Both isomers were substrates: the (2R,3R)-isomer was 
decarboxylated into optically active 4-amino-3-fluorobutyrate (166), whereas the 
(2R,3S)-isomer lost the fluorine atom during the reaction yielding succinic 
semialdehyde (167). The difference between the two isomers demonstrates that the 
external aldimine is present at the active site under a rigid conformation. The C“-C0 2 ‘ 
bond must be perpendicular to the plane of the pyridinium rlng.^ "* In order for p-
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elimination to occur the C^-F bond must be coplanar with the C“-C0 2 ‘ bond. It is most 
likely that the C^-F bond will be trans to the C“-C0 2 * bond resulting in ant/-elimination, 
as is depicted in Scheme 2.23. The external aldimines for the (2R,3R)- and (2R,3S)-3- 
fluoroglutamates (168,169) are shown with the distal CH2CO2' group occupying the 
same space. It can be seen that the CP-F bond is correctly positioned for elimination in 
the external aldimine (169) but this is not the case for the aldimine from (2R,3R)-3- 
fluoroglutamic add (168).
Therefore we would expect the Schiff's base for each of the serine O-sulphate 
inhibitors at the active site of GAD (170 ,171 ) to be held in a rigid conformation 
(Scheme 2.24, 2.25). The conformational preferences of the (2S)-and (2R)-serine O- 
sulphate were assessed using the Monte Carlo simulation. The trans and anti- 
conformations were found to be highly populated.
For both the (2S)- and the (2R)-serine O-sulphate the cleavage of the C “-H and C “- 
CO2 bonds on the 0 -4 - re-face of the coenzyme occurs in preference to the expected 
reaction on the C-4’-sMace of the coenzyme due to the position of the OSO3' leaving 
group enabling a facile elimination to occur. These events lead to the inactivation of 
the enzyme, without decarboxylation for (2S)-serine O-sulphate and with 
decarboxylation for (2R)-serine O-sulphate.
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Scheme 2.23. Reaction of GAD with (2R,3R)- and (2R,3S)-3-fluorogiutamate.
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NHc
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CH CH
H
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Scheme 2.24. inactivation of GAD by (2S)-serine O-sulphate, showing the 
rigid conformation of the Sch'rff’s base.
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Scheme 2.25. Inactivation of GAD by (2R)-serine O-sulphate, showing the rigid 
conformation of the Schiff’s base. -1 :
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CHAPTER THREE
SERINE HYDROXYMETHYLTRANSFERASE
I
3.0 Serine hydroxymethyitransferase (SHMT)
'i
Serine hydroxymethyltransferase (SHMT) (EC 2.1.2.1)^^^ is a pyridoxal 5'-phosphate 
(PLP) dependent enzyme which catalyses the reversible retro-aldol cleavage of (2S)- 
serine to glycine and formaldehyde. Under physiological conditions, tetrahydrofolic 
acid (FH4) traps the nascent formaldehyde and is converted to 5,10-methylene 
tetrahydrofolic acid (S.IO-CHgFH^) (Scheme 3.1).
H
NH.
,0H HN
HN
tetrahydrofolic acid {FH4 )
HN
serine hydroxymethyltransferase 
(SHMT)
C02H
glycine
5,10-methylene tetrahydrofolic acid
(5,10-CH2FH4) ^^CHgCHoCOoH
COgH
Scheme 3.1. The physiological reaction catalysed by SHMT.
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Considerable indirect evidence, from feeding labelled substrates to wfiole animals, 
has suggested that the physiological role of SHMT is the generation of one-carbon 
groups in the form of 5 ,10 -methylene-FH4 . These units are required in the biosynthesis |
of many primary metabolites including purines, thymidylate, and methionine.
The one-carbon units transferred to the tetrahydrofolic acid from serine by SHMT are 
also used in the formation of secondary metabolites. The enzyme, therefore, performs 
a key role, linking primary and secondary metabolism. SHMT is widely distributed in 
nature and has been studied in, and purified from, prokaryotic^^^ and eukaryotic 
systems (vertebrate,invertebrate^^ and plant^®).
3.1 Properties and structure of SHMT
3.1.1 Properties and structure of mammalian SHMT
Mammalian SHMT has been purified to homogeneity from rat,^^ r a b b i t , b e e f , ^  and 
sheep liver. ^  The enzyme is known to be present in mammalian brain, kidney, uterus, 
prostate and lymphocyte tissue. SHMT exists in both the cytosol and the mitochondria 
of eukaryotes. The cytosolic and mitochondrial isoenzymes have been purified to 
homogeneity from rabbit^ ®^  and from rat l i v e r . T h e  mammalian isoenzymes possess 
different amino acid sequences and molecular weights (Table 3.1) indicating that they 
are the products of different genes,
:
Table 3.1. SHMT protein properties.
Source Mr
(Daltons)
Subunit
(Daltons)
No.
(per
Cys I . E . P . 
subunit)
rabbit liver (cyt.) 215000 55000 8 7.2
rabbit liver (mit.) 210000 53000 6 7.2
rat liver (cyt.) 216000 56000 3 4.95
rat liver (mit.) 204000 54000 3 5.30
E. cold 95000 47000 3 <6.QA
F. me thy1ot roph 100000 100000 B
F. methylotroph (M)232 200000 50000 C
A 30% homology with rabbit liver (cyt.), B activated by Ca^+, K+, Na+, Mg^+, Mn^+, Zn^+, C activated 
byCa^+, K+, Na+.
It has been proposed^^® that the cytosolic and mitochondrial enzymes participate in a 
shuttle system to link one-carbon metabolism in the two cellular compartments. The 
mitochondrial membrane is Impermeable to tetrahydrofolic acid, but serine and glycine 
are readily transported through the membrane. SHMT could, therefore, act as a major 
control enzyme in balancing the two isolated tetrahydrofolic acid pools (Scheme 3.2).
SHMT has also been found in nerve tissue,^^ where it is proposed to be important in 
either supplying methyl groups, via S.IO-methylene-FH^, required for the biosynthesis 
of various neurotransmitters (e.g. histidine and tryptophan), or in regulating the glycine 
pool. Note that glycine is a major inhibitory neurotransmitter.
I l l
glucose
3-phospho-
glycerate
\\
^ serine
cholinepyruvate
serine
thymidylate
SHMT SHMT
\ I
glycine
purines
glycine
methionine
NAD
NADH
CO2 + NH4+ 
MATRIX
|mltochondrlal 
: membraneCYTOSOL
Scheme 3.2. The location of SHMT In mammallian systems.
3.1.2 Properties and structure of plant SHMT
SHMT activity has also been found in plant tissue. In higher plants the activity is 
restricted to the mitochondrial matrix.^ ®® The enzyme has been partially purified from 
cauliflower where It was found to utilise PLP and FH4 as coenzymes. The addition of 
the potassium ion was found to stimuiate the enzyme catalysed reactlon.^^® A report on 
the purification of SHMT from mung bean (Wgna radiata)^^^ to homogeneity claimed 
that the enzyme did not require added PLP for full catalytic activity. The mung bean
1 1 2
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enzyme is, to date, the only known non PLP-dependent SHMT and therefore PLP may
not be involved in the reaction catalysed by this enzyme. A study of the mung bean Ii
enzyme active site and the catalytic mechanism of action of this enzyme may give an 
insight into the role of PLP. In plants the metabolism of glycine and (2S)-serine is 
closely linked with the glycolate pathway and photorespiration as shown in Scheme
3.3.
I
JA primary role of plant SHMT is as a catalyst for the formation of {2S)-serine. The 
(2S)-serine is converted by a series of reactions to 3-phosphoglycerate, which is 
utilised in the Calvin cycle. Scheme 3.4.
SHMT has also been studied in baker's yeast {Saccharomyces cerevisiae) where it is 
involved in the synthesis of methionine and S-adenosylmethionine.^^®
L.-;,
rîbulose diphosphate
CO2
tvia the Calvin.. 3-Phospho
S
§Ti
Ç
a
cycle glycerate phosphoglycolate
hexoses
1
glycei ate
r
glycolate
hydroxypyruvate
glycolate
glyoxylate
serine amino
donor
glycine
glycine
glycine cleavage 
system
glycine
serine
SHMT
"O
3
i
0
1
2IiS>
Scheme 3.3. The role of (2S)-serine and glycine in photorespiration and the
glycolate pathway.
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Scheme 3.4, The Calvin cycle.
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3.1.3 Properties and structure of bacterial SHMT
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SHMT has been purified to homogeneity from both E. and a facultative
methylotrophic bacterium.^^^ For both microorganisms, the enzyme’s major function is 
to provide glycine for protein and purine synthesis and 5,10-methylenetetrahydrofolic 
acid for the one-carbon pool. In the case of microorganisms which use reduced 
one-carbon compounds as the sole source of carbon, the biosynthesis of serine is I
utilised by the microorganism as a energy generating pathway. The problem these 
organisms face in regulating two pathways which require the same chemical 
conversions has been tackled by the expression and use of two different isoenzymes.
For a methylotrophic bacterium, one isoenzyme predominates when the organism is 
grown on methane or methanol, and this was found to be activated by glyoxaiate.
When the organism is grown on succinate, a different isoenzyme, which is activated by 
Mg^+, Mn^+, or Zn^+, is p rodu ced .S o m e  pathways involving SHMT in methylotrophic 
bacteria are shown in Scheme 3.5.
Cell material
Oxaloacetic acidI
Phosphoenol Pyaivate
3-Phosphoglycerate
Phosphohydroxypyruvate
Phosphoserine
Glycerate
Hydroxypyruvate
Serine Serine
FH4 
SHMT (S)
Glycine
MethionineAdenine
Guanine
Glycine
Methanol
Glyoxaiate
Methane
Thymine S-Adenosylmethionine 
Scheme 3.5. Pathways involving SHMT in methylotrophic bacteria.
117
I l•*
3.1.4 Serine hydroxymethyltransferase as a chemotherapeutic 
target
Methionine has been observed to exacerbate the symptoms of schizophrenia in some 
patients. The observation has suggested that elevated levels of SHMT may, in part, be 
a cause of this d i s e a s e . A s  there is some evidence that in both prokaryotic and in 
eukaryotic cells, methionine levels regulate SHMT, by an as yet unknown mechanism, 
it is possible that the level of activity of brain and liver SHMT in schizophrenic subjects 
is abnormal. The levels of activity of liver SHMT were discovered to be higher in 
schizophrenic patients compared with non-schizophrenic patients after methionine 
loading.24° However until the method of control exerted by (2S)-methionine on SHMT 
is understood, this result is of little therapeutic potential.
Rapidly proliferating tissues require an increased supply of one-carbon groups. These 
one-carbon groups are used for the synthesis of the purine and pyrimidine bases 
required in the biosynthesis of DMA. It would, therefore, be expected that these tissues 
should have elevated levels of SHMT. The level of SHMT is found to be elevated in 
some types of tumour cell. Patients with chronic lymphocytic leukaemia have raised 
levels of SHMT, "^^  ^ whilst malignant mouse L1210 cells were found to contain SHMT 
with altered kinetic properties. "^^  ^ (2R)-Cyc/oserine (172) (Figure 3.1) has been shown 
to Inhibit the growth of Friend leukaemia cells in mice,^^  ^ and tetrahydrohomofolic 
acid^ i^ (173) (Figure 3.1) inhibits SHMT from L I210 cells. (2R)-Cyc/oserine (172) and 
tetrahydrohomofolic acid are not specific for SHMT and so their cytotoxicity is not 
clearly linked to the inhibition of SHMT, The reason for their inhibitory effects requires 
further study.
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HpN
HN
O
O 
(172) 
(2R)-cyc/oserine
tetrahydrohomofolic acid 
Figure 3.1. Inhibitors of SHMT.
^CHgCHgCOgH
COgH
Inhibiting SHMT interferes with the supply of one-carbon units for thymidylate 
synthetase. However SHMT has serious disadvantages as a chemotherapeutic target 
compared to thymidylate synthetase [inhibited by 5-fluorouracil (174)], or dihydrofolate 
reductase [Inhibited by methotrexate (175)]^^^ (Scheme 3.6), due to its wide tissue 
distribution and probabie regulatory role in nervous tissue.
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Scheme 3.6. The synthesis of thymidylate.
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3.1.5 Substrate and reaction specificity
SHMT has been shown to exhibit a broad substrate and reaction specificity (Table 3.2). 
As well as catalysing the aldolase activity (reactions 1 _g244-249 pelow) in which a 
3-hydroxyamino acid undergoes a reversible retro-aldol cleavage, the enzyme has 
also been shown to catalyse several other reactions. These reactions include a slow 
(10'^ times the rate of reaction with (2 S)-serine/FH4) half transamination reaction with 
(2R)-alanine (reaction 13),^ ^® the condensation of a number of 2-ketoacids with 
pyridoxamine 5' phosphate (PMP) in the reverse of this r e a c t i o n , a n d  a fast 
decarboxylation reaction with aminomalonate®'^ (three times the rate of reaction with 
(2 S)-serine/FH4 ) (reaction 18). SHMT has also been shown to catalyse exchange of 
the pro-S  hydrogen of glycine (but not the pro-R hydrogen) (reaction 9),^ ®  ^ the 
exchange of the a-hydrogen of several (28)-amino acids (reactions 11 and 12 ),^ ®^  and 
most recently the racémisation of a l a n i n e . S H M T  demonstrates the catalytic activity 
of several classes of pyridoxal 5’-phosphate dependent enzymes and so an in-depth 
study of the structure-function relationships in SHMT has been made.
Table 3.2. The reaction and substrate specificity of SHMT.
ALDOLASE REACTION
1. (2S)-serine + FH4
2. (2S)-a-methylserine + EH4
3. (2S/3S)-threonine
4- (2S,3R)-threonine
5. (2S/3R)-3-phenylserine J
6. (2S,3S)-3-phenylserine
7. (2S,3R)-3-phenylserine 
methyl ester
Ref.
—  glycine+5,IO-CH2BH4 244
(2r)-alanine + 5 ,10-CH2FH4 245
glycine + acetaldehyde 246
glycine +• acetaldehyde 246
Ütr glycine+benzaldehyde 247
^  glycine+benzaldehyde 247
glycine methyl ester 
benzaldehyde 247
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e-1 rimethy1-3-hydroxy- 
lysine
glycine + y-butyrobetaine 
aldehyde 248
also a substrate; (2S,3S)-3-phenylcysteine (NT29)
a-PROTON EXCHANGE :
(2S)-proton
9. (2S)- [ -glycine + H2O :
10- (2R)-[^H]-alanine + H2O :
(2R)-proton
11- (2S)-[3h ]-alanine + HgO (2S)-alanine + % 0  252
12- (2S)-phenylalanine + ^H2C W  : —  (2S) - [2-^H]-phenylalanine 252
glycine + ^H20 
(2R)-alanine + ^H20
(2S)-alanine 20
251
228
also substrates; {2S}-tryptophan, (2S)-cyanoglycine, (2S)-leucine, 
(2S)-isoleucine and (2S)-valine
TRANSAMINATION :
13. (2R)-alanine + PLP
14- (2S)-alanine + PLP
15- glyoxaiate + PMP
16. f luoropy ruvat e + PMP
n o t  transaminated;
pyruvate + PMP 
pyruvate + PMP 
glycine + PLP 
(2R)-3-fluoroalanine
228
252
250
250
(2S)-serine, 
(2R)-threonine, and (2R>-phenylalanine.
glycine, (2R) -serine.
RACEMISATION;
17. (2S)-alanine
DECARBOXYLATION:
18 - aminomalonic acid
(2R) -alanine
glycine + CO2
253
64
1 2 2
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3.1.6 Role of pyridoxal 5 -phosphate
initial mechanistic studies on SHMT took advantage of the fact that the conjugated 
K-system of the PLP-Schiffs base couid be used as a uv active probe to investigate the 
catalytic events of the physiological reaction. The holoenzyme has an absorption 
maximum at 428 nm due to the internal aldimine (Scheme 3.6, (176)). The addition of 
saturating levels of glycine to the incubation mixture resulted in the appearance of 
three new bands at 343, 425 and 495 nm. The order of appearance of these new 
bands was determined using rapid reaction kinetics, and allowed structural 
assignments for these bands to be made [structures (177), (178) and (179)].^®'* High 
concentrations of (2S)-serine produced absorption maxima at 495, 427 and 343 nm.
The use of a combination of stopped-flow and temperature-jump kinetic studies 
enabled the assignment of these absorptions to the structures (179), (180) and (181) 
as shown (Scheme 3.7).
The holoenzyme (176) undergoes nucleophilic attack at C-4’ by the amino group of 
the substrate to give a geminal diamine (177). A synchronous proton transfer from the 
glycyl nitrogen to the e-amino group of the active-site lysine group also occurs. After the 
proton transfer the lysine e-amino group leaves concertedly with the formation of 
another imine at C-4’. This completes the transaldimlnation reaction and gives the 
external aldimine (178). As yet SHMT is the only enzyme for which the geminal 
diamine (177) has been observed, suggesting that for SHMT there may be a large 
conformational change in the protein on formation of the external aldimine (178). I
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Scheme 3.7. The proposed mechanism for the reaction catalysed by SHMT 
with assigned uv absorption maxima.
124
'  - -~
'41
. V-"
Following the formation of the external aldimine (178) (Scheme 3.7.) abase on the 
enzyme then removes the pro-S hydrogen of glycine moiety of the external aldimine to 
form the quinoid intermediate (179). The quinoid intermediate has several contributing 
resonance structures which give rise to the characteristic absorption maximum at 495 
nm. In the absence of an aldehyde the reaction, which is thus far completely reversible, 
stops and an equilibrium distribution of complexes (176) to (179) can be observed.
(2S)-Serine is the substrate for the retro-aldol cleavage reaction. The retro-aldol 
reaction involves a similar series of events, culminating in the cleavage of the C“-C*^  
bond. Studies on the retro-aldol reaction^^® have shown that the enzyme can cleave 
(2S)-serine to glycine and formaldehyde in the absence of tetrahydrofolic acid, but the 
formaldehyde remains at the active site preventing further reaction unless 
tetrahydrofolic acid is added.
Kallen et aA 3^o,2S6 studied the pre-steady state and steady state kinetics of the 
conversion of (28)-3-phenylserine to glycine and benzaldehyde, using the enzyme 
from iamb liver, in the absence of FH4 a detectable concentration of the quinoid 
intermediate (179), absorbing at 505 nm, was formed. Stopped-flow experiments have 
indicated that the cleavage of (2S)-3-phenylserine is followed by an ordered release of 
products, benzaldehyde and then glycine. In deuterium oxide the release of glycine 
shows an isotope effect of 6  on V^ax, suggesting that addition of the proton to the 
quinoid intermediate (179) is the rate determining step in the release of glycine.
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3.1.7 Role of tetrahydrofolic acid
The observation that only reactions 1 and 2 (Table 3.2) have a requirement for FH4 
suggests that the involvement of formaldehyde in these two reactions introduces 
constraints which are not imposed by the other aldehydes. Formaldehyde exists almost 
totally as the hydrate in aqueous solution and so the primary role of FH4 is probably to 
transport formaldehyde to and from the active site in a chemically useful form. High 
concentrations of formaldehyde have been found to inhibit SHMT,^^^ The inhibition 
suggests that the hydrated form of formaldehyde is a competitive inhibitor.
The addition of FH4 to incubations of (2S)-serine and SHMT has been shown to 
increase the overall rate of the retro-aldol cleavage reaction by a factor of 160. In the 
reverse direction FH4 Increases the equilibrium concentration of the quinoid 
intermediate (179) 25-10 .^^^^  ^ It was first thought that these Increases were due to 
either or more likely acting as a base. However studies using analogues of 
5 ,1 0 -methylene-FH4 in which or is blocked (i.e. N^°-formyl, N®-methyl), 
have shown similar increases In the reaction rate, implying that FH4 does not 
participate directly in formation of the quinoid intermediate. Temperature jump 
experiments, in the absence of FH4 and formaldehyde, have shown that the rate of 
formation of the quinoid intermediate from glycine is two orders of magnitude greater 
than the rate of exchange of the a-proton of glycine with those of the solvent. Addition 
of FH4 accelerates the proton exchange reaction by more than two orders of 
magnitude, possibly due to greater exposure of the base to the solvent, while the rate 
of formation of the quinoid intermediate is increased less than fourfold. The changes in 
the presence of FH4 are thought to be due to the FH4 slowing down the step in which 
reprotonation of the quinoid Intermediate occurs.
1 2 6
In the absence of FH4, the rate determining steps in the very slow reversible 
conversion of glycine and formaldehyde to {2S)-serine, have been shown to be either 
the slow addition of formaldehyde at the active site in a reactive form (serine 
synthesis), or the slow release of formaldehyde from the active site (serine 
breakdown).
Indeed the presence or absence of FH4 changes the kinetic mechanism of serine 
hydroxymethyltransferase.^®^ In the absence of FH4 , the binding of 
substrates/debinding of products is sequentially ordered.
However, the addition of FH4 causes the binding of substrates/debinding of products to 
change to a random process. The change of mechanism suggests that addition of FH4 
not only makes the addition/removal of formaldehyde from the active site less rate 
determining, but also causes the protein to form an ‘open’ conformation which allows 
glycine or (2S)-serine to bind in the presence of FH4 or 5 ,10 -methylene-FH4, 
5 -Methyl-FH4 and 5 ,10-methylene-FH4 are both non-competitive inhibitors of 
(2S)-serine, suggesting that the one-carbon binding site can accommodate two 
one-carbon units simultaneously without steric hindrance.
In a series of elegant experiments, Chen et a/.^^ showed that FH4 is converted to 5,10- 
methylene-FH4 which acts as a one-carbon carrier for the enzyme. It was established 
that the one-carbon moiety did not leave the active site as either HCHO, or 
5 -hydroxymethyl-FH4. It was also showed that the formation of 5,10 -methylene-FH4 
from HCHO and FH4 was not catalysed by SHMT.
There are still many questions concerning the involvement of tetrahydrofolic acid In the
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ireaction catalysed by SHMT that remain unanswered. These include, how the 
one-carbon unit is transferred from serine to FH4, and also what the distance and 
orientation of the FH4 binding pocket are with respect to the external aldimine. It is 
possible that the binding of FH4 and analogues causes a large conformational change 
in the protein, possibly revealing a concealed active-site base which is used to 
mediate the transfer of the hydroxymethyl group.
3.1.8 Stereochemical studies
The reversible retro-aldol cleavage catalysed by SHMT is specific for (2S)-3-hydroxy 
amino acids. SHMT catalyses the reaction with both threo- and erythro- 
diastereolsomers. (2S,3R)-Threonine and (2S,3S)-threonine are s u b s tra te s ,a s  are
(25.35)- and (2S,3R)-3-phenylserines.^'^^ For the retro-aldol cleavage, all pure SHMT 
enzymes so far studied show higher V^ax and lower Km values for the (2S,3R)-isomer. 
The SHMT catalysed condensation of glycine and acetaldehyde gives 98%
(25.35)-threonine and 2% (2S,3R)-threonine.® '^^®^
The irreversible inactivation of SHMT by (2R)-alanine has been shown to be due to a 
slow transamination reaction in which (2R)-alanine is converted to pyruvate, and the 
active-site PLP is converted to PMP (Scheme 3.8). The PMP readily dissociates from 
the active site, leaving the inactive apoenzyme. This reaction could be predicted by 
Dunathan’s postu latefor stereoelectronically assisted cleavage. If one assumes that 
each amino acid is bound with the carboxyl group In the same position, the a-proton of 
(2R)-alanine occupies the same position as the hydroxymethyl group of (2S)-serine.
Using the same postulate, Dunathan predicted that SHMT would catalyse the removal J
of only one of the a-protons of glycine, that in the pro-S position. This has since been
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confirmed.^®"^®  ^ The external aldimine in the transamination of (2R)-alanine is 
deprotonated/protonated at both C“ and C-4’ from the 4’-s/-face of the coenzyme 
(Scheme 3.8)/®'^®® This indicates that the 4’-s/-face of the coenzyme is exposed to the 
solvent. In all (2S)-amino acid transaminases that have been studied the aldimine is 
also protonated from the 4’-s/-face of the coenzyme. This has been interpreted as 
evidence for an evolutionary relationship among PLP dependent enzymes. It has also 
been suggested that all vitamin Be dependent enzymes have evolved from a common 
precursor enzyme, from which the orientation of the pyridoxyl ring has been preserved. 
A difference between transaminases and SHMT is that for a transaminase the glycine 
pro-R proton is transferred to 0-4’, whereas in SHMT it is the glycine pro-S proton that 
is transferred. This difference illustrates that the amino acid substrates are bound 
differently in the external aldimine of these enzymes.
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Scheme 3.8. The stereochemical course of the transamination of (2R)-alanine catalysed by
SHMT.
There are three reactions described in the literature for which the reported 
stereochemical courses were not in accord with our current understanding of the 
mechanism of SHMT. First, the rapid decarboxylation of aminomalonic acid^ was 
reported to occur without stereochemical preference for either the carboxyl bond 
cleavage step, or the quinoid intermediate reprotonation step. Second, the exchange 
of the a-proton of (2S)-phenylalanine and several other amino acids^ "^ *^^ ®^  with 
deuterium. Third, the racémisation of a l a n i n e . A  rationalisation for the
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aminomalonate decarboxylation reaction is presented in section 3.2.2.
investigation of the exact mechanism of the cleavage of the bond of (2S)-serine, 
using stereochemical probes, has also produced some puzzling results. Benkovic et 
a l .^  investigated the stereochemical course of one-carbon transfer using samples of 
(2S)-serine stereospecifically labelled with tritium at C-3, and found that the reaction 
was only partially stereospecific. If free formaldehyde was produced, it should be able 
to freely rotate at the active site and hence produce 5,10-methylene-FH^ labelled 
equally in both positions. If however, the formaldehyde was covalently bound at the
active site as a hemithioacetal, for example, one might expect either retention or 4
IInversion of configuration of the C-3 moiety in the transfer to 5 ,10-methylene-FH4- They |
determined the stereochemical purity of the labelled 5,10-methylene-FH^ using an 
enzymic method in which the 5,10-methylene-FH 4 was oxidised to 5 ,10 -methenyl-FH4 
with 5,10-methenyltetrahydrofolate dehydrogenase and NADP+. Starting with 
(2S)-[3-®H] serine, 76% of the label was retained in the 5 ,10 -methenyl-FH4. When 
(3R)-[3-^H] serine was used, the 5 ,10 -methenyl-FH4 contained 24% of the tritium.
These results were in accord with earlier experimental findings^ with rat liver slices, 
which had shown that [®H]-formate was converted to (2S)-[3-^H]-serine with 72% of the 
label in the 3-pro-S position. From these findings it was impossible to determine 
whether formaldehyde transfer was via an intermediate thiohemiacetal.
Relevant to this work, Akhtar et a l .^  discovered that acetaldehyde produced from the 
SHMT catalysed retro-aldol cleavage of (2S,3R)-[3-^®0]-threonine contained This 
result eliminated the possibility that the acetaldehyde could form an intermediate imine 
with the active-site lysine residue after it had undergone the C®-CP bond cleavage, 
since formation of the imine would involve the loss of from the acetaldehyde.
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3.1.9 Active-site structure
No X-ray crystal structure for SHMT from any source has been reported although 
crystals of the rabbit liver mitochondrial enzyme have been produced.^^^ Attempts to 
Identify the amino acid residues present at the active site have, therefore, relied upon a 
combination of chemical and molecular biological techniques.
The first active-site amino acid to be identified was the lysine residue which forms an 
internal Schiff’s base complex with PLP. The reduction of the imine with sodium 
borohydrlde followed by acid hydrolysis of the enzyme resulted in the isolation of 
£-pyridoxyllysine.^^® A similar procedure using tritiated sodium borohydrlde, followed 
by proteolytic digestion, allowed the isolation and identification of a nonapeptide 
containing the e-pyridoxyllysine residue.^®  ^Through the use of a combination of such 
techniques and gene sequencing, it has since been shown that the decapeptide 
encompassing the active-site lysine is VVTTTTHKTL and the sequence is identical for 
the cytosolic and mitochondrial enzyme from rabbit liver and from E. co//.^^° The 
sequence contains the motif S(N,T)-X-H-K which is common in many PLP dependent 
enzymes which display decarboxylase activity including E.co l i  glutamate 
decarboxylase (see section 2 .1.8 for a table of active-site structures).
Although there are X-ray crystal structures available for some decarboxylases,^ they 
are not refined enough to determine the role of individual amino acids. Some insight 
into the role of the individual amino acids has been gained from examination of the 
active-site structures of aspartate aminotransferase (AAT) and tryptophan synthase, the 
only PLP-dependent enzymes for which good high-resolution X-ray crystal structures
are available (see section 2.1.8). Attention has been focused on the possible catalytic
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role of the histidine residue that is adjacent to the Schiff’s base forming lysine residue. 
The 3-hydroxy group of the serine residue (Ser257) that occupies an analogous 
position in AAT is known to form a hydrogen bond with one of the negatively charged 
oxygens of the PLP 5’-phosphate group.
Extensive kinetic studies on (2S)-methionine decarboxylase from Dryopteris 
fHix-mas,^^ and glutamate decarboxylase from £  colM^ have shown that there are (at 
least) two distinct bases involved In the catalytic mechanism of these enzymes (see 
section 2.1.7). These catalytically important histidine and lysine bases are also 
conserved in SHMT.
Evidence for several ionisable groups at the active site of SHMT has been produced 
using a variety of kinetic and spectral studies. A cationic group of pKa 6.2, which binds 
anions that are competitive inhibitors of the normal substrates has been found.^ ®® This 
cationic group is not at the binding site for the substrate amino acid a-carboxyl group in 
the external aldimine form as the for (2S,3S)-threonine is invariant between pH 5.8 
and 7.6. The uv spectrum of the enzyme-glycine complex varies as a function of pH as 
the different forms of the complex are obtained. Studies of this variation have 
concluded that the spectral shifts are due to the dissociation of a single proton from the 
enzyme-glycine complex with a pK@ of 6.9. For the rabbit liver mitochondrial enzyme, it 
is possible to observe that a group of pKa 9.0 affects the concentration of the quinoid 
intermediate. This ionisable group is probably the a-proton of the external 
glycine-Schiffs base complex.
Pre-steady state kinetic techniques have been used to investigate the cleavage of 
(2S,3R)-3-phenylserine by lamb liver SHMT. Ching and Kallen^^ observed a group of
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pKa 7.1 which was involved in the transaldimination process (compared with the group 
of pKa 6.9 in the rabbit liver enzyme and of pKg 6.2 in decarboxylases). Catalytically 
important groups of pKa 6.9 and 7.7 were also found, which were thought to be 
involved in the formation of the quinoid intermediate. The group of pKg 7.7 was 
proposed to be involved in the reprotonation of the group of pKg 6.9.
From these studies it was proposed that the conserved histidine residue was the group 
which possessed apKgOf 6 .2 , which was involved in the transaldimination and quinoid 
reprotonation steps. Site-directed mutagenesis (SDM) experiments were carried out 
on SHMT from E  co//, with His228 being replaced by an asparagine residue.^^®
The use of sulphydryl attacking reagents has suggested that there are one or more 
cysteine residues at the active site of SHMT from rabbit liver or Eco//.^^^ One of the 
cysteine residues was found to be involved In the mechanism-based Inactivation of the 
cytosolic rabbit liver enzyme by (2S)-3-fluoroalanine (Scheme 3.9).^^ -^^^^
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In the presence of tetrahydrofolic acid and {2S)-3-fluoroalanine, the enzyme was found 
to partition between transamination and irreversible inactivation. The inactivation 
reaction was shown to proceed via the attack of an active-site cysteine side chain at C- 
3 of the nascent aminoacrylate, to form a covalently attached inhibitor (Scheme 3.9). 
Interestingly, this same sulphydryl group was the putative acceptor group for transfer of 
nascent formaldehyde to serine and tetrahydrofolic acid via an intermediate 
hemithioacetal. Studies have now shown that this cysteine residue can be selectively 
blocked with methyl methanethiosuiphonate to form a methyl disulphide without 
affecting the catalytic activity.
Lamb liver SHMT is also inactivated by (2S)-3-fluoroalanine, however rabbit liver 
SHMT is not inhibited by this compound. It would be anticipated that the enzyme from 
E  coli would not be inhibited as it has no analogous cysteine residue. This raises the 
question of whether this cysteine residue is involved in a regulatory role, rather than a 
catalytic one.
A second active-site cysteine which is protected by PLP and which can only be 
chemically modified by denaturing the enzyme (6 M urea), or by forming the 
apoenzyme (through reaction of the holoenzymes with (2 R)-alanine or (2S)-cysteine) 
has been discovered. Chemical modification of this group with iodoacetate prevents 
reassociation of the apoenzyme with PLP.^^^ Blocking the group as a methyl 
disulphide, formed using methyl methanethiosuiphonate, results in the formation of an 
inactive holoenzyme. This result suggests that the cysteine residue may have a role in 
the catalytic mechanism of the enzyme. The residue is conserved in both the rabbit 
liver mitochondrial and E. coli enzymes (see Figure 3.2)
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3.2 The decarboxylation of aminomalonic acid by SHMT
The properties and reactions of serine hydroxymethyltransferase have been discussed 
in section 3.1. The report by Palekar, Tate and Meister®  ^ that SHMT catalysed the non- 
stereospecific decarboxylation of aminomalonic acid, was of interest to previous 
workers in the group, since the claim was the first and only reported example of a non- 
stereospecific decarboxylation reaction catalysed by a PLP dependent enzyme. The 
non-stereospecific nature of the reaction was established on the basis of two 
experiments. In the first, 2-aminomalonic acid was incubated with SHMT and PLP in 
tritiated sodium phosphate buffer for 30 min. at 37 °C. The reaction was quenched by 
the precipitation of the enzyme with ethanol after 40% of the substrate had been 
consumed. The unreacted 2-aminomalonate was separated from the tritiated glycine 
formed in the reaction and the tritium content of the glycine was measured. The glycine 
was then oxidised to pyruvic acid using D-amino acid oxidase, a process known to
137
.'.K 'v . •-- - :
remove the pro-S hydrogen of glycine selectively.^®  ^ Approximately 48% of the tritium 
label was released, suggesting that reprotonation of the quinoid Intermediate formed 
during the decarboxylation was non-stereospecific {Scheme 3.10). In the second, 
incubation of (2R)-[1-^'^C]-aminomalonic acid, synthesised in three steps from (2R)-[3- 
^^C]-serine (Scheme 3.11), with SHMT and PLP in potassium phosphate buffer (pH 
6.5) for 30 min. at 25 ^C. Half of the radiolabel was lost as and half was retained 
in the glycine product (Scheme 3.12), again suggesting that the decarboxylation 
reaction was non-stereospecific.
NHc
D-amino acid 
oxidase
HOpC
H
COgH
TgO
O
X
H
NH2 
HOgC------
T
HgO 
O
Î
Scheme 3.10. Determination of the stereochemical 
course of reprotonation for the decarboxylation of 2- 
aminomalonate catalysed by SHMT.
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The conclusion that SHMT catalysed a completely non-stereoselectlve 
decarboxylation reaction, therefore, seemed to be Irrefutable. However the result 
appeared to contradict Dunathan’s proposals regarding stereoelectronic control in PLP 
dependent enzymes.*
Palekar suggested that the substrate, 2-aminomalonic acid, might be able to bind in 
two equally populated conformations at the active site of the enzyme, such that each of 
the two carboxyl groups was positioned correctly for decarboxylation at 90° to the 
plane of the coenzyme. If the decarboxylation and subsequent protonation steps 
occurred stereospecifically for each form, then the observed results would be obtained 
(Scheme 3.13). This proposal is supported by the fact that both (2R)- and (2S)- 
antipodes of several amino acid substrates bind to and are processed by the 
enzym e,a lthough  the Km values for the (2R)-antipodes are tenfold larger than for the 
(2S)-amino acids.
However, if racémisation of the substrate occurred prior to the decarboxylation, the 
same observations might have been expected. Prior racémisation it appeared could be 
ruled-out in view of Palekar’s earlier finding; that the PLP-dependent enzyme, 
aspartate p-decarboxylase, catalysed the stereospecific decarboxylation of 
aminomalonate.^
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3.2.1 Re-examination of the decarboxylation of 2-aminomalonic 
acid by SHMT
Recent work in our laboratories with mammalian cytosolic and E  coll SHMT, using the 
chiral ^^C-labelled isotopomers of the very slow decarboxylation substrate 2-amino-2- 
methylmalonic acid,^ "^^ ’^ ®^ had shown that cleavage of the pro-R carboxy group of the 
substrate occurred with retention of configuration to give {2R)-aIanine. Thus, in the 
context of the earlier work, either the bulkier substrate was only able to bind to the 
enzyme in one of the two conformations available to 2-aminomalonic acid, or Palekar’s 
explanation for non-stereospecificity with 2 -aminomalonic acid as the substrate was 
incorrect.
In order to test these possibilities, Thomas^^® repeated Palekar’s ^  experiments with 2- 
aminomalonic acid and used chemical assays for the chirality of the product glycine.
I
2-Aminomalonlc acid (30 mM, 3 times Km) was incubated with SHMT and PLP in ÿ
deuteriated buffer under the exact conditions described by Palekar et al.^  but, on a 20- 
fold larger scale, and the decarboxylation products were obtained. The glycine was i
treated with (1S,4R)-camphanoyl chloride to give the (1’S,4’R)-camphanamide 
derivative (1 8 2 ) which was examined by NMR spectroscopy. The unlabelled 
camphanamide derivative (183) and the 2-dldeuterio isotopomer (1 8 4 ) were known to 
display well separated AB-type signals for the diastereotopic C-2 hydrogens of the 
glycine moiety in the proton and deuterium NMR spectra, Hr and Hs occur at ô 4.05 
and 4.16, respectively in the 360 MHz proton NMR spectrum. Hence, on the 
basis of the earlier work^ the spectra of the derivatives of the decarboxylation products 
were expected to show the incorporation of «50 atom% solvent derived hydrogen in
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each of the C-2 positions. In actuality the incorporation of solvent hydrogen was close 
to 100  atom% for each of the 0 -2  positions as judged by the proton and deuterium 
NMR and mass spectrum of the camphanamide derivative (182). Thus, it was evident 
that either a-hydrogen exchange had occurred prior to decarboxylation or that the 
product glycine had racemised.
As Palekar "^  ^ had used tritium for his experiments and analysed the chirality of the 
tritiated glycine product using (2R)-amino acid oxidase, which is known to transfer the 
2-proS  hydrogen of glycine to the solvent, their apparent results were identical with 
those obtained by Thomas.^^^ However, the result of T h o m a s h a d  shown that too 
much solvent derived hydrogen had been incorporated into the glycine.
In order to determine whether non-enzymic a-hydrogen exchange between the 
substrate and the solvent could occur during the enzymic decarboxylation reaction, 
Thomas^^® measured the rates of a-deuterium atom incorporation into the unlabelled 
substrate in a vast excess of deuterium oxide under pseudo-first order conditions over 
the pD range 5.0-8.0 at 20 °C. The reaction was followed by proton NMR spectroscopy. 
It was found that for pD 5.0-6.5, the half-lives for the exchange reactions were 15-20 
min, whilst those for pD 7.0-8.0 were 35,55 and 95 min respectively. Under Palekar's^ 
conditions, pH 6.0 and 37 ®C, the half-life for exchange would have been «5 min, a 
considerably shorter period than the duration of the experiments upon which Palekar 
performed the original stereochemical analyses.
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3.2.2 Re-examination of the decarboxylation reaction in the light of 
the findings of Thomas
It was now evident that a substantial amount of the 2-aminomalonic acid substrate had 
undergone a-hydrogen exchange or had been racemised prior to the actuai enzyme 
catalysed decarboxylation reaction in the original experiments and it was absolutely 
clear that SHMT, in fact, had not been shown to catalyse decarboxylation non- 
stereospecifically. From the kinetic analysis of the competition for the unlabelled 
substrate between the exchange/racemisation reaction, a pseudo-first order process, 
and the enzyme-catalysed decarboxylation, an effectively first order process with 
respect to substrate at [S]>Km (the standard conditions at the start of the reactions) it 
seemed expedient to reassess the stereochemical course in incubations containing 
much larger amounts of enzyme.
2-Aminomalonic acid (34) was prepared by heating diethyl aminomalonate 
hydrochloride in potassium hydroxide solution, and was purified by ion exchange 
chromatography as recorded by Thomas.^^® It was planned that SHMT would be 
obtained from Verne Schirch (Virginia Commonwealth University) as a dry powder and 
that on arrival at St. Andrews the activity would be regenerated by dialysis. However 
problems were encountered in obtaining fully active enzyme. The maximum activity 
measured on assaying the enzyme for (2S,3S)-threonine aldolase activity was 0.5  
unit/mg (where 1 unit is the amount of enzyme required to convert 1 p-mole of (2S,3S)- 
threonine to glycine and acetaldehyde per minute at 37 X ) ,  the expected activity was 
«15 unit/mg. In the presence of glycine and 5-formaldehyde-tetrahydrofolic acid, the 
active enzyme should exhibit a uv absorption of about 0.4-0.5 absorbance units at 500 
nm. In our hands the cytosolic enzyme showed a small amount of (2S,3S)-threonine
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aldolase activity and had an absorption of 0.216 units at 500 nm. The E. coti enzyme 
had no detectabie (2S,3S)-threonine aldolase activity and did not have a measurable 
absorption signal at 500 nm. There was no doubt that the cytosolic enzyme was not 
very active but, fortunately, we had enough enzyme to carry out the necessary 
decarboxylation reactions.
The cytosolic enzyme («25 units) was dissolved in deuterium oxide (5 ml) and the pL 
was adjusted to 7.0. 2-Aminomalonate (6 mg) (34) was added in two portions at five 
minute intervals and the solution incubated at 37 °C for a total of 15 min. Dénaturation 
of the enzyme was accomplished by the addition of an equal volume of ethanol, and 
the precipitated enzyme removed by filtration. The mixture of 2-aminomalonate and 
glycine was purified by preparative tic ('PrOHiNHarHaO 26:6:5) and the glycine was 
Isolated and converted to its (1’S,4’R)-camphanamide derivative (185).
Deuteriated 2-aminomalonate (186), prepared by the exchange reaction in deuterium 
oxide at 37 °C, was incubated with the enzyme in protium oxide. The glycine product 
was isolated and derivatised as a camphanamide (187) under identical conditions to 
those described for the non-deuteriated 2-aminomalonate (34).
Examination of the proton and deuterium NMR spectra and mass spectra of the glycine 
camphanamide derivative (1 8 5 ) from the non-deuteriated aminomalonate (34) 
indicated that very little dideuterioglycine (<5%) had been formed and that the 
monodeuteriated glycine was of (2S)-configuration only. For the [2-^H]-2- 
aminomalonic acid (186), the spectral analyses of the derivatised glycine (187) 
indicated that only (2R)-glycine had been formed. The proton NMR spectra and the 
mass spectra for the enzymically derived (2R)- and (2S)-[2-^H]-glycine-(1 'S,4'R)-
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camphanamide (187,185) along with the spectra for glycine-(1’S,4’R)- 
camphanamide (183) and [2-^H2]-glycine-(1 'S,4'R)-camphanamide (184) are shown 
in Figures 3.3, 3,4a and 3.4b. From these results it is clear that SHMT catalyses the 
stereospecific decarboxylation of 2 -aminomalonic acid.
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Figure 3.3. The 400 MHz proton NMR spectra in CDGI3 of I) the (1’S,4’R)-camphanamlde of 
(2RH2-2Hl-glycine (187), ii) the (1’S,4’R)-camphanamide of (2S)-[2-^H]-glycine (186), Hi) the 
(1’S,4’R)-camphanamide of glycine (183) and Iv) the (1'S,4’R)-camphanamide of [2-2H2]-glycine 
(184).
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Figure 3.4a. The mass spectra of i) the ( r s ,4 ’R)-camphanamicle of glycine (183) and ii) the 
(1’S,4’R)-camphanamide of [2 -^H2 ]-giycine (184).
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Figure 3.4b. i) The mass spectra of the {1’S,4’R)-camphanamide of (2S)-[2-2H]-glyclne (185) 
and ii) the (1’S,4’R)-camphanamide of (2R)-[2-^H]-glycine (187).
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3.3 Conclusions
In the light of earlier work carried out in Professor Gani’s group with 2-methyl-2- 
aminomalonic acid^^"^ and studies with the enzyme (2S)-methîonine 
d e c a r b o x y l a s e t h e  work described here indicates that cleavage of the pro-R 
carboxy group of 2-aminomalonic acid occurs with retention of configuration. Hence 
protonation introduces the 2-pro-S hydrogen of glycine, and all of this chemistry occurs 
on the 4'-s/ face of the coenzyme (Scheme 3.14).
pro-R
+H+ glycine-CO;
PO
CH.
H
Scheme 3.14. The decarboxylation of 2- 
amlnomalonlc acid on the C-4’-srface of the 
coenzyme.
These results support the notion that there is an evolutionary relationship between 
(2S)-amino add transaminases, (2S)-a-amino acid decarboxylases and SHMT.
A recent report^^® states that an enzyme from Alcaligenes bronchisepticus KU 1201 
decarboxylates a-methyl-a-phenylmalonic acid to give (2R)-phenylpropionic acid. The 
result indicates that the pro-R carboxyl group of a-methyl-a-phenylmalonic acid is 
removed to form (2R)-phenylpropionic acid with inversion of configuration. This is in 
sharp contrast to the situation discussed above for SHMT. Note that the
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decarboxylation of S-methylmalonyl-CoA by malonyl-CoA decarboxylase^®® also 1
occurs with retention of configuration.
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CHAPTER FOUR
EXPERIMENTAL
4.0 Experimental
Melting points were determined using an Electrothermal melting point apparatus and 
are uncorrected.
Elemental analyses were carried out in the departmental microanalytical laboratory.
Optical rotations were measured at room temperature using an AA 1000 polarimeter at 
St. Andrews University and an AA 100 polarimeter at Southampton University. 10 cm 
or 20  cm path-length cells were used.
Infrared spectra were recorded on a Perkin-Elmer 1710 IR FT spectrometer, a Perkin- 
Elmer 1330 IR spectrometer, or a Perkin-Elmer 1500 series FT IR spectrometer. The 
spectra were recorded as thin films between sodium chloride discs. The absorption 
maxima are given in wavenumbers (cm'^) relative to polystyrene standard.
Nuclear magnetic resonance spectra were recorded at 90 MHz on a Jeol FX90Q, at 
200 MHz on a Varian Gemini-200, at 270 MHz on a Jeol JNM-GX270, at 300 MHz on a 
Bruker AM-300, and at 360 MHz on a Bruker AM-360 instrument. The ^H nuclear 
magnetic resonance spectra recorded at 400 MHz were obtained from the SERC NMR 
service at Warwick University. All NMR spectra are described in parts per million 
downfield shift from TMS and are reported consecutively as position (6h)» relative 
integral, multiplicity (s-singlet, d-doublet, t-tripiet, q-quartet, m-muitiplet, dd-double 
doublet, sp-septet and br-broad), coupling constant (J Hz), and assignment 
(numbering according to lUPAC nomenclature for the compound).
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Nuclear magnetic resonance spectra were recorded at 22.6 MHz on a Jeol FX90Q, 
at 50.30 MHz on a Varian Gemini-200, at 67.8 MHz on a Jeol JNM-GX270, at 75.47 
MHz on a Bruker AM-300, and at 90.56 MHz on a Bruker AM-360 instrument. The 
nuclear magnetic resonance spectra recorded at 100.61 MHz were obtained from the 
SERC NMR service at Warwick University.
^H Nuclear magnetic resonance spectra were recorded at 61.44 MHz by the SERC 
NMR service at Warwick University and are quoted in ppm relative to CDCI3 at 7.27 
ppm.
CHCI3 was used as an internal standard for CDCI3 spectra. HOD was used as an 
internal standard for D2O, DC! and NaOD spectra referenced at 4.7 ppm. For ®^C 
spectra run in D2O, DCI and NaOD, dioxane {67.3 ppm) and methanol (49.9 ppm) were 
used as internal standards.
Mass spectra and accurate mass measurements were recorded at Southampton 
University on a VG 70 250 BE, at St. Andrews on a Kratos MS 50, or by the SERC 
service at Swansea using a VG ZAB E. Major fragments are given as percentages of 
the base peak intensity (100%). Fast atom bombardment (FAB) spectra were recorded 
using glycerol as a matrix.
Electronic absorption spectra were obtained using a Pye-Unicam SP8-500 uv/vis 
spectrometer.
“Flash” chromatography was performed according to the procedure of Still^®  ^ yging 
Sorbsil C60 silica gel.
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Analytical thin layer chromatography was carried out on 0.25 mm precoated silica gel 
plates {MN SIL G/UV254) or on 0.1 mm precoated cellulose plates (CEL MN 300-10 
UV254). and compounds were visualised by uv fluorescence, iodine vapour, 
phosphomolybdic acid in ethanol, aqueous potassium permanganate or ninhydrin.
Solvents were dried and purified according to the methods of Perrin and Armarego.^®®
Enzymes other than aspartate aminotransferase (AAT) and serine 
hydroxymethyltransferase were obtained from Sigma Chemical Co., Poole, UK. and 
were used without further purification.
Aspartate aminotransferase (AAT) [Glutamate-oxaloacetate transaminase (GOT)] was 
obtained from Boehringer Mannheim UK, Lewes, UK. and was used without further 
purification.
Serine hydroxymethyltransferase was donated by Professor Verne Schirch of Virginia 
Commonwealth University and was reconstituted prior to use.
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Potassium (2S)-serine O-suIphate (21)
NHc
C0 2H
(2S)-Serine (1 g, 9,6 mmol) was added at room temperature to cone, sulphuric acid 
(sp. gr. 1.84, Analar, 2 ml). The mixture was stirred in vacuo until the serine had fully 
dissolved (about 2 h). Ice cold water (10 ml) was added, and the pH adjusted to 7.25 
with an aqueous solution of barium hydroxide (saturated). The precipitated barium 
sulphate was removed by centrifugation and the clear supernatant was concentrated in 
vacuo to a small volume (approx 2 ml) at 38 °C. This solution was passed through an 
Amberlite lR-120(H) ion exchange column and eluted with water. Fractions (10 ml) 
were collected and checked by tic (using 'PrOHrNHaiHeO 26:6:5 and visualised with 
ninhydrin) for the presence of the product. The product containing fractions were 
combined, adjusted to pH 7.8 with 5% aq. KOH and concentrated to dryness in vacuo 
at 38 ""C. The white residue was dissolved in the minimum amount of cold water and 
precipitated by the dropwise addition of ice cold ethanol. The (2S)-serine 0-sulphate 
was filtered off and dried overnight (550 mg, 30%), m.p. 150 °C (dec.); (Found: 0 , 
16.16; H, 2.56; N, 6.16; /IT, 223.0981. Calc, for CaHeNOeSK: 0 , 16.14; H, 2.71; N, 
6.26%; M, 223.0936); [ajo-10.25° (c. 1.0 in HgO) [lit.,^ ^^  _g 50 5  ^  HgO)]; v^ax
(nujol) 3400-3100 (OH) and 1650 cm-‘‘(amino acid 0=0); Ôh (90 MHz, DgO/NaOD) 3.53 
(1H, t, J5Hz, 2  CJi) and 4.18 (2H. m, 3 GHz); Sc (67.5 MHz, DgO/NaOD/dioxane) 47.7 
(3 GHg), 71.5 (2 QH) and 178.4 (CO2H).
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(2S)-Serine 0-sulphate (21a)
Chlorosulphonic acid (1 ml, 15 mmol) was added dropwise to a stirred solution of (2S)- 
serine (1.05 g, 10 mmol) in trifluoroacetic acid (10 ml). As the chlorosulphonic acid was 
added a white solid precipitated. Once the addition was complete, the mixture was left 
to stand at room temperature for 20 min. The excess chlorosulphonic acid was 
destroyed by the addition of ethanol (1 ml). Four volumes of diethyl ether (40 ml) were 
added to complete the precipitation. The solid was filtered off and dried. The crude 
product was recrystallised from water and ethanol (1.38 g, 62%), m.p. 228-230 °C; 
(Found: C, 19.72; H, 3.65; N, 7.57. Calc, for CsHyNOgS: C, 19.46; H, 3.81; N, 7.56%); 
nVz (Found: 186.0072. CaHsOeNS requires, 186.0072); M o +10.03° (c. 3.4 in 1
M HCI) M d”  +9.8° (c. 3.4 in 1 M HCI)]; [ajo -2.96° (c. 1.145 in 5% KOH); v,max
(nujol) 3200 (NH/OH sir). 2800-3000 (CH str and nujol) and 1755 cm ' (acid COgH 
monomer): 8h (200 MHz, DgO/DCi) 4.1-4.35 (m, 2 CM and 3 CM2): 8c (50 MHz, 
DgO/DCI/dioxane) 54.81 (3 CHg), 68.95 (2 QH) and 171.01 (COgH).
Aminomalonate monoammonium salt (34)
4-
COp- NH4
Diethyl aminomalonate hydrochloride (11.11 g, 52.5 mmol) was dissolved in 2 M KOH 
(110 ml) and the resulting solution refluxed for 15 min. The solution was cooled in ice 
and adjusted to pH 6.0 using 30% acetic acid solution. Two volumes of 95% ethanol 
were added, the resulting precipitate filtered off and washed with ethanol. This 
precipitate was taken up in the minimum amount of water (approx 100 ml) and applied 
to a column (30 x 2 cm) of Amberlite IRA 400 anion exchange resin (acetate form). The
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column was washed with water to remove inorganic salts, and the desired product was 
displaced using 2 M ammonium acetate. Fractions 2-33 (ninhydrin positive) were 
concentrated to dryness in vacuo, recrystallised from 2 M ammonium hydroxide and 
ethanol giving a white solid (3.64 g, 51%), m.p. 208 °C (lit.,^ ^^  208 °C); (Found: C,
26.58; H, 5.60; N, 20.80. Calc, for C3H8N2O4: C, 26.47; H, 5.92; N, 20.58%); 6h (200
iî
MHz, CDCI3 ) 4.1 (1H, s, 2 CH); 8c (50 MHz, CDCI3) 62.04 (2 C), 173.08 (acid carbons); |  
m/z (El) 75 ([M+H-C0 2 NH4]+, 5%), 44 (80, [CO2HD and 30 (100, [CH2NH2j+).
Potassium (2R)-serlne 0-sulphate (59)
NHg
H ^ v^ ^ O S O jK
cbgH
This was prepared in an identical manner to the (2S)-antipode (21) starting from (2R)- 
serine in 30% yieid. M.p. 164-166 °C; (Found; C, 16.28; H, 2.67; N, 6.22; Af, 223.0954. 
Caic. forC3 H6 N0 6 SK:C, 16.14; H.2.71; N, 6.26%; M. 223.0936); M o 6.3° (c. 1 in HgO); 
Vroax(nujoi) 3400-3100 (OH), 1650 (amino acid C=0), 1609 (NHg bend), 1210 (8 -0 )  
and 794 cm ' (C-O-S); Sh (90 MHz, DgO/NaOD) 3.55 (1H, t, J  4.3 Hz, 2 OH), and 4.2 
(2 H, m, 3 CHa). 5c (22.5 MHz, DgO/MeOH) 52.06 (3 £Hg), 64.52 (2  0 ) and 168.63 
(COaH).
(2R)-Serine 0-su lphate  (59a)
This was prepared in an identical manner to (2S)-serine 0-sulphate (21a) using (2R)- 
serine following the method of Previero^^ in 70% yield. M.p. 188-190 °C; (Found: C, 
19.37; H, 3.58; N, 7.51. Calc, for C3H7NO6S: C, 19.46; H, 3.81; N, 7.56%); [a]o -9° (c.
3.4 in 1 M HCI) [lit.,^^ [a]o^ +9.8° (c, 3.4 in 1 M HCI for (2S)-isomer)]; [ab  +3.5° (c.
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1.085 in 5% KOH); v^ax (nujol) 3200 (NH/OH str), 2800-3000 (CH str and nujol) and 
1760 cm^ (acid CO2H monomer); Ôh (200 MHz, D20/Na0D) 4.29 (1H, m, 2 CH) and 
4.39 (2H, m, 3 CM2); 6c (50 MHz, DgO/NaOD/dioxane) 54.94 (3 QH 2), 68.52 (2 QH) and 
171.35 (GO2H).
Potassium (2S,3R)-threonine O-sulphate (60)
NH2 OSO3K
COgH
This was prepared in an identical manner to potassium (2S)-serine O-sulphate (21) 
using (2S,3R)-threon!ne in 51% yield. M.p. 150 °C (dec.); (Found: C, 18.61; H, 3.74; N, 
5.35. Calc, for C4H8NO6SK.H2O: C, 18.82; H, 3.95; N, 5.50); [0^0 -20°(c. 9.7 in HgO) 
Bit., 192 [ajpi® -20.6° (c. 9.7 in HgO)]; Vmax (nujol) 2800-3500 (OH) and 1640 cm  ^ (amino 
acid C=0); 0h(90 MHz, DgO/NaOD) 1.38 (3H, d, J 5  Hz, 4 CMs), 3.22 (1H, d, J 6  Hz, 2 
CM) and 4.55 (1H, dof q, 3 CM); 6c (67.5 MHz, DgO/NaOD/dioxane) 18.2 {4 QH3 ), 61.7 
(3 GHg), 79.4 (2 C) and 178.6 (QOgH); m/z (FAB) 238 [M +H]\
Potassium (2S,3S)-threonine O-sulphate (61)
NHo psO ,K  
"CHcCOoH
This was prepared in an identical manner to potassium (2S)-serine O-sulphate (21 ) 
using (2S,3S)-threonine in 30% yield. M.p. 224-226 °C; [a]o+0.8° (c. 0.56 in H2O); Vmax 
(nujol) 3400-3000 (NH/OH str), 3000-2800 (nujol and CH str) and 1650 cm'i (amino
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acid C=0); Ôh (90 MHz, DgO/NaOD) 1.10 (3H, d, J6.4 Hz, 4 CHs), 3.32 (1H, d, J5.5 Hz, 
2 CH) and 4.05 (1H, d of q, 3 CH); ôc (75 MHz, DgO/NaOD/dioxane) 15.45 (4 QHs),
59.58 (3 CH), 77.15 (2 CH) and 175.53 (COgH); m/z (FAB) 238 [yW+Hf.
(ISH-)-Camphanoyl chloride
0001
Distilled thionyl chloride (10 ml) was added to the (1S)-(-)-camphanic acid 
monohydrate (0.84 g, 3.88 mmol), and the solution refluxed for 2 h. The thionyl chloride 
was removed in vacuo and the resulting solid left to dry in vacuo (0.84 g, 100%), m.p. 
71-73 °C; Vmax (nujol) 1800 (acid chloride C=0) and 1780 cm‘  ^ (ester C=0).
(1’S,4’R)-Camphanamlde of (2S)-serine O-sulphate (62)
OONH
OOgH
OSO3H
Camphanoyl chloride (0.3 g, 1.37 mmol) was dissolved in toluene (5 ml). (2S)-Serine 
O-sulphate (0.44 g, 1.97 mmol) and potassium hydroxide (0.22 g, 3.94 mmol) were 
dissolved in water (5 ml). The pH of the aqueous layer was checked (pH > 9). The two
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solutions were mixed and stirred vigorously overnight. The mixture was extracted with 
dichioromethane (3x10  ml), and the aqueous layer concentrated to dryness in vacuo. 
The product could not be isolated in an organic solution due to the polar nature of the 
compound. 6h (200 MHz, D ^ )  0.95 (3H, s, 4" CJda), 1.08, 1.13 (6 H, 2s, 2 x 7" Cfcb), 1.7-
2.5 (4H, 3m, 5' CHg and 6 ' CHg), 4.37-4.55 (2H, m, 3 CHg) and 4.9 (1H, t  J4.8  Hz. 2 
CH);5c (100 MHz, DgO/Na TMS salt) 9.26 (4" Q.H3), 16.29, 16.54 (2  x 7" OH3), 28.99,
29.95 (5' and 6 ’ QH2), 53.49, 55.21, 56.25 (2 Q,H, 4' C, 7' C), 67.43 (3 QH2 ), 94.22 (1* 
C), 169.75, 172.29 and 182.58 (ester, amide and acid C=0).
(1’S,4’R)-Camphanamide of (2R)-serlne O-sulphate (63 )
CONH
H ^^v^^O SO gH
cbgH
This was prepared in an identical manner to the (1’S,4’R)-camphanamide of (2S)- 
serine O-sulphate (62). ôh (200 MHz, DgO) 0.95 (3H, s, 4" CJda), 108, 1.13 (6 H, 2s, 2  x 
7" CJHLs), 1.7,2.08, 2.5 (4H, 3m, 5' CÜ2 and 6 ' % ) ,  4.45 (2 H, m, 3 CH 2) and 4.78 (1H, 
t, J4.9  Hz, 2  CH); 5c (100  MHz, DgO/ NaTMS salt) 9.30 (4" QH3), 16.33, 16.64 (2 x 7" 
Q.H3), 29.04, 30.10 (S' and 6 ' QH 2), 54.18, 55.33, 56.32 (2 QH, 4' 0 , 7’ 0), 67.50 (3 
QH 2I  94.27 (T 0), 169.83, 172.58 and 182.66 (ester, amide and acid Q=0).
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(2S)-[U-^'*C]-Serine O-sulphate (64)
(2S)-[U-^'^C]-Serine (24.5 |xCi) in aqueous ethanol was added to (2S)-serine (50 mg, 
0.22  mmol) in a small round bottomed flask. The solution was lyophilised. The (2S)-[U- 
^"^Cj-serine O-sulphate was prepared in an identical manner to the non-labelled 
material. Fractions (10 ml) from the ion exchange column were collected and checked 
for the presence of compound by tic (visualising with ninhydrin) and scintillation 
counting of a small portion of each fraction. The product containing fractions were 
combined and the pH adjusted to 7.8 by the addition of aqueous 5% potassium 
hydroxide solution. The product accounted for 4 fxCi (109 mg, 16%).
Ethanolamlne hydrochloride (67a)
(2S)-Serine (100 mg, 0.95 mmol) and 4-methoxyacetophenone (65) (200 mg, 1.33 
mmol) were ground together. The mixture was heated in a stream of nitrogen from 160- 
190 °C. The effluent gas was passed through barium hydroxide solution. When the 
solution no longer became cloudy (approx 1 h) the reaction mixture was cooled. The 
red/brown mixture was refiuxed with conc. HCI (5 ml) for 2  h and cooled. The residue 
was added to cold water (5 ml) and extracted five times with chloroform. The aqueous 
layer was decolourised with charcoal (50 mg). The charcoal was filtered off and the 
solution concentrated to dryness in vacuo yielding a yellow solid (70 mg, 75%), m.p. 
50 °C ( l i t . , 75-77 "C); v„ax (nujol) 3300-2200 (H bonding) and 1599 cm ' (NH3+ 
bending): 8 h (90 MHz, DgO) 2.9 (2H, t  J 6  Hz, Ctb-N) and 3.55 (2H, t, J 6 Hz, CHa-O); 
5c (22.5 MHz, DaO/dloxane) 42.49 (QHa-N) and 58.76 (CHa-O); m/z{B\) 61 ([/M-HOI]+, 
10%), 36 (45, [HCI] *) and 30 (100, [Af-HCI-CH 20 ]+).
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[U-^'*C]-Ethanolamine hydrochloride (67)
(2S)-Serine (100 mg) was added to (2S)-[U-^'^C]-serine (0.1 ml, 5 \iC\) in aqueous 
ethanol. The solution was lyophilised. 4-Methoxyaoetophenone (65) (200 mg) was 
added to the (2S)-[U-^'^C]-serine and the powders ground together. The procedure was 
followed as for ethanolamine.HCl (67a) omitting the decolourisation step.
(2S)-[2-^H]-Serlne O-sulphate (68)
This was prepared in an identical manner to (2S)-serine O-sulphate (21) using (2S)-[2- 
^H]-serine (69) using the method of Previero^®  ^ in 55% yield. M.p. 220 °C; (Found: C, 
19.37; H, 3.21; N, 7.47. Calc, for CsHeNOeDS: C, 19.36; H, 3.25; N, 7.52%); [ab  -0.92° 
(c. 1.035 in 5% KOH);Vmax (nujol) 2800-3000 (CH str and nujol), 1766 (acid COgH 
monomer), 1216 and 724 cm'  ^ (C-O-S); Ôh (DgO/NaOD) 3.35 (0.05H, t, J4.5 Hz, 2 CH 
non deuteriated), 4.00 (1H, d, J 10 Hz, 3 CHa) and 3.97 (1H, d, J 10  Hz, 3 CHb); 5c 
(DgO/NaOD/NaTMS salt) 55.4 (t, 2  QD), 72.34 (3 QHg), and 180.0 (QOgH); Ôq 
(DgO/NaOD) 3.47 (2 CD).
(2S)-[2-^H]-Serlne hydrochloride (69a)
This was prepared in an identical manner to (2S)~serine hydrochloride (76a) using 
(2S)-[2-^H]-methyl-N-trifluoroacetyi-0-(m-chlorobenzoyl)-serinate (91) in 100% yield. 
Spectral data agreed with the proposed structure and tic spot co-ran with an authentic 
sample of (2S)-serine hydrochloride.
(2S)-[2-2H]-Serine (69c)
This was prepared in an identical manner to (2S)-serine (76c) using (2S)-[2-^H]-0- 
benzyi serine methyl ester (125) in 72% yield (95% deuteriated by proton NMR). M.p. 
220-222 X ; (Found: C, 34.24; H, 5.95; N, 13.37; Af, 106.0489. Calc, for CaHgNOaD: C,
1 6 2
33-96, H, 570; N, 13.20%; M, 106.0489); M o +12.72° (c. 1 in 1 M MCI) [ lit ,212.213 
+14.5° (c. 1.0 in 1 M MCI) for (2S)-serine)]; v^ax (nujol) 3400 (NHg str), 3000-2800 {CH 
str) and 1597 cm'i (COg); Ôh (400 MHz, DgO/NaOD) 3.51, 3.33 (2H, 2d, J 11 Hz, 3 
CH 2); ôc(100 MHz, DaO/NaOD/dioxane) 59.10 (t, J20.85 Hz, 2 CD), 66.19(3 C H 2) and 
182.32 (C=0); Ôd(61.4 MHz, HgO/NaOH) 3.24 (2 CD); m/z (Ci) 107 ([m H]+, 100%), 61 
(80, [M-COgHD and 45 (30, [COgHD.
(2S)-a-M ethyl-N -trifluoroacetyi-p -aspartyi-m -chlorobenzoyl peroxide (70)
CFXONH G
COgMe
The acid chloride (74) (1 .5 g, 6  mmoi) and 85% mete-chloroperbenzoic acid (1.03 g, 6 
mmol) were added to dry diethyl ether (45 ml) and the solution was stirred under 
nitrogen in an ice-sait bath. Pyridine (800 |xl, 9 mmoi) in dry diethyl ether (3 ml) was 
added to the mixture dropwise and the stirring continued for 4 h at 0 °C after the 
addition was complete. The solution was filtered, washed with water and aqueous 1 M 
sodium carbonate, and dried over sodium sulphate. The solvent was removed in vacuo 
to yield a white solid which was recrystaiiised from diethyl ether/petroleum ether 
yielding the pure product (0.5 g, 21%), m.p. 106-107 °C; (Found: C, 42.46; H, 2.53; N,
3.53. Calc, for C14H11CINF3O7: C, 42.28; H, 2.79; N, 3.52%); [a]o +6 8 ° (c. 0.69 in I
chloroform); Vmax (nujol) 3269 (amide NH), 1795, 1758 (peroxy-anhydride C=0 ), 1751 I1(ester C =0) and 1714 cm'  ^ (trifluoroacetyl C=0); ôh (90 MHz, CDCI3) 3.25 (2H, m, 3 j
CH2), 3.88 (3H, s, OMe), 5.00 (1H, m, 2 CH) and 7.35-8.00 (5H, aromatic protons and |
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NH br); ôc (22.5 MHz, CDCI3) 32 (3 QHg), 48 (OGH3), 54 (2 QH) and 128-135 (aromatic 
carbons); m/z (Cl), 415 ([M+NH4] \  5%), 371 (6 , [M+NH4-C0 2 H]+), 261 (100, [M- 
C7H4O3I+), 217 (30, [M-C8H4Cfe]^ ) and 35 (60, [01]+).
(2 S)-Methyl N -trifluoroacetyl-0-(m -chlorobenzoyl)serinate (71)
CFoCONH
COoMe
(2S)-a-Methyl N-trifIuoroacetyl-p-aspartyI m-chlorobenzoylperoxide (70) (500 mg, 1.2 
mmol) was heated to reflux in carbon tetrachloride (40 ml) under nitrogen for 6 d. The 
solvent was removed in vacuo yielding a gummy solid. Purification by column 
chromatography on silica (petrol:ethyI acetate 7:3) yielded the product which was 
recrystallised from diethyl ether/petrol to give a white crystalline solid (110 mg, 30%), 
m,p. 77-78 °C; (Found: 0,44.25; H, 2.93; N, 3.76. Calc, for C13H 11CIF3NO5: 0, 44.15; H, 
3.13; N, 3.96%); [a]D+50.3° (c. 0.295 in chloroform); Vmax (nujol) 3245 (NH str), 1740 
(aliphatic ester 0=0), 1730 (aromatic ester 0=0) and 1700 cm'  ^ (trifluoroacetyl 0=0); 
ÔH (2 0 0  MHz, ODOI3) 3.85 (3H, s, OO2OH3), 4.75 (2 H, m, 3 OM2), 4.97 (1H, m, 2  CH.) 
and 7.35-8.00 (>5H, m, aromatic protons and NH); 6c (50 MHz, ODOI3) 52.87 (2 OH), 
54 (OO2OH3), 64.19 (3 OH2) and 128-134 (aromatic carbons); nVz (01) 371 ([/W+NH4I+, 
100%), 307 (50, [M-0 0 2 H-H]+), 261 (38, [M O 6H4OD and 35 (50, [01]+).
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a-Methyl N-trlfluoroacetyl-(2S)-aspartate (73)
CF3CONH
1- ^
COgMe
Trifluoroacetic acid anhydride (25 g, 120 mmol) was added to a stirred suspension of 
(2S)-aspartic acid (1.6g, 12 mmol) in dry tetrahydrofuran (50 ml) at 0 °C over 30 min 
under nitrogen. The reaction mixture was allowed to warm to room temperature and 
stirred for a further 2 h. After this time the dissolution was complete. The solvent was 
removed in vacuo and the solid thoroughly dried. The anhydride intermediate (72 ) was 
treated with dry methanol (25 ml) at 0 °C and the solution warmed to room 
temperature. The solvent was removed in vacuo yielding an off white solid, a mixture of 
the a- and p-methyl esters (2:1 a:p) (2.49 g, 85%). Ôh (90 MHz, CDCI3) 3,02 (m, 3 CJda),
3.7 (s, p-methyl ester), 3.85 (s, a-methyl ester), 4.85 (m, 2 CH) and 7.5 (NH, broad).
The pure a-methyl ester was obtained by hydrolysis overnight in water at room 
temperature of the pure p-acid chloride in 96% yield. M.p. 101-103 °C; [a]o+10.9° (c. 
0.623 in chloroform:methanol 9:1) [lit.,^^ [a]o^+27.9° (c. 0.623 in chloroform:methanol 
9:1)]; Vmax (nujol) 1745 (ester C=0), 1730 (acid C=0) and 1700 cm^ (trifluoroacetyl 
C=0); ÔH (90 MHz, CDCI3 ) 3.3 (2H, m, 3 CHg), 4.05 (3H, s, OCH3) and 5.1 (1H, m, 2 
CH); ÔC (22.5 MHz, CDCI37TMS) 35.2 (3 CHg), 48.86 (2  OH), 53.9 (OOH3) and 188.0 
(OOgH); m/z (Cl), 261 ([M+NH4I+, 100%) and 35 (35, [Cl]+).
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a-Methyl N-trifluoroacetyl-(2S)-aspartyl-p-acid chloride (74)
CFqCONH
.COCIH
COgMe
The mixture of monoesters (73) (2 g, 8.2 mmol) was refluxed In redistilled thionyl 
chloride (25 ml) for 1 h. The solution was cooled and the solvent removed in vacuo 
yielding a yellow/white solid which was recrystallised from diethyl ether and petroleum 
ether yielding the pure p-acid chloride, a white crystalline solid (2.02 g, 99%), m.p. 116- 
117 °C; [a]o+53.4° (c. 1.49 in chloroform) [lit., [cx]d^  +62.6° (c. 1.830 in chloroform)]; 
Vmax (nujol) 1798 (acid chloride C=0), 1740 (ester C=0) and 1709 cm "' (trifluoroacetyl 
C=0); ÔH (90 MHz, CDCI3) 3.65 (2H, dd, 3 CM2), 3.85 (3H, s, methyl ester) and 4.79 (1H, 
m, 2 CM); ÔC (22.5 MHz, CDCI3) 47.6 (3 CHg), 49.7 (QCH3) and 54.3 (2 QH); m/z (Cl), 
279 ([M+NH4]+, 35%), 261 (40, M+), 260 (100, [M-H]+), 243 (65, [MfNHa-CI]+) and 35 
(35, [Cl]+).
(2S)-Serlne hydrochloride (7 6 a )
(2S)-Methyl N-trifluoroacetyl-0-(m-chlorobenzoyl)-serinate (71) (63.7 mg, 0.18 mmol) 
was refluxed in 5 M HCI (10 mi) for 2 h under nitrogen. The solution was cooled and 
washed with chloroform (3 x 1 0  ml) and the aqueous layer lyophilised to give a white 
solid (10 mg, 32%), m.p. 140 °C (dec.); [a]o+11.5° (c. 0.5 in HgO) [lit.,^ ®^  [oc]d3>+7.2° (c.
1.2 in H2O)]; Vmax (nujol) 3815 (NH), 3500-3000 (OH), 3000-2800 (CH), 1760 (acid 
CO2H monomer) and 1590 cm"" (CO2 ); ôh (200 MHz, DgO/NaOD) 3.32 (1H, t, J5  Hz, 2 
CM) and 3.65 (2H, m, 3 CM2); Sc (50 MHz, DgO/NaTMS salt) 57.67 (3 CHg), 62.27 (2 
£H ) and 173.22 (CPgH); m/z (Cl) 106 (100%, [M-CI]+), 88 (30, [MOH]+), 60 (50, [M- 
COgHgr) and 44 (50, [COgD.
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(2S)-Serine hydrochloride (76b)
This was prepared in an identical manner to (2S)-serine hydrochloride (76a) using 
(2S)-/sopropyl N-trifluoroacety!-0-(m-chlorobenzoyl)-serinate (8 0 )  in 75% yield. 
Spectral data agreed with the proposed structure and the tic spot co-ran with an 
authentic sample of (2S)-serine.
(2S )-S erlne (76c)
(2S)-0-Benzyl serine methyl ester (116) (0.36 g, 1.72 mmol) was added to 6 M HCI 
(10 ml) and the mixture refluxed for 3 hours. The acid was removed in vacuo, and the 
residue dried over phosphorus pentoxide. The residue was dissolved in dry ethanol 
(30 ml) and propylene oxide (30 ml) and refiuxed for 15 min. The solvents were 
removed in vacuo, and the product recrystallised from water and ethanol to give a 
white crystalline solid (0.1 g, 55%), m.p. 214 °C (dec.); (Found: C, 34.20; H, 6.39; N, 
13.03. Calc, for C3H7NO3: C, 34.29; H, 6.71; N, 13.33%); [ab  +13.2° (c. 1.0 in 1 M HCI) 
[li, 212.213 [„]p23 +14,50 (g 1.0  in 1 M HCI)]; Vma* (nujol) 3400 (NH2 str), 3000-2800 (OH 
str) and 1590 cm ' (CO2 ); 5h (200 MHz, DjO/NaOD) 3.19 (1H, t, J 5  Hz, 2 CH) and 3.57 
(2H, m, 3 CHz); 8c (75 MHz, D20/Na0D/Me0H) 58.58 (2 CH), 65.76 (3 CH2) and
181.65 (C=0); nVz (Cl) 106 ([M+H]% 100%), 88 (35, [A40H]+) and 44 (50, [CO2I I .
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a  /sopropyl N -trlfluoroacetyl-(2S)-aspartic acid (77)
CFoCONH
COa'Pr
To a suspension of (2S)-aspartic acid (3 g, 22.5 mmol) in dry THF (60 ml) at 0 °C in an 
atmosphere of nitrogen was added trifluoroacetic anhydride (27 ml, 190 mmol) 
dropwise over 30 min. The reaction mixture was left to stir for 2 h at 0 °C during which 
time the dissolution was complete. The solvent was removed in vacuo to yield a white 
solid which was dried at reduced pressure. The dry material was dissolved in dry 
/sopropanol (25 ml) and the stoppered reaction flask was kept at 37 °C for 12 h. The 
solvent was removed in vacuo to give the crude /sopropyl ester. Traces of /sopropanol 
were removed by washing the crude compound with cold diethyl ether, recrystallisation 
from diethyl ether and petrol gave a white solid (5.8 g, 95%), m.p. 88-90 °C; (Found: C, 
39.65; H, 4.58; N, 5.14. Calc, for C9H12F3NO5: C, 39.86; H, 4.46; N, 5.16%); [a]o+41.7° 
(c. 0.5 in chloroform); Vmax (nujol) 3320 (NH str), 2800-3000 (CH strand nujol), 1760 
(ester C=0), 1745 (acid C =0) and 1710 cm'  ^ (trifluoroacetyl C=0); §h (200 MHz, 
CDCI3) 1.27 (6 H, dd, J 6  Hz, 2  X 'Pr CHa), 3.17 and 2.98 (2 H, ABX, Jab 17.6 Hz, 
jAX=4x=4.4 H z,3 CH2), 4.79 (1H,m, 2  CH),5.11 (1H, sp, J 6  Hz, ^PrCH) and 7.45 (1H, 
br s, NH); ôc (50 MHz, CDCI3) 21.38, 21.52 (2 x 'Pr 1QH3), 32.21 (3 CHg), 48.85 (2 CH), 
70.97 C’PrCH), 168.39 and 175.43 (COg'Pr and C O 2H); m/z (El) 226 ([/W-COgHr, 10%), 
212 (25, [M-OCH(CH3)2r). 184 (60, [M-C02H-CH(CH3)2ll, 166 (50, [M-C02CH(CH3)2- 
OH21+), 139 (60, [AfC0 2 CH(CH3)2-C0 2 H]+) and 43 (100, [CH(CH3)2j+). .
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a-/sopropyl N-trif!uoroacetyl-(2S)-aspartyl-p-aclcl chloride (78)
CF3CONH
^,COCI 
COs'Pr
Thionyl chloride (20 ml) was added to a-/sopropyl N-trifluoroacetyl-(2S)-aspartic acid 
(77) (2 g, 7.38 mmol) and the mixture refiuxed for 1 h. The solvent was removed in 
vacuo to yield the product (2.07 g, 92%), m.p. 123-125°; (Found: C, 37.26; H, 3.30; N, 
4.73. Calc, for CgHn F3NO4CI: C, 37.31; H, 3.63; N, 4.83%); [a]o +65.8° (c. 0.63 in 
chloroform); Vmax (nujol) 3320 (NH str), 2800-3000 (CH str and nujol), 1810 (acid 
chloride C=0), 1740 (ester C=0) and 1715 cm‘  ^ (trifluoroacetyl C=0); ôh (200 MHz, 
CDCI3) 1.3 (6H, dd, J 6 Hz, 2 X f r  CH3), 3.62 (2H, m, 3 CHz), 4.7 (1H, m, 2 CH) and 
5.15 (1H, m, #  CH); 5c(50 MHz, CDCI3) 21.46, 21.56 (2 x Vr CH3), 47.4 (3 CHg), 49.4 
(2 CH) and 71.65 ('Pr CH); m/z (Cl) 307 ([M+NH4]+, 100%), 288 (75, [AfH]+) and 271 
(25, [M-CI+OHD.
(2S )-a -/soprop yl-N -trlfluo ro acety l>p -asparty l-m -ch lo rob enzoy! perox ide  
(79 )
CF.CONH O
COg'Pr
This was prepared in an identical manner to (2S)-a-methyl-N-trifluoroacetyl-p-aspartyl 
m-chlorobenzoylperoxide (70) from a-/sopropyl N-trifluoroacetyl-(2S)-aspartyl-p-acid 
chloride (78) in 49% yield. M.p. 110-112 °C; (Found: C, 44.93; H, 3.38; N, 3.71. Calc.
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for C16H15NCIF3O7: C, 45.17; H, 3.55; N, 3.29%); M o  +67.5° (c. 0.54 in chloroform); 
Vmax (nujol) 3300 (NH str), 2800-3000 (CH str and nujol), 1805, 1770 (peroxy 
anhydride 0=0), 1750 (ester 0=0) and 1710 cm’  ^ (trifluoroacetyl 0=0); Ôh (200 MHz, 
ODOI3) 1.3 (6 H. d, J6.3 Hz, 2 x'Pr OH3), 3.1-3.4 (2 H, m,3 OJdg), 4.9 (1H, m, 2  OH), 5.15 
(1H, sp, J6.3  Hz, 'Pr OH) and 7.4-8.05 (5H, m, aromatic protons and NH); 5c (75 MHz, 
ODOI3) 2 1 .33, 21.48 (2  x 'Pr OH3), 31.97 (3 QHz), 48.92 (2 QH), 71.36 {'Pr CH), 126.47-
135,07 (aromatic carbons) and 156.80-167.32 (4 C = 0  and CF3); nVz (01) 443 
([M+NH4]+, 100%) and 289 (40, IM-0 7 H4Cy+).
(2S )-/sopropyl N-trifluoroacetyl-O-(m-chiorobenzoyl) serinate (80 )
CFoCONH
COg'Pr
This was prepared in an identical manner to (2S)-methyl N-trifluoroacetyl-0-(m- 
chlorobenzoyl)serinate (71 ) from (2S)-a-/sopropyl-N-trifluoroacetyl-p-aspartyl m- 
chlorobenzoyl peroxide (79) in 4% yield. M.p. 74-75 °0; m /z (Found: [M^NH 4]+, 
399.0935. 0 isHig0 sN2 0 IF3  requires 399.0935); [a]o -k61.5° (c. 0.335 in chloroform); 
Vmax (nujol) 3240 (NH str), 2800-3000 (OH str and nujol), 1730 (ester 0= 0 ) and 1700 
cm'i (trifluoroacetyl 0=0); 0h(200 MHz, ODOI3) 1.24-1.39 (6 H, 2d, J6.4  Hz, 2 x 'Pr 
CHa), 4.75 (2 H, d, J5 Hz. 3 OH2 ), 4.9 (1H, m,2 OH), 5.15 (1 H, sp, J6.4 Hz, 'Pr OH) and 
7.3-8.0 (5H, aromatic protons and NH);5c(75 MHz, ODOI3) 21.47, 21.55 (2 x 'Pr C H 3), 
52.49 (2  CH), 63.69 (3 CH 2 ), 71.17 ('Pr CH), 127.67, 129.66, 129.84, 130.50, 133.58,
134.69 (aromatic carbons), 164.72 and 167.22 (1^ 2'Pr, OF3CONH).
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(2S)-[2-2H]-Aspartic acid (82)
(2S)-Aspartic acid (3 g, 22.5 mmol) was added to deuterium oxide (50 ml) and the pH 
adjusted to 7.25 with ammonia solution. Pyridoxal phosphate (5 mg, 20 pmol) and 
aspartate aminotransaminase (AAT) (1 mg, 300 unit) were added and the solution 
incubated at 37 °C, the reaction progress was monitored by proton NMR spectroscopy. 
The reaction was found to be complete after 72 h. The pH was readjusted to 7.25 after 
24 h (if necessary). The solution was boiled, filtered, and concentrated to dryness in 
vacuo. The off white solid was purified by crystallisation from hot water (pH 4) and 
ethanol, yielding the free amino acid (2.19 g, 72%), m.p. >300 °C; [a]o+21.05° (c. 0.95 
in 6 M HCI); Vmax (nujol) 3000-2500 (OH stretching), 1688 and 1643 (carboxylate 
anion) and 1586 cm '' (N-H deformations); Ôh (270 MHz, D2O/DCI) 3.12 (2H, d, J2.7 Hz, 
3 CH2 ) and 4.4 (1/13H, t, 2  CH., 7% undeuteriated amino acid); ôc (67.5 MHz, 
D2 0 /dioxane) 34,32 (3 C H 2), 49.68 (2 CD), 171.44 and 173.80 (carboxylate carbons); 
m/z (FAB), 135 {[M i-Hf, 70%), 134 (30, [M\^) and 74 (52, [M-HCI-COg]-^).
a - and p-Methyl N-trifluoroacetyl-(2S)-[2-^H]-aspartate (84)
This was prepared in an identical manner to that described for a-methyl N- 
trifluoroacetyl-(2S)-aspartate (73) using (2S)-[2-^H]-aspartic acid (82) in 100% yield. 
ÔH (200 MHz, CDCI3) 2.85-3.25 (m, 3 CHz in a- and p esters), 3.75 (s, 8 -methyl ester),
3.85 (s, a-methyl ester), 7.45 and 7.55 (two broad singlets, N-H of both esters).
a-/sopropyl N-trlfluoroacetyl-(2S)-[2-^H]-aspartate (85)
This was prepared in an identical manner to that described for a-/sopropyl N-
1
trifluoroacetyl-(2S)-aspartate (77) using (2S)-[2-^H]-aspartic acid (82) in 55% yield. ?jM.p. 85-87 °C; [a]o +52.9° (c. 0.48 in chloroform); Vmax (nujol) as for the non-deuteriated |
sample (77); 8h(200 MHz, CDCI3) 1.25 (6 H, 2d. J 6  Hz, 2 x 'P rC tb ), 3.05 (2 H, q, J18  |
171 !
Hz, 3 CH2 ), 5.1 (1H, sp, J 6 Hz, 'Pr CH) and 7.35 (1H, br s, NH); 5c (75 MHz, CDCI3) 
21.26, 2 1 .39 (2 x f r  CH 3), 35.02 (3 ÇHg), 48.56 (t. J 21 Hz, 2  CD), 70.86 ('Pr CH), 
115.44 (q, J285  Hz, CF3), 156.98 (q, J 38 Hz, CF3CO), 168.31 and 175.15 (CO '^Pr, 
CO 2H); m/z (El) 227 ([M-C0 2 H]+, 5%), 213 (15, [M-0 CH(CH3)2|+), 185 (48, [/VKXDgH- 
CH(CH3)2l+), 167 (22, [/lfC02CH(CH3)2-OH2]^), 140 (40, [M-C02CH(CH3)2-C02H]+) 
and 43 (1 00 , [CH(CH 3)21-^ ).
a-Methyl N -trifluoroacetyl-(2S)-[2-2H ]-asparty l-p -acid  chloride (87)
This was prepared in an identical manner to a-methyl N-trifluoroacetyl-(2S)-aspartyl-p- 
acid chloride (74) using a-methyl N-trifluoroacetyl-(2S)-[2-^H]-aspartate (84) in 93% 
yield. M.p. 112-113 °C; [ab  +66.3° (c. 0.395 in chloroform); Ôh (200 MHz, CDCI3 ) 3.62 
(2 H, d, J 5.2 Hz, 3 CH2), 3.9 (3H, s, CO2 CH3 ) and 7.25 (1H, br s, NH); ôc (50 MHz, 
CDCI3 ) 47.83 (CH 2COCI), 54.32 (CO2 CH3 ); m/z (El) 227 {[M-C\]\ 10%), 203 (70, [M- 
COaCHaJ^) and 199 (35, [M-COCI]+).
a-/sopropyl N -trifluoroacetyl-(2S)-[2-^H ]-asparty l-p -acid  chloride ( 8 8 )
a-/sopropyl N-trifluoroacetyl-(2S)-(2-^H]-aspartate (8 5 )  (1 g, 3.69 mmol) was 
suspended in dry toluene (70 ml) and the mixture heated under nitrogen until the 
dissolution was complete. Thionyl chloride was added and the mixture refiuxed for 6 h. 
The solvent was removed in vacoo yielding an off white solid (1.06 g, 100%); 0h(200 
MHz, CDCI3 ) 1.3 (6 H, dd, J 6  Hz, 2 x'Pr CHs), 3.62 (2 H, m, 3 CH2 ), and 5.15 (1H, m, 'Pr 
CH).
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(2S )-[2 -^H ]-a -M ethyl-N -trifluoroacety l-p -asparty l-m -ch Iorobenzoyl 
peroxide (89)
This was prepared in an identical manner to (2S)-a-methyl-N-trifluoroacetyl-p-aspartyl 
m-chlorobenzoyl peroxide (70) using a-methyl N-trifluoroacetyl-(2S)-aspartyl-p-acid 
chloride (87) in 40% yield. M.p. 102-103 °C; [a]o +49.5° (c. 0 .6 6  in chloroform); v^ax 
(nujol) 3260 (NH), 1790, 1770 (peroxy-anhydride C=0), 1750 (ester C=0) and 1710 
cm ' (trifluoroacetyl C=0); Sh (200  MHz, CDCI3) 3.25 (2 H, dd, J 16Hz, 3 CJda), 3.9 (3H, 
s, CO2CH3) and 7.4-8.1 (5H, m, 4 aromatic protons and NjH); 6c (50 MHz, CDCI3) 32.58 
(CH2CO), 49.35 (t, J 21 Hz, CD), 54.21 (CO2CH3), 126.98, 128.36, 130.27, 130.78, 
135.20, 135.67 (aromatic carbons), 157.28, 162.08, 166.65 and 168.97 (4 x C=0); m/z 
(Cl) 416 ([M+NH4I+, 100%) and 262 (35, [AfC7H403r).
(2S )-[2 -^H ]-a -/sopropyi-N -trifluoroacety l-p -asparty l-m -ch iorobenzoyl 
peroxide (90)
This was prepared in an Identical manner to (2S)-a-/sopropyl-N-trifluoroacetyl-p- 
aspartyl m-chlorobenzoyl peroxide (79) using a-/sopropyl N-trifluoroacetyl-(2S)-[2-^Hj- 
aspartyl-p-acid chloride (8 8 ) in 2 1 % yield. M.p. 104-105 °C; m/z (Found: [M+NH4)+, 
444.0896. C 16H18N2O7CIF3FD requires 444.0896); [a]d+42.2° (c. 0.54 in chloroform); 
Vmax (nujol) 3300 (NH str), 2800-3000 (CH str and nujol), 1790, 1760 (peroxy 
anhydride C=0), 1740 (ester C=0) and 1700 cm*^  (trifluoroacetyl C=0); 6h (200 MHz, 
CDCI3) 1.3 (6 H, d, J 5  Hz, 2x  'PrCJia), 3.18, 3.3 (2 H, dd, J17.5 Hz, 3 Ctb), 5.15 (1 H, 
sp, J 5  Hz, CH) and 7.4-8.0 (5H, m, aromatic protons and NH); 6 c (75 MHz, CDCI3) 
21.43, 21.58 (2 x'PrC H 3 ), 31.97 (3 CH 2), 48.97 (2 CD), 71.42 ('Pr CH), 126.53-135.15 
(aromatic carbons) and 156.89-167.41 (4C = 0  and CF3); m/z{C\) 444 ([AA-NH,j+, 2%) 
and 290 (100,
173
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(2S)-[2-^H]-Methyl-N-trlfluoroacetyl-0-(m-chlorobenzoyI)-serinate (91 )
This was prepared in an identical manner to (2S)-methyl-N-trifluoroacetyl-0-(m- 
chlorobenzoyi)-serinate (71) using (2S)-[2-^H]-a-methyl-N-trifluoroacetyl-p-aspartyi m- 
chlorobenzoyl peroxide (89) in 27% yield. M.p. 73-74 °C; [o^d +79.3° (c. 0.295 in 
chloroform); Vmax (nujol) 3245 (NH str), 3000-2800 (CH str and nujol), 1750 (aliphatic 
ester C=0), 1730 (aromatic ester C=0) and 1705 cm'  ^ (trifluoroacetyl C=0); ôh (200 
MHz, CDCI3) 3.88 (3H, s, CO2CM3), 4.72 (2H, s, 3 CH2), 7.25 (1H, br s, NJd) and 7.4-
7.95 (aromatic protons); ôc (75 MHz, CDCl3)52.1 (t, J20 Hz, CD), 53.6 (CO2CH3), 63.7 
(CH2O), 115.5 (q, J285 Hz, CF3), 127.8, 129.95, 129.79, 130.6, 133.7, 134.8 (aromatic 
carbons), 157.1 (q, J 3 8  Hz, CF3CO), 164.9, 168.3 (CO 2'Pr and CF3CONH); m/z (Cl) 
372 ([M+NH4]+, 100%).
N-Benzyl (2S)-serlne (94 )
(2S)-Serine (2.1 g, 20 mmol) was dissolved in 2 M NaOH (10 ml) and freshly distilled 
benzaldehyde (2.04 ml, 20 mmol) was added. After 30 min of vigorous stirring, sodium 
borohydride (226 mg, 6 mmol) was added portionwlse keeping the temperature of the 
reaction mixture below 15 °C. After 30 min a further equivalent of benzaldehyde, 
followed by sodium borohydride was added as above. The mixture was stirred for a 
further 2 h. The solution was washed with diethyl ether (3 x 50 ml) and the pH of the 
aqueous layer was adjusted to 6 by the addition of 6  M HCI. The product precipitated 
from solution and was isolated by filtration (2,96 g, 75%), m.p. 216-217 °C (lit.,^^ 220- 
222 °C); nVz (Found: [A4H]+, 196.0974. C10H14NO3 requires 196.0974); M o  +5.9° (c.
1.0 in 2 M HCI) [lit.,^ ^^  [a]^ +6 .8° (c. 1.0 in 2 M HCI)]; v^ax (nujol) 3200-3300 (NH str and |
OH str), 2800-3000 (CH str and nujol), 1630 (acid COgH), 1575 (CO2 ) and 1540 cm'^
(RNH2 deformations); ôh (200  MHz, D2O) 3.61 (1H, t, J4 .2  Hz, 2 CH), 3.86 (2 H, 2d, J
4.2 and 1.4 Hz, 3 CH2), 4.18, 4.20 (2 H, 2  s, 4' CH2) and 7.38 (5H, s, aromatic protons);
174
ô c  (75 MHz, DgO/dioxane) 51.01 (2 CH), 60.42 (3 CHa), 63.69 (benzyl CHa), 130.29,
130.70, 131.01, 131.69 (aromatic carbons) and 172.32 (COaH).
N-Benzyloxycarbonyl (2S)-serlne isopropyi ester (105)
(2S)-Serine /sopropyl ester hydrochloride salt (108) (2 g, 10.8 mmol) was suspended 
in dry THF (80 ml) and triethylamine (3.44 ml, 24 mmol) was added, this mixture was 
cooled to 0°C and benzylchloroformate (1.716 ml, 12 mmol) was added dropwise, the 
mixture was warmed to room temperature and stirred overnight. Water (50 ml) and 
diethyl ether (50 ml) were added, the mixture shaken and the diethyl ether layer 
isolated, washed with water (20 ml), dried (MgSO^), and concentrated in vacuo to 
dryness yielding a clear oil. The oil was crystallised from ethyl acetate and petroleum 
ether yielding a white solid (2.31 g, 76%), m.p. 74-75 °C; (Found: C, 60.07; H, 6.83; N,
4.97. Calc, for C14H19NO5 : C, 59.78; H, 6.81; N, 4.98%); [ab +11.4° (c. 0.9 in 
dichioromethane); v^ax (nujol) 3480, 3380 (NH and OH str), 2800-3000 (CH str and 
nujol) and 1715 cm'^ (ester and urethane C = 0 );0 h (200 MHz, CDCI3 ) 1.25 (6 H, d, J7.5 
Hz, 2  X 'Pr CHa), 1.9 (1H, br s, OH), 3.98 (2 H, d, J3.6 Hz, 3 CH2). 4.4 (1H, t, J3.6 Hz, 2
CH), 5.0-5.2 (3H, s and sp, 'Pr CHs, benzyl CH2), 5.7 (1H, br s, NH) and 7.35 (5H, s, |
I
aromatic protons); ôc (50 MHz, CDCI3 ) 21.7 (2 x 'Pr CH3 ), 56.2 (3 CHa), 63.2 (2 CH),
67.3 (benzyl CHa), 128.1, 128.2, 128.5, 136.1 (aromatic carbons), 156.2 (urethane 
C=0) and 169.9 (ester C=0); (El) 281 ([A^ +, 5%), 108 (30, [CeHgCHaOH]^). 91 (100, 
[CsHsCHall and 43 (40, [CH(CH3)2f)-
N -(9-F luorenylm ethyloxycarbonyl)-(2S)-serlne /sopropyl ester (106)
(2S)-Serlne /sopropyl ester hydrochloride salt (108) (1 g, 5.5 mmol) was suspended in 
dry THF (40 ml) and triethylamine (1.68 ml, 12 mmol) was added. The mixture was 
cooled to 0 °C and 9-fluorenylmethyloxycarbonylchloride (1 0 5 ) (1.55 g, 6 mmol)
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added. The product was isolated in the same manner as the benzyloxycarbony! 
analogue (1.56 g, 77%), m.p. 94-95 °C; {Found: C, 67.99; H, 6.26; N, 3.76. Calc, for 
C21 Has NO5: C, 68.28; H, 6.28; N, 3.79%); [a]o +2.9° (c. 0.324 In chloroform); Vmax (nujol) 
3340, 3360 (OH and NH str), 2800-3000 (CH str and nujol), 1730 (ester C=0) and 
1665 cm 1 (urethane C=0); 6h (200  MHz. CDCIg) 1.3 (6 H, d, J7 .5  Hz, 2  x 'Pr CHs), 19  
(1H, br s, OU), 3.95 (2 H, s, 3 CHa), 4.25 (1H, t, J7.5 Hz, 2  CH), 4.4 (2 H, s, FMOC CHg), 
4.45 (1H, s. FMOC CH), 5.1 (1H, sp. J7.5  Hz. 'Pr CH), 5.72 (1H, br d, NH) and 7.28-7.8 
(8 H, m, FMOC aromatic protons); ôc (75 MHz, CDCI3) 21.57, 21.59 (2 x 'PrCHg), 46.99 
(FMOC CH), 56.09 (3 CHa), 63.31 (2 CH), 67.04 (FMOC CHa), 69.72 (ÎPr CH), 119.85, 
124.93, 126.94, 127.59,141.15, 143.54 (aromatic carbons of FMOC), 156.14 (urethane 
C=0) and 169.81 (ester C=0); m/z (Cl) 370 {[M+H]\ 25%).
N-Benzyl (2S)-serine /sopropyl ester (107)
N-Benzyl (2S)-serine (94) (500 mg, 2.5 mmol) was suspended in dry /sopropanol (15 
ml) and the mixture cooled in an ice bath. Thionyl chloride (935 pi, 12.8 mmol) was 
added dropwise. The mixture was stirred in an ice bath for 2  h and refiuxed for 3 d. The 
solution was cooled, and triethylamine added (1.4 ml, 10 mmol). Water (25 ml) was 
added, and the product extracted into dichioromethane (3 x 25 ml). The organic layer 
was dried (MgSO^), and concentrated in vacuo. The pure product was obtained by 
recrystallisation from diethyl ether and petrol (220 mg, 36%), m.p. 54-55 °C; (Found: C, 
63.69; H, 8.18; N, 5.66. Calc, for C13H 19NO3. I/2 H2O: C, 63.39; H, 8.18; N, 5.69%); m/z 
(Found: [M+HY, 238.1443; C13H20NO3 requires 238.1443); [ab -44.65° (c. 1.0 In 
dichioromethane); v^ax (nujol) 3500-3000 (OH and NH), 3000-2800 (CH str and nujol) 
and 1720 (ester C = 0 );0 h (200 MHz, CDCI3) 1.27, 1.28 (6H, 2 d, J 6 .2  Hz, 2 x 'Pr CHa). 
2.43 (2 H, br s, OH and NH), 3.41 (1H, ABX, Jax 4.5 Hz, 6.3 Hz, 2  CH), 3.59-3.86
(2H, ABX, Jab 10.6 Hz, Jax 4.5 Hz, ^  6.3 Hz, 3 CHa), 3.78, 3.93 (2H, 2d, J 12.5 Hz,
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PhCJda), 5.08 {1H, sp, J6.2Hz, 'Pr CJi) and 7.28-7.36 (6H, m, aromatic protons and 
NH); ÔC (50 MHz, CDCI3) 21.65, 21.79 (2 x 'PrQHs), 51.99 (2 ÇH), 61.88 (3 CHg), 62.26 
(PhCHa), 69.18 ('Pr CH), 127.54, 128.46, 128.61, 138.58 (aromatic carbons) and 
171.99 (ester C=0); m/z (El) 238 ([MfH]+, 15%), 206 (70, [M-H(CH3)2] )^, 164 (73, [M- 
CH(CH3)2-CH0H]+), 150 (90, [A&C02CH(CH3)2|+), 106 (80, [CeHgCHaNH]^), 91 (100, 
[C6H5CH2I+) and 43 (100, [CH(CH3)2]+).
(2S)-Serine /sopropyl ester hydrochloride salt (108)
(2S)-Serine (500 mg, 4.75 mmol) was suspended in dry /sopropanol (40 ml) and the 
suspension cooled to 0 °C. Thionyl chloride (760 pi, 10.45 mmol) was added dropwise, 
the resulting suspension was refiuxed for 5 h and cooled. The solution was poured into 
dry diethyl ether (100 ml) and after a few minutes white crystals were formed. The 
crystals were filtered off and dried (640 mg, 92%), m.p. 141-142 °C (lit.,^ ®® 142-143 °C); 
(Found: C, 39.42; H, 7.23; N, 7.63, Calc, for CsHuCINOs: C, 39.24; H, 7.68; N, 7.63%); 
[ajo -7.5° (c. 2 in H2 0 );vmax (nujol) 3370 (NH strand OH str), 2800-3000 (CH str and 
nujol) and 1730 cm^ (ester C=0); Ôh (200 MHz, DgO) 1.23 (6 H, d, J 7.5 Hz, 2 x  Pr CHa),
4.1 (3H, m, 2 C H  and 3 CH2 ) and 5.1 (1H, sp, J 7.5 Hz, 'Pr CH); ôc (50 MHz, 
DgO/NaTMS salt) 23.72 (2 x 'Pr CH3), 57.76 (3 CH2), 62.20 (2 CH), 75.37 ('Pr CH) and 
170.83 (ester C=0); m/z{E\) 148 ([M-CIJ+, 100%) and 106 (100, [C3H8N03J+).
(2S)-Serlne /sopropyl ester (108a)
Dry THF (10 ml) was added to the hydrochloride salt of (2S)-serine /sopropyl ester 
(108) (250 mg, 1.36 mmol) and triethylamine (200 pi, 1.36 mmol) was added. The 
mixture was stirred overnight and the solid was removed by filtration. The solution was 
concentrated in vacuo to give a clear colourless oil (190 mg, 97%). 6h (200 MHz, 
CDCI3) 1.25 (6H, d, J7.6 Hz, 2 x 'Pr Cjdb), 2.8 (3H, br s, OH and NH2 ), 3.5-3.9 (3H, m, 2
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CH and 3 CJbb) and 5.07 (1H, sp, J7.6 Hz, 'Pr CH); 5c (50 MHz, CDCI3 ) 21.61 ( 2  x 'Pr
CH 3 ), 55.91 (3 CHg), 63.66 (2 CH). 68.72 ('Pr CH) and 173.09 (COg'Pr).
N -B enzyloxycarbonyl-(2S )-serine-/sopropyi ester bis sulphite ester (109)
o o
X  JLPhOHgO"'"^  ^ N H  HN^'^OCHgPh
COg'Pr COg'Pr
N-Benzy!oxycarbonyl-(2S)-senne /sopropyl ester (105) (300 mg, 1.07 mmol) was 
suspended in dry toluene (25 ml) and cooled to 0 °C over an ice/salt bath. 
Triethylamine (327 pi, 2.35 mmol) in toluene (5 ml) and thionyl chloride (85 pi, 1.17 
pmol) in toluene (5 ml) were added dropwise successively over 15 min. The mixture 
was warmed to room temperature and stirred for 1.5 h. Water (10 ml) and ether (10 ml) 
were added. The diethyl ether layer was isolated and concentrated to dryness in 
vacuo, and after several washes with small portions of diethyl ether yielding a pale 
brown solid. The solid was recrystaiiised from ethyl acetate and petrol to yield a white 
solid (0.3 g, 92%), m.p, 106-108 °C; (Found: C, 55.48; H, 6.04; 4.61. Calc, for 
(Ci4Hi7NOs)2SO: C, 55.25; H, 5.96; N, 4.60 %); [a]o +20.7° (c. 1.15 in 
dichioromethane); v^ax (nujol) 3280 (NH str), 2800-3000 (CH strand nujol), 1730 
(ester C=0) and 1670 cm*  ^ (urethane C=0); 5h(200 MHz, CDCI3) 1.25 (12H, d, J5  Hz, 
4 x'Pr Chb), 4.1-4.65 (6H, ABX, 2 C jj and 3 CJda), 4.9-5.2 (6H, sp and s, benzylic Cth  
and Pr CH) and 7.3 (10H, s, aromatic protons); 6c (50 MHz, CDCI3 ) 21.5 (4 x 'Pr CH3),
53.7 (2 CH), 62.6 (3 CH2), 67.0 (benzyl CHa), 70.2 ('Pr CH), 127.9, 128.1, 128.4, 135.9 
(aromatic carbons), 155.63 (urethane C=0), and 168.1 (ester C=0); m/z (FAB) 609 
{[M+HY, 55%), 281 ([CiaHaaNOsf, 100) and 238 (95, [CnHiaNQg]^).
178
a
N-(9-FluorenylniethyîoxycarbonyI)-(2S)-serine-/sop r o py I ester bis
sulphite ester (110)
COJPr
HN
COg'Pr
The F-MOC bis sulphite ester ( 1 1 0 )  was prepared from N-(9- 
fluorenylmethyloxycarbonyl)-(2S)-serine /sopropyl ester (106) in an identical manner 
to that described for the BOG analogue In 64% yield. M.p. 104-105 °C; [a]D+9.5° (c. 
0.25 in chloroform); v^ax (nujol) 3300 (NH str), 2800-3000 (CH strand nujol), 1740, 
1730 (0=0 ester and urethane) and 1690 cm'  ^ (aromatic 0=0); 5h(200 MHz, ODOI3) 
1.29 (12 H, d, J  6.2 Hz, 4 x 'Pr OH3 ), 4.15-4.7 (12H, m, 2 OH, 3 OH2 , FMOO OH and 
OH2). 5.15 (2H, sp, 'Pr OH), 6.85 (2H, NH) and 7.2-7.9 (16H, m, aromatic protons); §c 
(50 MHz, ODOIs) 21.62, 21.69 (4 x'Pr OH3), 46.99 (FMOO OH), 53.88 (3 OH2), 62.30 (2 
OH), 67.36 (FMOO OH2), 70.4 ('Pr OH), 119.95, 125.09, 127.05, 127.69, 141.23,
143.70 (aromatic carbons), 155.73 (urethane 0=0) and 168.70 (ester 0=0); m/z {FAB) 
785 ([/lf+H]+, 5%) and 179 (100, [OisHgOH^-^).
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N-Benzyl-2,2-dioxO“1,2,3-oxathiazolidlne-(4S)-carboxyllc acid /sopropy!
ester (111)
PhCH,N'' ' 'O  
CO^Pr
The mixture of diastereoisomers of N-ben2yl-oxo-1 ,2 ,3 -oxathlazolidine-(4 S)-carboxylic 
acid /sopropyi ester (112) (0.83 g, 2.93 mmol) was dissolved in dry acetonitrile (15 ml) 
and cooled to 0 °C over ice. Ruthenium (111) chloride monohydrate (<1 mg) was added 
followed by sodium periodate (0.69 g, 3.223 mmol). Water (15 ml) was added. The 
mixture was stirred for 30 min at 4 °C and for 1 h at room temperature, a thick white 
precipitate appeared. The solution was diluted with diethyl ether (75 ml). The phases 
were separated, the aqueous phase re-extracted with diethyl ether (3 x 30 ml), and the 
combined organic fractions washed with saturated aqueous sodium bicarbonate (50 
ml) and brine (50 ml), dried (MgS0 4 ), filtered, and concentrated in vacuo to yield an oil 
(0.71 g, 81%); m/z (Found: [M+Hy, 300.0906. C13H18O5NS requires 300.0906); [«]□- 
30.6° (0 . 1.2 in dichloromethane); Vmax (neat) 2980 (CH str), 1730 (C=0), 1340-1360 
and 1180 cm'^  (sulphate modes); 5h(200 MHz, CDCI3) 1.25, 1.26 (6 H, 2d, J 6.4 Hz, 2 x 
'Pr CHa), 4.02 (1H, ABX, Jax 3 Hz, Jqx 9.2 Hz, 4 CM), 4.52 (2H, d, J2 .2  Hz, CM2Ph),
4.65 (2 H, ABX, Jab 6.6  Hz, Jax 3 Hz, Jgx 9.2 Hz, 5 CM2), 5.06 (1H, sp, J6 .4  Hz, 'Pr CM), 
and 7.3-7.S (5H, m, aromatic protons); 6c (75 MHz, CDCI3) 21.45, 21.50 (2 x 'Pr QHs), 
50.21 (CHaPh), 58.12 (4 CIH), 67.36 (5 QH2 ), 70.63 (Pr QH), 128.54, 128.74, 129.03,
133.58 (aromatic carbons) and 167.18 (ester C=0); m/z (Cl) 317 ([A^NH4f ,  100%), 
300 (20, [m H D ,1 0 8  (30, [PhCHgOHD and 91 (20, [P h C H jl.
180
i
■•£ 1^1 ' - -■ -■ •' >• I"—' --
i
■I
N-Benzyl-(2RS)-oxo-1,2,3-oxathiazolidine-(4S)-carboxyllc acid /sopropyi
ester (112)
o r
PhCHaN
COg'Pr
To a solution of N-benzyl (2S)-serine /sopropyi ester (107) (0.94 g, 3.97 mmol) in dry 
toluene (20 ml) at 0 °C in an ice-salt bath was added dropwise, successively, 
triethylamine (1,22 ml, 8,734 mmol), followed by freshly distilled thionyl chloride (0.315 
ml, 4.367 mmol) over a period of 15 min. The temperature was allowed to rise to room 
temperature and after a further hour, diethyl ether (75 ml) was added and the mixture 
extracted with water ( 2 x 1 0  ml). The organic layer was dried (IVIgSO^), filtered, and 
evaporated to dryness in vacuo to yield an oil (diastereomeric ratio 5:1 by proton NMR 
spectroscopy) (0.83 g, 74%). v^ax (neat) 2960 (CH str), 1725 (C =0 ester) and 1300- 
1100  cm ' (8-0); 5h(400 MHz, CDCI3 ) major isomer 1.24 (6 H, t,J6 .6  Hz, 2 x 'Pr CH3),
4.08 (1H, dd, 4 CÜ), 4.27 and 4.47 (2 H, ABq, J 13.8 Hz, CUzPh), 4.62 (1H, dd, 5 Chy.
4.95 (1H, dd, 5 Cüb), 5.05 (1H, sp, J  8.3 Hz, 'Pr CM), 7.28-7.53 (5H, m, aromatic 
protons), minor isomer 1.24 (6 H, t, J  6 .6  Hz, 2x  'Pr CHs), 3.92 (1H, dd, 4 C jj) , 4.27 and 
4.47 (2H, ABq, J 13.8 Hz, CHaPh), 4.56 (1H, dd, 5 CHa), 4.98-5.10 (2H, m, 'Pr CH and 5 
CHb) and 7.28-7.53 (5H, m, aromatic protons); 6c (1 0 0  MHz, CDCI3) major isomer 
21.56 (2 X 'Pr GH3), 49.07 (CHgPh), 60.35 (4 ^H), 69.88 ('Pr QJti), 71.96 (5 CHg), 
128.08, 128.58, 129.02, 135.54 (aromatic carbons) and 168.80 (ester G=0); m/z (Ci) 
284 {[M +Hf, 40%), 196 (47, [M-COzCHiCH^)^^) and 91 (100, [PhCHg]+).
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(3R )-2 ,5 -D lm ethoxy-3-/sopropy î”3,6-dihydropyra2ine (113)
OCH
A suspension of cyc/o-((2R)-val-giy) (121) (400 mg, 2.56 mmol) and trimethyloxonium 
tetrafluoroborate (950 mg, 6.41 mmol) in dry dichloromethane was stirred vigorously 
for 3 d with a further portion of trimethyloxonium tetrafluoroborate (380 mg, 2.56 mmol) 
being added after 24 h. To the resulting mixture a solution of disodium hydrogen 
phosphate (8.5 g) and dihydrogen sodium phosphate (2.25 g) in water (40 ml) was 
added. The organic phase was separated, and the aqueous phase extracted with 
dichloromethane ( 3x10 ml). The organic portions were combined and dried (MgS0 4 ), 
the solvent was removed in vacuo yielding a yellow oil (0.31 g, 66%). m/z (Found: Af, 
184.1212. CgHieNaC^ requires 184.1212); [a]o-120.7° (c. 1.0 in ethanol) [lit.,^ ®^
106.3° (c. 1.0 in ethanol) for the (6S)-isomerj; Vmax (neat) 2940 (CH) and 1680 cm  ^
(C=N); ÔH (200 MHz, CDCI3) 0.75, 1.03 (6H, 2 d, J 7 Hz, 2 x f r  CH3), 2.22 (1H, dsp, 'Pr 
CH), 3.68,3.71 (6H, 2s, 2 and 5 OCH3) and 4.0 (3H, br s, 3 CH and 6 CH 2); §c (75 MHz, 
CDCI3) 16.9, 18.2 (2 X 'P r^ H 3), 32.42 ('Pr CH), 46.54 (6 CHa), 52.47, 52.51 (2 and 5 
OCH3). 61.02 (3 CH), 162.28 and 164.85 (2 and 5 C); m/z (El) 185 ([MfH]+, 30%) and 
171 (100, [AfCH]+).
1 8 2
(3R,6S)-2,5-Dlmethoxy-3-/sopropyl-6-ben2yloxymethyl-3,6 
dihydropyrazine (114)
,OCHo
H 3C O ^l5 l^H ,O C H ,P h
nBuLi (2 M in Hexane) (750 |xl, 1.474 mmol) was added to a stirred solution of (3R)-2,5- 
dimethoxy-3-/sopropyl-3,6-dihydropyrazine (113) (0.25 g, 1.34 mmol) in dry THF (3.5 
ml) at -80 °C. The mixture was stirred until the solution warmed to -60 °C to allow for 
the formation of the anion. A solution of benzylchloromethylether (0.315 g, 2.01 mmol) 
in dry THF (750 pJ) at -70 °C was added dropwise to the solution containing the anion 
and the mixture was stirred at -70 °C overnight. The solvent was removed in vacuo and 
the crude product shaken with 100 mM potassium phosphate solution (pH 7, 5 ml). The 
aqueous phase was extracted with diethyl ether ( 4 x 5  ml), dried (MgSO^), and the 
volatile products removed in vacuo. The product was purified using flash 
chromatography (petrollethyI acetate 9:1), the fractions with Rf «0.3 (when visualised in 
iodine and uv light) yielded a pale yellow oil (250 mg, 60%). (Found: C, 67.24; H, 8.10; 
N, 9.52. Calc, for Ci7H24N20^: C, 67,08; H, 7.95; N, 9.20%); m/z (Found: [M+H] + 
305.18651. C 17H25N2O3 requires 305.18651); [a]o+2.6° (c. 0.8 in dichloromethane); 
Vmax (neat) 2800-3000 (CH str), 1685 (C=N), 1230, 1065 (=C(R)OMe) and 1120 cm'i 
(CH2 0 CH2Ph); §h (200  MHz, COCI3) 0.71, 1.08 (6 H, 2d, J 6 .8  Hz, 2  x 'Pr CHa), 2.32 
(1H, m, 'Pr CM), 3.72 (6 H, 2s, 2 and 5 OCM3), 3.7-4.2 (4H, m, 3’ CM2 , 3 CM, 6 CM), 4.55 
(2H, s, PhCMaO) and 7.3 (5H, s, aromatic protons); ôc (75 MHz, CDCI3) 16.47, 19.02 (2 
x'Pr CH 3's), 31.37 ( frC H ), 52.53, 52.41 (2  OCH3 and 5 OCH3), 56.78 (6  CH), 60.69 (3 
CH), 71.29, 73.08 (CH2QCH2Ph), 127.29, 128.11, 138.45 (aromatic carbons), 161.49 
and 164.81 (2 and 5 C); m/z (El) 305 ([MTH]+, 100) and 91 (30, [PhCHg]^).
183
?
J
(S)-O-Benzyl serine methyl ester (116)
,OCH3
V uCHgOCHgPh
{3R,6S)-2,5-Dimethoxy-3-/sopropyl-6-benzyloxymethyI-3,6-dihydropyrazine (114) 
{0.19 g, 0.625 mmol) was added to 0.1 M hydrochloric acid (12.5 ml) and the mixture 
stirred at room temperature overnight. The aqueous solution was extracted with diethyl 
ether ( 3 x 1 0  ml). The aqueous portion was evaporated in vacuo. The residue was 
dissolved In water (2 ml) and aqueous 25% ammonia solution (0.2 ml) added. The 
mixture was extracted with diethyl ether. The diethyl ether extract was dried (MgSO^) 
and concentrated to dryness in vacuo. The mixture of (2R)-valine methyl ester and the 
(S)-O-benzyl serine methyl ester were separated by flash silica chromatography 
(diethyl etherrethanol 19:1), the uv active fractions (Fr 6-11) were combined and 
concentrated to dryness in vacuo to yield the pure (S)-O-benzyl serine methyl ester (40 
mg, 31%). m/z (Found: 210.113. CnHisNOa requires 210.1130); Vmax(nujol)
3200 (NH str), 2800-3000 (CH str and nujoi) and 1730 cm'  ^ (C=0); M o +1.24 (c. 1.208 
in dichloromethane); ôh (2 0 0  MHz, CDCI3) 1.95 (2 H, br s, NJda), 3.64-3.74 (6 H, m, 
CO2CM3, 2  CH, 3 CH2), 4.53 (2 H, s, OCHaPh) and 7.32 (5H, m, aromatic protons); 8 c 
(50 MHz, CDCI3) 52.09 (2  CH), 54.80 (CO2CH3), 71.83, 73.20 (3 C H 2 and 3' CH2), 
127.55,127.67, 128.33,137.76 (aromatic carbons) and 174.07 (ester C=0).
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(3R)-[6-^H2]-2,5-Dlmethoxy-3-/sopropyl-3,6-dlhydropyrazine (117)
D
{3R)-2,5-Dimethoxy-3-/sopropyl-3,6-dihydropyrazine (113 ) (1.09 g, 5.9 mmol) was 
added to CD3OD (5 ml) and KOH (5.9 mmol) In HgO (0.5 ml). The solution was refluxed 
under nitrogen for 3 h and cooled. Water (10 ml) containing one equivalent of HCI was 
added. The product was extracted into dichloromethane ( 3 x 1 0  ml), dried (MgS0 4 ), 
and concentrated in vacuo (0.8 g, 80%). [a]o -74.2° (c. 1.016 in ethanol); Vmax (neat) 
2800-3000 (CH str) and 1697 cm"' (C=N); 8h (200 MHz. 0 0 0 1 3 ) 0 .7 8 , 1.01 (6 H, 2d, J 7  
Hz, 2 X Pr OÜ3). 2 .1-2.3 (1 H, m, 'Pr OH), 3.69, 3.73 (6 H, 2 s, 2  and 5 OOH3) and 3.97 
(1H, d, J3.8 Hz, 3 OH): 8c (50 MHz, ODOI3) 16.91, 18.96(2 x Pr GH3), 32.37 ('Pr CH),
52.42 (2 and 5 OCH3), 60.99 (3 CH), 162.26 and 164.81 (2 and 5 0); 8o (61.4 MHz, 
OHOI3) 3.97 and 3.93 (6 OC2 ); m *  (01) 187 (M+, 100%).
Glycine methyl ester hydrochloride (118)
Glycine (7 g, 90.9 mmol) was suspended in dry MeOH (70 ml) and cooled In ice. 
Thionyl chloride (7.7 ml, 105.5 mmol) was added dropwise. The resulting solution was 
refluxed for 30 min, cooled, and concentrated to dryness in vacuo. A hygroscopic white 
solid was obtained (12.3 g,100%), m.p. 176-178 "0 [lit.,^ ®® 174 "0 (dec.)]; v„ax (nujoi) 
2500-3300 (NH, OH str and nujoi) and 1740 cm'' (ester 0=0); 8h (200 MHz, D2O) 3.76 
(3H, s, OOH3 ). 3.86 (2H, s, 2  OU2 ); 8 q (50 MHz, DaO/MeOH) 41.1 (2 CHa), 54.4 (QCH3) 
and 169.7 (C=0); m *(E i) 89 (Af, 10%) and 30 (100, [OHaNHaj*).
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N-Carbobenzoxy-(2R)-valine (119)
Sodium bicarbonate (12.55 g, 150 mmol) was suspended in water (100 ml) and (2R)- 
valine (5 g, 42.7 mmol) added with vigorous stirring. Benzylchloroformate (8  g, 47 
mmol) was added in 5 portions over 30 min. The mixture was stirred overnight, and 
extracted with diethyl ether (25 ml) and the aqueous layer adjusted to pH 2 using 5 M 
HCI, this was extracted with ethyl acetate (3 x 25 ml), the ethyl acetate portions were 
combined, dried (MgSO^) and concentrated in vacuo yielding an oil (9.4 g, 8 8 %) which 
was carried on to the next step without further purification, ôh (200 MHz, CDCI3 ) 0.9, 1.0 
(6 H, 2d, J 8 Hz, 2 X 'Pr CH3 ), 2.25 (1H, m, 'Pr CjH[), 4.38 (1H. dd, J5  Hz, 2 CH), 5.51 (2H, 
s, 2' CH2) and 7.35 (5H, s, aromatic protons); ôc (50 MHz, CDCI3 ) 17.3, 18.9 (2 x 'Pr),
31.0 ('Pr QH), 58.8 (2 QH2), 67.16 (2' QH), 128.08, 128.18, 128.48, 136.06 (aromatic 
carbons), 156.42 (urethane Q=0) and 176.48 (acid Q=0).
N-Carbobenzoxy-(2R)>vanne glycine methyl ester (120)
o
NH
CONN
^COgMe
N-Carbobenzoxy-(2R)-valine (119) (9.4 g, 37.4 mmol) was dissolved in dry THF (125 
ml) and cooled to -5 °C in an ice/salt bath. This was treated with N-methyl morpholine 
(4.1 ml, 37.4 mmol), isobutylchloroformate (4.8 ml, 37.4 mmol) and left to stir for 3 
minutes. A suspension of glycine methyl ester hydrochloride salt (118) (4.675 g, 37.4 
mmol) in DMF (20 ml) containing N-methylmorpholine (4.8 ml, 37.4 mmol) was added. 
After stirring for 2 h a further portion of DMF (45 ml) was added. The reaction mixture
1 8 6
was stirred overnigtit. Addition of water (100 ml) caused the suspension to dissolve, 
the solution was concentrated slightly in vacuo yielding a white precipitate, this was 
filtered off at the pump washed with water and dried. Recrystallisation from 
dichloromethane and petrol yielded the pure product (10.44 g, 87%), m.p. 139-140 °C 
(lit 287.288 130-132, 151-153 °C); [a]o +6 .8 ® (c. 1.0 in dichloromethane); v^ax (nujoi) 
3290 (NH str), 2800-3000 (CH strand nujoi), 1750 (esterC=0), 1685 (urethane C=0), 
1645 and 1535 cm'^  (amide); Ôh (200 MHz, CDCI3) 0.93, 0.97 (6 H, 2d, J 7  Hz, 2 x 'Pr 
CH3), 2.1 (1H, m. J7  Hz, 'Pr CJH), 3.7 (3H. s, 1 OCH3), 3.9 4.3 (3H, m. 2’ CH and 2 CtW,
5.1 (2 H, s, PhCHa), 5.6 and 6.9 (2 x NH) and 7.35 (5H, m, aromatic protons); ôc (50 
MHz, CDCI3) 17.69, 19.12 (2x'Pr QH3), 31.04 ('PrQH), 41.01 (2  QH2), 52.26(1 OQH3). 
60.21 (2 ' QH), 67.00 (PhQHg), 127.92, 128.1, 128.47, 136.18 (aromatic carbons), 
156.18 (urethane Q=0), 170.10 and 171.74 (ester and amide Q=0); m/z (FAB) 323 
([M+H]+, 100%).
Cyc/o-((2R)-val-gly) (121)
"N
N-Carbobenzoxy-(2R)-valine glycine methyl ester (1 2 0 ) (2 .21  g, 6 .8  mmol) was 
dissolved in dry methanol (12 ml) and dry dichloromethane (36 ml), and 10% Pd/C 
(100 mg) was added. Hydrogen gas was bubbled through the solution until the starting 
material was no longer detected by tic (ethyl acetate) (time varies from 3 h-3 d). The 
solution was filtered through Celite to remove the catalyst, concentrated to dryness in 
vacuo, and the residue was refluxed in dry toluene (35 ml) for 12 h to complete the 
cyclisation. The resulting suspension was cooled to 0 ®C to allow for the precipitation of
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the product, the white solid was filtered off, washed with diethyl ether, and 
recrystallised from hot water (0.48 g, 45%), m.p. 257-259 ®C; [ode-25.3® (c. 0.9 in HgO); 
Vmax (nujoi) 3180 (NH str), 2800-3000 (CH strand nujoi) and 1670 cm"^  (amide C=0's); 
ÔH (200 MHz, DgO) 0.87,0.96 (6 H, dd, J7 Hz, 2  x 'Pr Cljg), 2.2 (1H, 2sp, J7Hz, 'Pr CH),
3.88 (1H, d, J3  Hz, 3 CH), 3.9 (1H, dd, J17 and 3 Hz, 6  CH) and 4.09 (1H, dd, J  17 and 
3 Hz, 6 CH); ÔC (75 MHz, DgO/NaTMS salt) 18.47, 20.70 (2 x 'Pr QHg), 35.72 ('Pr QH), 
46.54 (6 QHg), 62.79 (3 QH), 171.72 and 173.13 (Q=0‘s); m/z (Cl) 157 ([/W4-Hf, 100%) 
and 114 (82.5, [M-CH(CH3)2+H]+).
(2R)-[2-2H3-Serfne (122)
This was prepared in an identical manner to (2S)-serine (73) using (2R)-[2-^H]-0- 
benzyl serine methyl ester (128 ) in 89% yield (95% deuteriated by proton NMR 
spectroscopy). M.p. 194 ®C; (Found; C, 33.95; H, 5.98; N, 13.05; M \  106.0489. Calc, for 
C3H6NO3D: C, 33.96; H. 5.70; N, 13.20%; M, 106.0489); [ah  -13.5® (c. 1.025 in 1 M 
HCI) [Ilt,2'2.2i3 [0^0® + 14 .50(0 . 1.0 In 1 M HCI) for (2S)-serlne]; Vmax (nujoi) 3200-2400 
(NHa, OH and CH str) and 1661 cm ’ (amino acid COgH); 8 h (400 MHz, DaO) 3.47, 3.29 
(2H, 2d, J 11 Hz, 3 CHg) and 3.04 (0.05H, m, 2 CH not deuteriated); 8 o (100 MHz, 
DaO/NaOD/dioxane) 58.81 (t, J20  Hz, 2 CD), 65.89 (3 CHg) and 182.02 (C=0); 8o (61.4 
MHz, HaO/NaOH) 3.21 (2 Cfi); m i(C I)  107 ([Aft-H]*, 100%), 61 (60, [WOOgH]*) and 45 
(20, [COaHn.
(2R)-[2-*H]-Serlne O-sulphate (123)
This was prepared in an identical manner to (2S)-serine O-sulphate (2 1 ) using (2R)-[2- 
^H]-serine (1 2 2 ) using the method of Previero in 17% yield. M.p. 228 ®C; (Found: C, 
19.25; H, 3.20; N, 7.53. Calc, for C3H6NO6DS: C,19.36; H, 3.25; N, 7.52%); [a]o +0.9® 
(c. 0.995 in 5% KOH); Vmax (nujoi) 2800-3000 (CH strand nujoi), 1766 (acid CO2H
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monomer), 1216 and 724 cm  ^ (C-O-S); Ôh (400 MHz, DgO/NaOD) 3.32 (0.05 H, t, J4.7  
Hz, 2  CH non deuteriated), 3.94 (1 H, d, J 10 Hz, 3 CHa) and 3.97 (1H, d, J 10 Hz, 3 
CHb); ÔC (100 MHz, DgO/NaOD/NaTMS salt) 72.03 (3 QHg); ôd (HgO/NaOH) 3.46 (2  
CÜ).
(3R ,6S )"[6 -^H ]-2 ,5-D lm ethoxy-3-#sopropyl-6-benzyloxym ethyl-3 ,6 - 
dihydropyrazlne (124)
This was prepared in an identical manner to (3R,6S)-2,5-dimethoxy-3-/sopropyl-6- 
benzyloxymethyl-3,6-dihydropyrazine ( 1 1 4 )  using (3R)-[6-^H23-2,5-dimethoxy-3- 
/sopropyl-3,6-dihydropyrazine (1 1 7 ) in 60% yield, m/z (Found: [M+H]^, 306.193. 
C17H24N2Q3D requires 306.1928); [a]o +2.52° (c. 0.396 in dichloromethane); v^ax 
(neat) 2800-3000 (CH str), 1670 (C=N) and 1230 cm*  ^ (C(R)OMe); Ôh (2 0 0  MHz, 
CDCI3) 0.70, 1.01 (6H. 2d, J 6.8  Hz, 2 x'Pr CHa), 2.15-2.4 (1H, m, 'Pr CH), 3.6-3.9 (8 H, 
s and dd, 2  OCH3, 5 OCH3 and CHgOCHgPh), 4.02 (1H, d, J3 .4  Hz, 3 CH), 4.54 (2H, s, 
CHaPh) and 7.2-7A  (5H, m, aromatic protons); ôc (75 MHz, CDCI3) 16.54, 19.13 (2 x'Pr 
QH3), 31.41 ('Pr QH), 52.43, 52.54 (2 and 5 OQH3), 56.40 (t, J21 Hz, 6  QD), 60.75 (3 
QH), 71.3, 73.16 (QH 20QH2Ph), 127.36, 128.19, 138.53 (aromatic carbons), 161.54 
and 164.95 (2 and 5 C); Ôd (61.4 MHz, CHCI3) 4.08 (6 CQ).
(2S )-[2 -2H ]-0-B enzyl serine methyl ester (125)
This was prepared in an identical manner to (S)-O-benzyl serine methyl ester (116) 
from (3R,6S)-[6-^H]-2,5-dimethoxy-3-/sopropyl-6-benzyloxymethyl-3,6-dihydropyrazine 
(124) in 51% yield, m/z (Found: [Mi-Hf, 211.1193. C 11H15NO3D requires 211.1193); 
[a]o +0.83° (c. 1.022 in dichloromethane); Vmax (neat) 2800-3000 (CH str) and 1737 cm' 
 ^ (C=0 ); ÔH (200  MHz, CDCI3) 1 .95 (br s, NHa), 3.7 (5H, m, CHa and CO2CH3), 4.55 (2 H, 
s, CHaPh) and 7.3 (5H, m, aromatic protons); ôc (50 MHz, CDCI3 ) 51.82 (OQH3), 54.22
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(t, J  20.55 Hz, 2^20), 71.59, 72.95 {3 QH2 andllHgPh), 127.34, 127.45, 128.12, 137.59 
(aromatic carbons) and 173.9 (Q=0); 6d (61.4 MHz, CHCia) 3.58 (2CD).
(3S)«[6-^H 2]-2,5-D im ethoxy-3-/sopropyI-3 ,6-d ihydropyrazine (1 2 7 )
This was prepared in an identical manner to (3 R)-[6 -^H2]-2 ,5 -dimethoxy-3 -/sopropyl-
3,6-dihydropyrazine (117) using (3S)-2,5-dimethoxy-3-/sopropy!-3,6-dlhydropyrazine 
(126) in 94% yield, [a]□+65.6° (c. 1.38 in ethanol); Vmax (neat) 2800-3000 (CH str) and 
1697 cm"! (G=N); Ôh (360 MHz, GDGI3 ) 0.75, 1.03 (6 H, 2d, J 7  Hz, 2 x 'Pr GHg), 2.23 
(1H, m, 'Pr GH), 3.68, 3.72 (6 H, 2s, 2 and 5 OGW3) and 3.99 (1H, d, J3.8  Hz, 3 GH); ôc 
(90 MHz, GDGI3) 16.92, 18.92 (2  x 'Pr CHg), 32.31 ('Pr £H ), 46.23 (t, J21.42 Hz, 6 QD),
52.43, 52.37 (2 and 5 QQH3 ), 61 (3 GH), 162.27 and 164.84 (2 and 5 G); m/z (Gl) 187 
{[M+HY, 100%).
(3 S ,6 R )’-2,5-D lm ethoxy-3-/5opropyl-6>benzyloxym ethyl>3,6- 
dihydropyrazlne (128)
J .
W ° " ’
H3CO ^^X îH aO C H aPh
This was prepared in an identical manner to (3R,6S)-2,5-dimethoxy-3-/sopropyl-6- 
benzyloxymethyl-3,6-dihydropyrazine (114) from (3S)-2,5-dimethoxy-3-/sopropyl-3,6- 
dihydropyrazine (1 2 6 ) in 56% yield, m/z (Found; 305.187. G 17H25N2O3
requires 305.1865); [a]o-3° (c. 0.7 in dichloromethane); v^ax (neat) 2900-3000 (GH 
str), 1690 (G=N) and1230 cm"* (G(R)OMe); Ôh (200 MHz, CDGI3) 0.7, 1.08 (6 H, 2d, J
7.5 Hz, 2 X 'Pr Gida), 2.3 (1H, dsp, 'Pr GH), 3.7 (6 H, s, 2 and 5 OGH3), 3.8 (2H, m, 
GH2 0 GH2Ph), 4.03, 4.08 (2H, 2m, 3 GH and 6  CH), 4.55 (2H, s, OGHgPh) and 7.3 (5 H,
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m, aromatic protons); ôc (50 MHz, CDCI3) 16.54, 19.11 (2  x 'Pr O H 3), 31.43 ('Pr OH), 
52.39, 52.48 (2 and 5 OOH3 ’s), 56.87 (6  CH), 60.76 (3 O H ), 71.36, 73.15 
(OHaOOHePh), 127.35, 128.18, 138.53 (aromatic carbons), 161.55 and 164.88 (2 and 
5 0).
(3S ,6R)-[6-^H 3-2,5-D im ethoxy-3«i'sopropyl-6-benzyloxym ethyl-3 ,6- 
dihydropyrazine (129)
This was prepared in an identical manner to (3R,6S)-2,5“dimethoxy-3-/sopropyi-6- 
benzyloxymethyl-3,6-dihydropyrazine ( 1 1 4 )  using (3 S)-[6 -^H2]-2 ,5 -dimethoxy-3 - 
/sopropyl-3,6-dihydropyrazine ( 1 2 7 )  in 54% yield, [o^d -2.7° (c. 0.748 in 
dichloromethane); v^ax (neat) 2800-3000 (GH str), 1698 (G=N) and 1240 cm'  ^
(G(R)OMe); 0h (360 MHz, GDGI3 ) 0.67, 1.07 (6 H, 2d, J 7  Hz, 2  x 'Pr GH3), 2.27 (1H, m, 
'Pr GH), 3.81 (6 H, 2s, 2  and 5 OGJH3), 3.7-3.85 (2 H, dd, GHgOGHaPh), 4.0 (1H, d, J 1.6 
Hz, 3 GH), 4.53 (2H, s, GH2Ph) and 7.22-7.34 (5H, m, aromatic protons); ôc (90 MHz, 
GDGI3) 16.5, 19.1 (2 X 'Pr OH3), 31.4 ('Pr OH), 52.4 (2 and 5 OOH3), 56.4 (t, J 21 Hz, 6 
OD), 60.80 (3 OH), 71.3, 73.2 (OHaOOHgPh), 127.4, 128.2, 139 (aromatic carbons),
161.5 and 165 (2 and 5 G); m/z (El) 306 ([Mi-Hr, 100%).
(R)-O-Benzyl serine methyl ester (130)
This was prepared in an identical manner to (S)-O-benzyl serine methyl ester (116) 
using  (3S,6R)-2,5-dimethoxy-3-/sopropyl-6-benzyloxymethyl-3.6-dihydropyrazine
(128) in 61% yield, m/z (Found: [M+H]\ 210.1130. Gn HieNO3 requires 210.1130); 
[a]o -2.22° (c. 0.9 in dichloromethane); v^ax (neat) 3600 (br NH2 str), 2800-3000 (GH 
str) and 1742 cm'i (GOgMe); ôh (200  MHz, GDGI3) 2.15 (2 H, br s, NHz), 3.7 (6 H, m, 
OGH3, 2  GH, 3 GH2), 4.5 (2 H, s, PhGHgO) and 7.3 (5H, m, aromatic protons); Ôc (50 
MHz, CDGI3) 51.92 (OGH3), 54.56 (2  QH), 71.58 (3 QH2), 73.00 (Ph^Hg), 127.38,
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127.51, 128.16, 137.59 (aromatic carbons) and 173.9 (G =0).
(2R )-[2-2H ]-0-B enzyl serine methyl ester (131)
This was prepared in an identical manner to (S)-O-benzyl serine methyl ester (116) 
from (3S,6R)-[6-2H]-2,5-dimethoxy-3-/sopropyI-6-benzyloxymethyl-3,6-dihydropyrazine
(129) in 70% yield, m/z (Found: 211.1193. C 11H15NO3D requires 211.1193);
[a]o -0.32° (c. 0.932 in dichloromethane); v^ax (neat) 2800-3000 (CH str) and 1740 
c m (0=0); ÔH (250 MHz, CDGI3) 1.56 (br s, NHg), 3.7 (5H, m, C tk  and GO2GH3), 4.53 
(2 H, s, GJHgPh) and 7.35 (5H, m, aromatic protons); Sc (75 MHz, GDGI3) 51.97 (OCH3), 
54.34 (t, J21 Hz, 2 OD), 71.68, 73.08 (3 OH2 and 0 H2Ph), 127.43, 127.56, 128.22, 
137.65 (aromatic carbons) and 174 (0=0).
(2R)-Serine (1 3 2 )
This was prepared in an identical manner to (2S)-serine (76) from (R)-O-benzyl serine 
methyl ester (130) in 20% yield. M.p. 221-223 °G (dec.); (Found: G, 34.41; H, 6.80; N, 
13.10. Gale, for G3H7NO3: G, 34.29; H, 6.71; N, 13.33%); m/z (Found: 106.050.
GgHsNOs requires 106.050); M o -13.6° (c. 1.02 in 1 M HGl) [lit.,2 2^.213 +14 ,5  (c.
1.0 in 1 M HCI) for (2S)-serine]; v^ax (nujoi) 3459 (NH/OH str), 2800-3000 (GH str and 
nujoi) and 1597 cm "' (GO2 ); §h (200 MHz, DgO/NaOD) 3.22 (1H, t, J 5 Hz, 2 GH) and 
3.60 (2H, m, 3 GHg); Sc (50 MHz, DgO/NaOD/MeOH) 58.12 (2 QH), 64.17 (3 QH2) and 
178.75 (CO2H); m/z (Gl) 106 {[M+HY, 100%), 60 (42, [/W-G0 2 H]+) and 44 (12, [GOj+).
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(3R,6S)-2,5-Dlmethoxy-3-/sopropyl-6-benzyl~3,6-dihydropyrazine (133)
193
CHgPh
(3R)-2,5-Dimethoxy-3-/sopropyl-3,6-dihydropyrazine (113) (250 mg, 1.36 mmol) was 
dissolved in dry THF (3 ml) and cooled to -80 °C. To this was added dropwise 2 M 
nBuLi (0.68 ml, 1.36 mmol). After 30 min a solution of benzyl bromide (349 mg, 2.04 
mmol) in dry THF (3 ml) was added and the mixture was stirred at -80 °C overnight.
The resulting solution was concentrated to dryness in vacuo. Potassium phosphate 
buffer (20 ml, 100 mM, pH 7) was added and the suspension extracted with diethyl
Iether (3x 20 ml). The diethyl ether layer was dried (MgSO^) and concentrated in vacuo |
1to yield the crude product. This was purified by flash chromatography (petroleum |
ether:diethyl ether 9:1). The product was uv and Ig active with an Rf «0.46. The product |
containing fractions were combined and concentrated in vacuo to yield the pure |
material as a colourless oil (260 mg, 70%), m/z (Found: [MfH]+, 275.176. C 16H23N2O2 |
jrequires 275.1756); [a]o+65.4° (c. 1.6 in dichloromethane); v^ax (neat) 2944, 2871 (CH 
str), 1698 (C=N) and 1495 cm'  ^ (Ph); 6h (200 MHz, CDCI3 ) 0.61, 0.95 (GH, 2d, J 6 .8  Hz,
2  x 'Pr CHs), 2.15 (1H, dsp, Pr CH), 3.10 (2H, d, J4.6  Hz, CHsPh) 3.27 (1H, dd, J3.4  
Hz, 3 CH), 3.70,3.73 (6H, 2 s, 2  and 5 OCH3), 4.35 (1H, 2d, J4 .6  Hz, 6 CH), and 7.07- 
7.23 (5H, m, aromatic protons); 8c (75 MHz, CDCI3) 16.39, 18.98 (2  x 'PrGH3), 31.1 ('Pr 
ÛH), 39.95 (QHaPh), 52.07, 52.31 (2  and 5 QGHg), 56.59 (6 QH), 60.16 (3 QH), 126.24,
127.76, 129.95, 137.26 (aromatic carbons), 162.38 and 163.91 (2 and 5 0); m/z (El)
275 {[M +Hf, 100%), 183 (20, [M-PhCHi^) and 141 (30, [M-PhCH2-CH(CH3 )2+ H f ).
&
(3R,6S)-I6-^H]-2,5-Dimethoxy-3-/sopropyl-6-benzyl-3,6-dlhydropyrazine
( 134 )
This was prepared in an identical manner to (3R,6S)-2,5-dimethoxy-3-/sopropyl-6- 
benzyl-3,6-dihydropyrazine (133)  using (3 R)-[6 -^H2]-2 ,5 -dimethoxy-3 -/sopropyl-3 ,6 - 
dihydropyrazine (117) in 8 8 % yield, m/z (Found: [M+HY, 276.1822. ,Ci6H22N2 0 ^D 
requires 276.1822); Vmax (neat) 2944 (CH str), 1696 (C=N) and 1496 cm'  ^ (Ph); [ol]d 
+40.4° (c. 1.556 in dichloromethane); 8 h (200 MHz, CDCI3) 0.64, 0.97 (6 H, 2d, J 6.8  Hz, 
2 X 'Pr CH3), 2.18 (1H, dsp, 'Pr CH), 3.11 (2H, s, CHgPh) 3.28 (1H, d, J3.2 Hz, 3 CH), 
3.70, 3.74 (6 H, 2s, 2 and 5 OCH3 ) and 7.1-7.3 (5H, m, aromatic protons); 8c(50 MHz, 
CDCI3) 16.31, 18.95 (2x PrQHg), 30.98 ('PrQH), 39.81 (QHgPh), 51.98, 52.23 (2 and5 
OQH3), 56.0 (t, J22  Hz, 6 QH), 60.07 (3 QH), 126.19, 127.70,129.89, 137.17 (aromatic 
carbons), 162.38 and 163.31 (2 and 5 C); 5d (61.4 MHz, CHCI3) 4.31 (6 CQ); m/z (Cl) 
276 {[M+H]\ 100), 184 (20, [AfPhCHa]^) and 142 (32, [M-PhCH2-CH(CH3)2+Hf).
(3R ,6S)<2,5-D im ethoxy-3-/sopropyl-6-ally l>3,6>d{hydropyrazlne ( 135)
(3R)-2,5-Dimethoxy-3-/sopropyl-3,6-dihydropyrazine (113) (250 mg, 1.36 mmol) was 
dissolved in dry THF (3 ml) and cooled to -80 °C. To this was added dropwise 1.9 M 
nBuLi (0.72 ml, 1.36 mmol). After 30 min a solution of aliyi bromide (329 mg, 2.72 
mmol) in dry THF (3 ml) was added and the mixture was stirred at -80 °C overnight. 
The resulting solution was concentrated to dryness in vacuo. Potassium phosphate 
buffer (20 ml, 100 mM, pH 7) was added and the suspension extracted with diethyl 
ether (3x 20 ml). The diethyl ether layer was dried (MgSO^) and concentrated in vacuo
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to yield the crude product. This was purified by flash chromatography (petroleum ;
etheriethyl acetate 7:3). The product was Ig active with an Rf «0.82. The product 
containing fractions were combined and concentrated to yield the pure material as a 
colourless oil (220 mg, 73%), m/z (Found: 224.1525. C12H20N2O2 requires
224.1525); [a]o+13.9° (c. 2.8 in dichloromethane); v^ax (neat) 3078, 2945, 2872 (CH 
str), 1699 (C=N) and 1642 cm ' (C=C); Sh (200 MHz, CDCI3) 0.68, 1.05 (6 H. 2d, J7.6  
Hz, 2 X Pr CÜ3), 2.27 (1H, dsp, 'Pr Chi), 2.55 (2H, m, 3' CJHa), 3.7 (6 H, 2s, 2 and 5 
OChb), 3.9 (1H, t, J3.4 Hz, 3 CH), 4.1 (1H, dd, 6 CH), 5.0-5.15 (2 H, m, 1' C d j) and 5.7 
(1H, m, 2' CH); 6c (50 MHz, CDCI3) 16.47, 19.03 (2 x'Pr CHa), 31.56 ('PrCH), 38.43 (3'
GHz), 52.25, 52.39 (2 and 5 OGH3), 55.41 (6  GH), 60.65 (3 GH), 117.77 (1' GHz),
133.78 (2' GHz), 163.06 and 163.77 (2 and 5C); m/z (El) 225 ([AA-H]h 100%), 183 (50, 
[/W-CHzCHCHzJT and 141 (43, [M-CH2CHCH2-CH(CH3)z+H]+).
(3R,6S)-[6*^H]-2,5-Dlmethoxy>3-/5opropyl-6-allyl-3,6-dihydropyrazlne ;
( 136 )
This was prepared in an identical manner to (3 R, 6S)-2,5-di meth oxy-3- /sopropy I-6 -al ly I -
3,6-dihydropyrazine (1 3  5 )  using (3 R)-[6-^H2]-2 ,5-dimethoxy-3 -/sopropyl-3 ,G- 
dihydropyrazine (117) in 65% yield, m/z (Found: M+225.1590. C12H 19N2O 2D requires 
225.1586); [0)0  +11.11° (c. 2.88 in dichloromethane); v^ax (neat) 3000-2800 (CH str),
1696 (C=N) and 1641 cm‘  ^ (C=C); 6h (200 MHz, CDCI3 ) 0 .6 8 , 1.02  (6 H, 2 d, J 6.8  Hz, 2  
X Pr CHa), 2.25 (1H, dsp, P r CH), 2.52 (2 H, d, J 7 Hz, 3’ CH2), 3.7 (6 H, 2 s, 2  and 5 
OCH3), 3.92 (1H, d, J3.2 Hz, 3 CH), 4.99-5.1 (2 H, m, V CH2 ) and 5.7 (1H, m, 2 ’ CH); 6 c 
(50 MHz, CDCI3 ) 16.48, 19.06 (2 x 'Pr GH3), 31.54 ('Pr GH), 38.37 (3' GHz), 52.28, j
52.43 (2 and 5 OCH3), 55.4 (t, J20  Hz, 6  GO), 60.65 (3 GH), 117.83 (V GHz), 133.79 
(2 ' GHz). 163.09 and 163.85 (2  and 5 C); 8 d (61.4 MHz, CHCI3) 4.06 (6  CQ); m/z (Cl) 'I
I
226 ([/WrH]h 100%), 212 (35, [AfCH z+Hf ), 184 (120, [M-CHzCHCHz]*) and 142 (15, [M- i
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CH2CHCH2-CH(CH3)2+H]^).
(3R ,6S )-2 ,5 -D lm eth o x y -3 -/so p ro p y l-d ih yd ro p y ra z in e -6 -ac e tlc -ac id  ethyl 
ester (137)
OCH
(3R)-2,5-Dimethoxy-3-/sopropyl-3,6-dihydropyrazine (113)  (1 g, 5.49 mmol) was 
dissolved in dry THF (25 ml) and cooled to -80 °C. To this was added dropwise 2.06 M 
nBuLi (2.67 ml, 5.49 mmol). When the mixture had warmed to -60 °C, the temperature 
was reduced to -90 and a cold solution of ethyl bromoacetate (0.92 g, 5.49 mmol) in 
dry THF (2 ml) was added and the mixture was stirred at -90 °C for 5 h. The resulting 
solution was concentrated to dryness in vacuo. Potassium phosphate buffer (20 ml, 
100 mM, pH 7) was added and the suspension extracted with diethyl ether (3 x 20 ml). 
The diethyl ether layer was dried (MgSO^) and concentrated in vacuo to yield the 
crude product. Purification using flash column chromatography in various solvent 
systems was unsuccessful. The proton NMR contained a quartet in the 3.5-4.0 ppm 
region characteristic of the p aspartic acid protons. The crude material was taken 
straight on to the next step.
(3R,6S)-[6-^H]-2,5-Dlmethoxy-3-/sopropyi-dihydropyrazlne-6-acetlc-acid 
ethyl ester (138)
This was prepared in an identical manner to (3R,6S)-2,5-dimethoxy-3-/sopropyl- 
dihydropyrazine-6 -acetic-acid ethyl ester (137) using (3 R)-[6 -^H2]-2 ,5 -dimethoxy-3 - 
/sopropyl-3,6-dihydropyrazine (117). The proton NMR contained a quartet in the 3.6-
4.0 ppm region characteristic of the p aspartic acid protons for a deuteriated sample.
196
The crude material was taken straight on to the next step.
(2S)-Phenylalanlne methyl ester (139)
^OCH.
'"CHgPh
(3R,6S)-2,5-Dimethoxy-3-/sopropyl-6-benzyl-3,6-dihydropyrazine (133) (750 mg, 2.74 
mmol) was added to 0.1 M HCI (55 ml) and stirred at room temperature overnight. The 
mixture was extracted with diethyl ether to remove un reacted starting material. The 
aqueous layer was concentrated in vacuo and dissolved in a small amount of water. 
The pH of the solution was adjusted to 8-10 with concentrated ammonia solution. The 
solution was extracted with diethyl ether (3 x 30 ml), dried (MgS0 4 ) and concentrated 
in vacuo. The mixture of (2R)-valine methyl ester and (2S)-phenylalanine methyl ester 
were separated by distillation under reduced pressure, (2S)-phenylalanine methyl 
ester having the lower boiling point (0.64 g, 70%), used for the next step without further 
purification. Ôh (200 MHz, GDGI3) 1.76 (2H, br s, NHg), 2.87 (1H, ABX, Jab 13.4 Hz, Jax
5.2 Hz, benzyl GhL), 3.11 (1H, ABX, Jab 13.4 Hz, Jbx 7.9 Hz, benzyl GJdb), 3.7-3.8 (4H, 
m, OGhb and 2 GH) and 7.15-7.4 (5H, m, aromatic protons); Ôc (75 MHz, GDGI3) 40.97 
(3 ÜHg), 51.92 (V QHq), 55.71 (2 QH), 126.77, 128.49, 129.19, 137.13 (aromatic 
carbons) and 175.26 (GO 2Me).
(2S)-[2-2H]-PhenylaIanlne methyl ester (140)
This was prepared in an identical manner to (2S)-phenylalanine methyl ester (139) 
using (3R,6S)-[6-^H]-2,5-dimethoxy-3-/sopropyl-6-benzyl-3,6-dihydropyrazine (134) in 
82% yield, used for the next step without further purification, ôh (200 MHz, GDGI3 ) 1.76
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(2 H, br s, NHg), 2.87 (1H, d, J14  Hz, benzyl CHa), 3.11 (1H, d, J14  Hz, benzyl CHb), 
3.73 (3H, s, OCHa) and 7.1-7.35 (5H, m, aromatic protons).
(2S)>Aliylglycine methyl ester (141)
(3R,6S)-2,5-Dimethoxy-3-/sopropyl-6-ally!-3,6-dihydropyrazine (135) (1.3 g, 5.8 mmol) 
was added to 0.2 M HCI (58 ml) and the suspension stirred at room temperature 
overnight. The mixture was extracted with diethyl ether (20 ml) to remove un reacted 
starting material. The aqueous layer was concentrated in vacuo and dissolved in a 
small amount of water (5 ml). The pH of the solution was adjusted to 8-10 with 
concentrated ammonia solution. This solution was extracted with diethyl ether (3 x 30 
ml), dried (MgSO^) and concentrated in vacuo yielding a mixture of (2R)-valine methyl 
ester and (2S)-allyl glycine methyl ester. The two products were separated using flash 
column chromatography on silica (diethyl ether and a drop of ammonia solution) 
(valine methyl ester Rf 0.38, allyl glycine methyl ester Rf 0.22) to give the required 
compound as a clear oil (0.2 g, 39%). m/!z (Found: [Mi-H] +, 130.087. CeH 12NO2 requires 
130.0868); [ajo +3.2° (c. 0.8 in dichloromethane); v^ax (neat) 3382 (NH2 str), 3079 
(C=C-H str), 2800-3000 (CH str), 1740 (CO2CH3) and 1642 cm"* (C=C); Ôh (200  MHz, 
CDCI3) 1.60 (2 H, s, NH2), 2.36 (2 H, m, 3 CH2 ), 3.5 (1H, 2d, J5  Hz, 2  CH), 3.66 (3H, s, 
OCH3), 5.04 (1H, d, J 1.2 Hz, 5 CH cis), 5.11 (1H, d, J5.8 Hz, 5 CH trans) and 5.6 (1H, 
m, 4 CH); 6c (75 MHz, CDCI3) 38.9 (3 GH2), 51.69 (OGH3), 53.66 (2  QH), 118.36 (5 
G H2), 133.17 (4 GH) and 175.37 (G=0); m/z (El) 130 ([mH]+, 100%) and 70 (58, [M- 
C02CHa|+) 44 (20, [C0^%
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(2S)-[2-^H]-Allylglyclne methyl ester (142)
This was prepared in an identical manner to (2S)-allyl glycine methyl ester (141 ) using 
(3R,6S)-[6-^H]-2,5-dimethoxy-3-/sopropyI-6-a!lyl-3,6-dihydropyrazine ( 136)  in 40% 
yield, m/z (Found: 131.093. CgHnNOgD requires 131.0931); [a]o +2.6° (c. 0.93
in dichloromethane); Vmax (neat) 3381 (NHg str), 3079 (C=C-H str), 2800-3000 (CH str), 
1735 (CO2CH3) and 1642 cm"* (C=C); 8 h (200 MHz, CDCI3) 1.55 (2 H, s, NHg), 2.4 (2 H, 
m, 3 CH2), 3.67 (3H, s, OCH3 ), 5.1 (2 H, m, 5 CH2) and 5.7 (1H, m, 4 CJd); 8c (75 MHz, 
CDCI3) 38.86 (3 CHg), 51.68 (OGH3), 53.34 (t, J 21.6  Hz, 2  CD), 118.35 (5 CHg), 133.19 
(4 GH) and 175.41 (G=0); Ôq (61.4 MHz CHCI3) 3.53 (2  CD); m/z (El) 131 ([M fH f, 
100%) and 71 (36, [M-CO2CH3I+).
(2S)-Aspartlc acid-a-methyl-p-ethyl ester (143)
^OCHa
1 -CHgCOgEt
Crude (3R,6S)-2,5-dimethoxy-3-/sopropyl-dihydropyrazine-6-acetic-acid ethyl ester
(137) (1.85 g, 6.9 mmol) was stirred overnight in 0.2 M HCI (69 ml, 13.8 mmol). The 
solution was extracted with diethyl ether (15 ml) and the diethyl ether discarded. The 
aqueous layer was concentrated to dryness in vacuo. It was dissolved in water (2 ml) 
and the pH adjusted to «8-10 with 25% ammonia solution. The basic solution was 
extracted with diethyl ether ( 3 x 1 0  ml). The diethyl ether extracts were combined, dried 
(MgSO^), and concentrated to dryness in vacuo to yield a mixture of the required 
product and (2R)-valine methyl ester. The esters were separated by flash column 
chromatography (19:1 diethyl ethenethanol with a drop of ammonia) and the products 
visualised with ninhydrin. The required product was obtained as a clear colourless oil
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contaminated with (2R)-vaiine methyl ester (0.32 g, 39%). ôh (200 MHz, CDCI3 ) 1.25 
(3H, t, J7.6 Hz, ethyl CJH3 ), 1.85 (2H, br s, NH^), 2.7 (2H, ABX, Jab 12.6 Hz, Jax 3 Hz, 
Jbx 9.6 Hz, 3 CH2), 3.7 (3H, s, OCH3), 3.8 (1H, ABX, Jax 3 Hz, J bx 9.6 Hz, 2  CM) and
4.15 (2 H, q, J7.6 Hz, ethyl CHg); ôc (50 MHz, CDCI3 ) 14,05 (ethyl QHg), 38.88 (3 QHg), 
51.08 (OÇH3), 52.24 (2GH), 60.72 (ethyl GHg), 171.07 and 174.59 (ester G=0).
(2S)-[2-^H]-Aspartic acid-a-m ethyl-p-ethyl ester (144)
This was prepared in an identical manner to (2S)-aspartic acid-a-methyl- p-ethyl ester 
( 1 43 )  using (3R,6S)-[6-^H]-2,5-dimethoxy-3-/sopropyl-dihydropyrazine-6“acetic-acid 
ethyl ester (138) in 41% yield. Ôh (200 MHz, CDCI3) 1.25 (3H, t, J7.6  Hz, ethyl CHa),
1.85 (2 H, br s, NH2), 2.7 (2 H, dd, J 17.7 Hz, 3 CH2), 3.7 (3H, s, OCH3) and 4.15 (2 H, q, J 
7.6 Hz, ethyl CHa)-
(2S)-[2-2H ]-Phenyla lan lne (145)
This was prepared in an identical manner to (2S)-phenylalanine (148) using (2S)-[2- 
^HJ-phenylalanine methyl ester (140) in 60% yield. M.p. 264 °C (lit.,^® 283°C (dec) for 
(2S)-phenylalanine); (Found: C, 64.83; H, 5.68; N, 8.23. Calc, for C9 H10NO2D: C, 65.04; 
H, 6.02; N, 8.43%); m/z (Found: [MfH]+, 167.0931 C9H11NO2D requires 167.0931); [ab  
-28.2° (c. 1.5 in H2O) [lit.,^ ^^  2 .O in H2O) for (2S)-phenylalanine]; v^ax
(nujoi) 2800-3000 (CH strand nujoi) and 1559 cm'  ^ (COf); Ôh (200 MHz, D2 0 /NaOD) 
2.69 (1H, d, J 13.2 Hz, 3 CHa), 2.84 (1H, d, J 13.2 Hz, 3 CHb) and 7.1-7.3 (5H, m, 
aromatic protons); ôc (75 MHz, D2 0 /Na0 D/Me0 H) 41.79 (3 GH2), 58.55 (2 GH), 127.68,
129.66, 130.50, 139.48 (aromatic carbons), and 183.52 (GO2H); Ôq (61.4 MHz, 
H2 0 /NaOH) 3.36 (2 CG).
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(2S)-[2-“H]-Allylglyclne (146)
This was prepared in an identicai manner to (2S)-aiiyi glycine (149) using (2S)-[2-^H]- 
aiiyigiycine methyl ester (142) in 59% yield. M.p. 246-248 °C (dec.); (Found: C, 51.42; 
H, 6.74; N, 11.94. Calc, for CgHoNOgD: C. 51.71; H, 6.94; N, 12.06%); m/z (Found: 
[/WfHr, 117.077. C 5H9 NO2D requires 117.0774); M d  -4.2" (c. 1.87 in 6  M HCi)[lit.,='= 
[a]o^ -rS.7 (c. 2.0 in 5 M HCI) for (2R)-ailyigiycine]; v^ax (nujoi) 3200-2600 (nujoi, CH str 
and OH str) and 1581 cm ' (CO2 ): 6 h (300 MHz, D2O) 2.49 (1H, d, J  4 Hz, 3 CJHa), 2.52 
(1H, d, J 3  Hz, 3 Cldb), 5.15 (2H, m, 5 C II2) and 5.6 (1H, m, 4 CH); 8c (75 MHz, 
D2 0 /dioxane) 35.43 (3 GH2), 54.36 (t, J 22  Hz, 2 CD), 121.20 (5 CH2), 132.03 (4 CH) 
and 174.73 (C=0); 8 d (61.4 MHz, H2O) 3.54 (2 CC): m/z (El) 117 (jM+H]+, 100%) and 
71 (20, [CO2H D .
(2S)-[2-2H]-Aspartic acid (147)
This was prepared in an identical manner to (2S)-aspartlc add (150) using (2 S)-[2 -^Hj- 
aspartic acid-a-methyl-p-ethyi ester (144) in 12% yield from the initial bis-iactim ether. 
M.p. >300 °C; (Found: C, 35.59; H, 4.54: N, 10.32. Calc, for C4 H6NO4D: C, 35.82; H, 
4.51; N, 10.44%); (Found: [AfrH]+, 135.0516. C4H7NO4D requires 135.0516); [afo 
+19.5" (c. 0.495 in 5 M HCI); Vmax (nujoi) 3000-2800 (CH str, NH str and nujoi), 1690, 
1643 (CO2 ) and 1591 cm ’ (NH3+ deformations); 8h (200 MHz, DaO/NaOD) 2.24 (1H, d, 
JfB 16 Hz, 3 CHa) and 2.54 (1H, d. Jab 16 Hz, 3CHb): Sc (100 MHz, D 2 0 /NaOD/dioxane) 
43.91 (3 CH 2), 54.41 (t, J20.7 Hz, 2 CD), 180.93 and 183.09 (1 and 4 CO2H); 8d (61.4 
MHz, H20 /Na0 H) 3.46 (2 CE).
(2S)-Phenylaianine (148)
(2S)-Phenyiaianine methyl ester (139) (0.82 g, 4.6 mmol) was suspended in 2M  HCI 
(50 mi) and refiuxed under nitrogen for 2 h. The solvent was removed in vacuo, the
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residue was dried over phosphorus pentoxide. The crude hydrochloride salt was 
added to dry ethanol {20 ml) and propylene oxide (20  ml) and the mixture refluxed for 
15 min. The product was filtered, dried and recrystallised from water and ethanol to 
yield white crystals (0.76 g, 60%), m.p. 275 °C [lit.,^  283 °C (dec.)]; (Found: C, 65.66; 
H, 6.40; N, 8.48. Calc, for CgHiiNOg:^ 65.44; H, 6.71; N, 8.48 %); m/z (Found: [M+H]\ 
166.0868. C9 H12NO2 requires 166.0868); [a b  -30.9° (c. 2.035 in H2O) (lit.,^^  ^ [ab^°- 
32.5° (c. 2.0 in H2O)); Vmax (nujoi) 2800-3000 (CH strand nujoi) and 1559 cm‘  ^ (CO2 ); 
ÔH (200 MHz, DgO/NaOD) 2.7 (1H, ABX, 7.4 Hz, Jab 13.4 Hz, 3 CHb), 2.85 (1H, ABX, 
Jax 5.5 Hz, Jab 13.4 Hz, 3 CJda), 3.36 (1H, ABX, 2 CJH) and 7.1-7.3 (5H, m, aromatic 
protons); 0c(75 MHz, DgO/NaOD/MeOH) 41.79 (3 GH2), 58.46 (2 GH), 127.63, 129.59,
130.43, 139.32 (aromatic carbons) and 183.41 (GO2H); m/z (El) 166 {[M+HŸ, 100%) 
and 120 (20, [M-COzHY).
(2S)-A liylglyclne ( 149)
(2S)-Allylglycine methyl ester (141) (0.27 g, 2.09 mmol) was added to 2 M HCI (10 ml) 
and the mixture refluxed for 2 h. The solvent was removed in vacuo and the residue 
dried over phosphorus pentoxide. Dry ethanol (10 ml) and propylene oxide (10 ml) 
were added and the mixture refluxed under nitrogen for 15 min. The suspension was 
cooled and the solid filtered off and dried (0.2 g, 83%), m.p. 254°C (dec.); (Found: C, 
52.21; H, 8.12; N, 12.14. Calc. forCsHgNOg: C, 52.16; H, 7.88; N, 12.17%); m/z (Found: 
[M+HY, 116.071. C5H 10NO2 requires 116.0712); [ajo -5.7° (c. 2.0 in 5 M HCI) [lit.,^ ^^  
[ajo^ '^  +5.7° (c. 2.0 in 5M  HCI) for (2R)-allylgiycine)]; v^ax (nujoi) 3200-2600 (nujoi, CH 
str and OH str), 1586 (COg ); ôh (300 MHz, DgO) 2.5 (2H, m, 3 CJI2), 3.7 (1H, dd, 2 CH),
5.15 (2H, m, 5 CJdg) and 5.7 (1H, m, 4 CM); 6c (75 MHz, DgO/dioxane) 35.55 (3 GHg), 
54.66 (2 GH), 121.21 (5 GHg), 132.06 (4 GH) and 174.69 (G=0); m/z (El) 116 
100%) and 70 (15, [COgHf ).
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(2S)-Aspartlc acid (150)
(2S)-Aspartic acid-a-methyl-p-ethyl ester (143) (0.32 g, 2.67 mmol) was refluxed in 5 
M HCI (10 ml) for 2 h. The solvent was removed in vacuo. The product was dried over 
phosphorus pentoxide. The product was dissolved in dry ethanol (10 ml) and 
propylene oxide (10 ml) and the solution refluxed for 15 min. The amino acid was 
filtered off and recrystallised from water and ethanol yielding a white crystalline solid 
(20 mg, 11% from the initial bis-lactim ether), m.p. 290 °C (dec.) ( lit . ,^  270-271 °C); 
(Found: C, 36.48; H, 5.73; N, 10.16. Calc, for C4H7NO4 : C, 36.09; H, 5.30; N, 10.52%); 
m/z (Found: [M+HY, 134.046. C4H8NO4 requires 134.0453); [a] d +21.8° (c. 0.495 in 5 M 
HCI) [lit,2^ 3 [a]o^ +24.1° (c. 0.56 in 5 M HCI)];Vmax (nujoi) 3000-2800 (CH, NH and 
nujoi), 1692, 1644 (COg) and 1599 cm * (NH3+ deformations); 5h (200 MHz, 
DgO/NaOD) 2.21 (1H, ABX, Jax 9.9 Hz, Jab 15.8 Hz. 3 Cida), 2.55 (1H, ABX, Jbx 3.5 Hz, 
Jab 15.8 Hz, 3 CjHt) and 3.48 ( 1H, ABX, Jax 9.9 Hz, Jbx 3.5 Hz, 2  CM); 6c 
(DgO/NaOD/dioxane) 42.46 (3 GHg), 54,30 (2 GH), 180.32 and 181.13 (1 and 4 GOgH); 
m/z (Cl) 134 ([A ^H f, 100%) and 44 (53, [COgf).
Kinetics of the pyrazine deuteriation reaction
(3R)-2,5-dlmethoxy-3-/sopropyl-3,6-dihydropyrazlne (113)  (0.5 g, 2.72 mmol) was 
added to CD3 OD (10 ml). To this was added a solution of KOH (0.15 g, 2.72 mmol) in 
DgO (1 ml). The mixture was refluxed under nitrogen. Aliquots (0.7 ml) were removed at 
t=0 and at intervals of 30 min until t=300 min. To each aliquot was added 5 M HCI (34 
111) to quench the reaction. A proton NMR spectrum was obtained for each aliquot. The 
aliquots were filtered (to remove precipitated KCI), and each diluted to 2  ml and the 
optical rotation measured for each sample. The samples were combined and 
concentrated in vacuo.
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N-Acetyl-{2RS)"Serine (152)
(2S)-Serîne (2  g, 19 mmol) was dissolved in water (20 ml) and pyridine (1.56 ml, 19 
mmol). Acetic anhydride (6  ml) was added to the solution dropwise. The resulting
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'4solution was stirred at room temperature overnight. The solution was poured onto an 
Amberlite IR-120(H) column. The column was eluted with water and fractions (25 ml) 
collected until an alkaline reaction to Congo Red indicator was obtained. The acidic 
fractions were pooled and concentrated to dryness in vacuo yielding an oil (2.1 g,
90%). Vmax (neat) 3348 (br, NH and OH str), 2977 (CH str) 1732 (acetyl C=0) and 1652 
cm ' (COg ); 8h (200 MHz, DgO/NaOD) 1.9 (3H, s, acetyl Ctb). 3.75 (2H, m, 3 CJig) and 
4.35 (1H, m, 2 CM): 8c (50 MHz, DgO/NaOD/MeOH) 22.7 (acetyl CHg), 55.84 (3 £Hz),
62.07 (2 GH) and 174.52, 175.39 (acid and acetyl GOgH); m ^(C I) 148 ([M t-H f, 100%),
130 (50, [M-OH]+), 102 (20, [M-COgHf) and 60 (20, [M-COgH-CHgCO+H]*). The N- 
acetyl-(2RS)-serine was taken on to the next step without further purification.
(2RS)-Serlne (153 )
N-Acetyl-(2RS)-serine (152) (2 g, 13.6 mmol) was dissolved in 2 M HCI (80 ml) and 
refluxed under nitrogen for 2 h. The solution was cooled, concentrated to dryness in 
vacuo, and dried over phosphorus pentoxide. The serine hydrochloride salt was 
dissolved in dry ethanol (20 ml) and propylene oxide (20 ml). The mixture was refluxed 
for 15 min. The solid was filtered, and recrystallised from water and ethanol to yield a 
white crystalline solid (0.86 g, 60%), m.p. 235-237 °C (dec); [a ]d +0.15° (c. 2 in 1 M 
HCI); Vmax (nujoi) 3200-2400 (NHg, OH and CH str) and 1661 cm** (amino acid COgH); 
ÔH (200 MHz, DgO/NaOD) 3.49 (1H, t, J4.6  Hz, 2 CH) and 3.72 (2H, m, 3 CHg); 6 c (50 
MHz, DgO/NaOD/dioxane) 57.09 (2 GH), 60.89 (3 GHg) and 173.05 (GOgH); m/z (Cl) 
106 {[M+Hf, 100%) and 60 (35, [AfCOgHf).
I
(2RS)-[U-i‘‘CJ-Serine (154)
(2S)-[U-^''C]-Serine (5 |iCi) in aqueous ethanol was added to (2S)-serlne (200 mg,
1.89 mmol) and lyophllised. The racemate (154) was prepared in an Identical manner 
to (2RS)-serine (153) in 77.5% overall yield. [a]D+3.0° (36 % (2R)-, 64 % (2S)-[U-^^C> 
serine).
(2 R S)-[U -^ '*C ]-Serine 0-sulphate (155 )
(2 RS)-[U-^'^C]-Serine (154) (0.1551 g, 1.47 mmol) was converted into (2RS)-[U-i4c]- 
serine O-sulphate (155)  using the method of TudbalP®^ in 18% yield.
(2R)-Serlne (157)
N-Acetyl-(2RS)-serine (152) (1 g, 6.75 mmol) was dissolved in water (60 ml). The pH 
was adjusted to 7,2 with aq. NH3. Pig liver acylase I (8 mg) was added and the mixture 
incubated at 37 °C for 24 h. The solution was poured onto an Amberlite IR-120(H) 
column and eluted with water until an alkaline reaction to Congo Red indicator was 
obtained. The acidic fractions containing N-acetyl-(2R)-serine (156) were pooled and 
concentrated to dryness in vacuo. The column was further eluted with 2 M HOI until a 
negative reaction to ninhydrin was obtained. The (2S)-serine containing fractions were 
pooled and concentrated. N-Acetyl-(2R)-serine (156)  (190 mg, 1.28 mmol) was 
dissolved in 2 M HOI (10 ml) and refluxed under nitrogen for 2 h. The hot solution was 
decolourised with charcoal, concentrated to dryness in vacuo and dried over 
phosphorus pentoxide. The oil was dissolved in dry ethanol (10 ml) and propylene 
oxide (10 ml). The mixture was refluxed for 15 min, and the solid filtered off and dried
(40 mg, 11%), m.p. 237-239 °C (dec); [ctjo + 1.75° (c. 0.8 in 1 M HOI) {[ajo +7.87° (c. 0.8 1
in 1 M HOI) for authentic (2R)-serine}; Ôh (200 MHz, DgO/NaOD) 3.75 (1H, br s, 2 OH) I
'tj
and 3.9 (2 H, br s, 3 CU2): 5c (50 MHz, DzO/NaOD/dioxane) 57.08 (2 £H ), 60.8 (3 GHg) ; J
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and 173.05 (COaH); m /z(C l) 106 ([/W4-H]*, 100%) and 60 (35, [M-COaH]^).
(N)-(")-CamphanoyI-2-amlno-(2R)-3-hydroxypropanolc acid (158)
CONH
OH
COgH
This was prepared in an identical manner to (N)-(-)-camphanoyl-2-amino-(2S)-3- 
hydroxypropanoic acid (159) using (2R)-serine in 63% yield. M.p. 133-135 X ;  [a]p 
-32.6° (c. 0.73 in 0.1 M NaOH); Vmax (nujol) 3408 (NH stretch), 3295 (broad, OH 
stretch), 1790 (lactone C=0), 1755 (acid C=0) and 1650 cm'  ^ (amide C=0 or NH 
bend); 8h (300 MHz, DgO) 0.98 (3H, s, 4" CHg), 1.08 and 1.13 (6 H, 2s, 2 x T  CHs), 1 72-
2.5 (4M, 3m, 5' CJtb and 6 ‘ CJdb), 4.0 (2 H, d, J 8.5 Hz, 3 GHz) and 4.62 (1H, t, J8.5 Hz, 2  
CH);Ôh (300 MHz, C5 D5 N) 1.05, 1.15, 1.24 (9H, 3s, 4" CH3  and 2 x 7" CH3 ), 1.5-2.75 
(4H, 3m, 5’ GHz and 6 ’ Gtb), 4.41 (1H, dd. Jab 11 Hz, Jax3.6  Hz, 3 GhW, 4.62 (1H, dd. 
Jab 11 Hz, ^ 4 . 1  Hz, 3 GJdb) and 5.28 (1H, m, 2 GH); ôc (100 MHz. G5 D5 N) 9.83 (4" 
GH3 ), 16.75 ( 2 x 7 "  QH3 ), 29.12, 30.61 (5' and 6 ’ QH2 ), 54.17, 55.45, 55.78 (2 GH, 4' G,
7' G), 62.46 (3 GHz), 92.82 (T  G), 167.45, 173.38 and 178.25 (ester, acid and amide 
G=0); m/z{C\) 286 ([mH]+,100%).
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(N )-{-)-Cam phanoyl-2-am lno-(2S)-3-hydroxypropanolc acid (159)
CONH
OH
(2S)-Serine (200 mg, 1.97 mmol) was dissolved in water (5 ml) and potassium 
carbonate (530 mg, 3.94 mmol) was added. The pH of the solution was checked and 
adjusted to >9 (if necessary). The basic solution was added to a suspension of 
camphanoyl chloride (300 mg, 1.38 mmol) in toluene (5 ml). The mixture was stirred 
vigorously overnight. The aqueous phase was isolated, washed with chloroform (2 x 
20 ml), acidified to pH 2 with 6 M HOI, extracted with chloroform ( 3 x 1 0  ml). The 
chloroform extracts were combined and dried with sodium sulphate. The solvent was 
removed in vacuo, yielding a white solid (190 mg, 48%), m.p. 179-181 °C; [c^d -28.1° 
(c. 0.75 in 1 M NaOH); v^ax (nujol) 3400 (N-H stretch), 3250 (broad, OH stretch), 1775 
(lactone 0=0), 1755 (acid 0 = 0 ) and 1635 cm'  ^ (amide 0 = 0  or N-H bend); ôh (300 
MHz, DgO) 0.92 (3H, s, 4" Ojda), 105 and 1.12 (6 H, 2s, 2  x 7" CJbb), 1.7, 2.08, 2.5 (4H, 
3m, 5' OHg and S' Otb), 3.9 (2 H, m, 3 OHg) and 4.55 (1H, m, 2  OHg); §h (300 MHz, 
O5D5N) 1.07, 1.09, 1.15 (9H, 3s, 4" Ojda and 2 x 7" OÜ3 ), 1 .5-2.7 (4H, 3m, 5* OH2 and 
6 ' CH2 ), 4.44 (1H, dd. Jab 10.9 Hz, Jax 3.5 Hz, 3 OHa), 4.61 (1H, dd. Jab 10.9 Hz, Jbx
4.1 Hz, 3 OHb) and 5.26 (1H, broad s, 2  OH); ôc (100 MHz, O 5D5N) 9.81 (4" QH3 ), 
16.62, 16.75 (2 x 7" QH3), 29.09, 30.61 (5' and 6 ’ QH2 ), 53.86, 55.32, 55.85 (2 QH, 4" 
O, 7' 0), 62.68 (3 QH2), 92.77 (T O), 167.28, 173.39 and 178.15 (ester, acid and amide 
G=0 ); m/z (01) 286 100%).
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(1’S ,4’R)-Camphanamlde of (2R)-serine methyl ester (160)
This was prepared in an identical manner to (1’S,4’R)-camphanamide of {2S)-serine 
methyl ester (161) from (1’S,4’R)-camphanamide of (2R)-serine (158) in 70% yield. §h 
(400 MHz, C5D5N) 1.06, 1.12, 1.15 (9H, 3s, 4” and 2 x 7” Chb), 1.51-1.6, 1.81-1.88, 
2.59-2.68 (4H, 3m, 5' and 6 ' CHg), 3.62 (3H, s, CO2CH3), 4.23-4.26 (1H, ABX, Jab 11.16 
Hz, Jax 4.44 Hz, 3 Cida), 4.39-4.43 (1H, Jab 11.16 Hz, Jbx 3.92 Hz, 3 CHb), 5.12-5.16 
(1H, ABX, Jax 4.44 Hz, Jbx3.92 Hz, 2 CH), 8.46 (1H, br d, J8.12 Hz, Njd); 6c(100 MHz, 
C5D5N) 9.89 (4” ÇH3), 16.68, 16.79 (2 x 7” QH3), 29,16, 30.66 (5' and 6 ' GHg), 52.16 
(CO2CH3), 54.29, 55.44 (4' and 7' C), 55.49 (2 GH), 61.99 (3 GHg), 92.72 {V C),
167.76, 171.45, 178.24 (3 G = 0  carbons).
(1’S ,4’R)-Camphanamlde of (2S)-serlne methyl ester (161)
(TS ,4’R)-Camphanamide of (2S)-serine (159) (100 mg, 0.35 mmol) was dissolved in 
water (5 ml) and dichloromethane (5 ml). The solution was cooled to 0 °C in an ice-salt 
bath. Diazomethane was added dropwise until a slight yellow colour remained. The 
solution was stirred for a further hour at room temperature. A stream of nitrogen was 
bubbled through the solution to remove the excess diazomethane. The solution was 
concentrated to dryness in vacuo yielding a white solid (70 mg, 70%). Ôh (400 MHz, 
C5D5N) 1.00, 1.05, 1.11 (9H, 3s, 4" and 2  x 7" CJda), 1.5-1.6 , 1.78-2.0, 2.58-2.65 (4H, 
4m, 5' and 6 ' GHz), 3.61 (3H, s, C0 2 Cjd3 ), 4.29-4.32 (1 H, ABX, J ab 11-12 Hz, Jax 4.6 
Hz, 3 CJda), 4.41-4.45 (1H, ABX, Jab 11.12 Hz, ^  4.02 Hz, 3 CHb), 5.16-5.21 (1H, ABX, 
Jax 4.6 Hz, J bx 4.02 Hz, 2  OH), 8.57 (1H, br d, J 8 .12  Hz, NH); ôc (100 MHz, G5D5N)
9.86 (4" GH3), 16.63, 16.79 (2 x 7" GH3), 29.14, 30.71 (5' and 6 ’ GHg), 52.19 
(GO2GH3), 53.99, 55.38 (4’ and 7' G), 55.52 (2  GH), 62.29 (3 GHg), 92.67 {V G),
167.67, 171.39, 178.17 (3 G = 0  carbons).
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1Chirality assay for the (2R)-sertne Isolated from the acylase resolution 
(162)
(2R)-Serine (157) (200 mg, 1.89 mmol) from the acylase resolution procedure was 
converted into the (1 ’S,4’R)-camphanamide methyl ester in an identical manner to that 
used to prepare the (TS,4’R)-camphanamide methyl ester of authentic (2R)-serine 
(158). Proton and carbon NMR spectra were obtained and compared with those for the 
pure materials. Comparison of the region 4.2-4.S ppm in the proton spectrum showed 
that the sample had been derived from a mixture of 57.4 % (2R)- and 42.6 % (2S)- 
serine.
(1’S,4’R)-(-)-N-Camphanoyl glycine (183)
Glycine (225 mg, 3 mmol) was dissolved in 1.0 M NaOH (3 ml) and the solution was 
shaken with freshly produced (1S,4R)-camphanoyl chloride (500 mg, 2.3 mmol) in 
toluene (2 ml) for 15 min. The resulting mixture was stirred vigorously for a further 2  h, 
diluted with water (5 ml) and dichloromethane (5 ml). The organic phase was 
separated and discarded, and the aqueous phase was adjusted to pH 2 using 5 M 
HCI. The solution was extracted with dichloromethane ( 3 x 1 0  ml), the combined 
organic layers were dried (MgS0 4 ) and concentrated in vacuo to yield a thick oil. 
Addition of a few drops of water to the thick oil caused crystallisation. The solid was 
recrystallised from diethyl ether/petrol to give white crystals (357 mg, 70%), m.p. 69-70 
°C (lit,2^ 73.5-74.5 ”C); (Found: C. 49.71; H. 7.23; N. 4.75. Calc, for C 12H17NO5.2 H2O: 
0 . 49.48; H, 7.27; N, 4.81%); [a]o -20.9° (c. 1.55 in methanol) [llt.,2^®[ab“  -19.7° (c. 
1.55 In methanol)]; (nujol) 3520 (OH), 3340 (NH), 2800-3000 (OH str), 1775 
(lactone 0 = 0 ), 1705 (acid 0 = 0 ), 1665 and 1550 cm’’ (amide 0 = 0  and NH); 8h (200 
MHz, 0 0 0 1 3 ) 0 .95  (3H, s,4" OH3 ). 1.10 and 1.15 (6H, 2s, 2 x 7 "  Oida), 1.60-2.68 (4H, 
m, 5' and 6' OJdj), 4.15 (2H, ABX, Jab 16.5 Hz, Jax=Jbx 6.5 Hz, 2 OHg), 7.3 (>1H,t br,
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NH) and 8.45 (1H, s br, OH); 5c (50 MHz, CDCI3) 9.62 (4" GH3 ), 16.42 and 16.62 (2 x 
7" Ç H 3 ), 28.94 and 30.14 (5' and 6' CHg), 40.67 (2 GHg), 54.27 (7  C), 55.36 (4' C), 
92.47 (1’ C), 167.81, 172.75 and 178.67 (3 x G = 0  carbons); m/z (El) 255 {M \  100%) 
and 209 ([yW-COaH-H]^, 20).
(1 ’S ,4 ’R)-(-)-N-Camphanoyl dideuterlo glycine (184 )
This was prepared in an identical manner to (1S,4R)-(-)-N-camphanoyl glycine (183) 
on a small scale and the following data was obtained for the crude product, ôh (400 
MHz, CDCI3) 0.9-1.15 (CHs camphanic acid and camphanamide), 1.65-2.5 (CH2 
camphanic acid and camphanamide) and 7.0 (NH); So (60 MHz, CDCI3) 4.15 and 4.00 
(CD2 of dideuteriated glycine camphanamide); m/z (El) 211 ([M-COaH-H]^ 100%).
Deuteriated amlnomatonate monoammonium salt ( 1 86 )
Aminomalonate monoammonium salt (60 mg, 29.4 mmol) was dissolved in deuterium 
oxide (1 ml) in an NMR tube, dioxane was added as an internal standard. After 19,5 h 
at 37 °C the product was 89% deuteriated as judged by proton NMR spectroscopy.
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Studies with Giutamate Decarboxyiase (GAD)
Giutamate Decarboxyiase Activity Assay (standard radioassay technique)
The enzyme activity was determined at pH 4.6 in 0.1 M pyridine/HCl buffer at pH 4.6. 
Each vial contained 200 |xl of solution, 8 8% of 18 mM (2S)-glutamic acid, 10% (2S)-[1- 
^"^C]-glutamic acid (5 fiCi in 2.3 ml) and 2% 50 mM PLP. The enzymic reaction was 
initiated by the addition of a 10 |il aliquot of a buffered GAD solution (2 units/ml) to 
each of seven assay vials at t=0. At t=0, 5, 10, 15, 20, 30, 40 min respectively the 
incubations were quenched by the addition of 6  M H2SO4 (200 jxl). After allowing for 
the complete liberation of carbon dioxide (about 30 min), scintillation fluid (3 ml) was 
added to each vial. Residual label was counted using a scintillation counter and 
the results represented graphically. Each assay was carried out in duplicate.
Inactivation of GAD by (2S)-serine O-sulphate
(2S)-Serine O-sulphate solutions (3.7, 10 mM) in 0.1 M pyridine/HCl buffer at pH 4.6 
(1.2 ml) containing 0.2 mg GAD were prepared. A reference solution containing 0.2 mg 
enzyme in buffer (1.2 ml) was also prepared. The solutions were assayed in duplicate 
for enzyme activity using the standard radioassay technique, at t=30 min, 4.5 h, 24 h, 
72 h.
inactivation of GAD by (2S,3R)-threonine 0-suiphate
(2S,3R)-Threonine O-sulphate solutions (3.7, 10 mM) in 0.1 M pyridine/HCl buffer at 
pH 4.6 (1.2 ml) containing 0.2 mg GAD were prepared. A reference solution containing 
0.2 mg enzyme in buffer (1.2 ml) was also prepared. The solutions were assayed in 
duplicate for enzyme activity using the standard radioassay technique, at t=30 min, 4.5 
h, 24 h, 72 h.
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Inactivation of GAD by (2S,3S)-threonine O-suiphate
(2S,3S)-Threonine O-sulphate solutions (10, 25, 50 mM) In pyridine/HCl buffer at pH
4.6 (1.2 ml) containing GAD (0.2 mg) were prepared. A reference solution was also 
prepared containing enzyme (0.2 mg) in buffer solution (1.2  ml). These solutions were 
assayed for enzyme activity at t=0, 5, 24 h.
Inactivation of GAD by (2R)-serine O-suiphate
(2R)-Serine O-sulphate solutions (10, 25, 50 mM) in a 0.1 M pyridine/HCl buffer (1.2 
ml) at pH 4.6 containing GAD (0.2 mg) were prepared. A reference solution was also 
prepared containing enzyme (0.2 mg) in buffer (1.2 ml) was also prepared. The 
solutions were assayed for enzyme activity using the standard method at t=0, 5, 24.5 
and 29 h.
Inactivation of GAD by (2S)-[U-^^C]-serine O-suiphate
This reaction was carried out in a Warburg apparatus. (2S)-[U-^'^C]-Serine O-sulphate 
solution (5.3 mM) in 0.1 M potassium acetate buffer solution at pH 4.6 was prepared.
An aliquot (400 jil, 0,1 t^Ci) was added to the enzyme (1.2 mg, 24 nmol) in one of the 
side arms of the Warburg apparatus. The main chamber of the apparatus contained 
barium hydroxide solution (25 ml) and there was a tube from the neck at the top to S
another vessel containing barium hydroxide solution (25 ml). The remaining opening
to the vessel was sealed with a stopper. After a 26 h incubation time several aliquots of ;
the enzyme solution, the internal barium hydroxide solution and the external barium ' ! 
hydroxide solution were removed and counted mechanically for the presence of "^*C. 1
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Kinetic studies of GAD inactivation by (2S)-serine 0-sulphates
{2S)-Serine O-sulphate and (2S)-[2-^H]-serine O-sulphate (1, 2, 3.5,5 mM) solutions in 
pyridine/HCl buffer (pH 4.6, 0.6 ml) containing GAD (0.1 mg) were prepared. A 
reference solution was also prepared containing enzyme (0.1 mg) in buffer solution 
(0.6 ml). These solutions were incubated at 37 °C and assayed for enzyme activity 
using the method given below at t=15 s, 45 min 15 s, 2 h 15 s, 4 h 15 s, 7 h 15 s after 
the addition of the enzyme.
Kinetic studies of GAD inactivation by (2R)-serine O-sulphates
(2R)-Serine O-sulphate and (2R)-[2-^H]-serine O-sulphate (2, 3.5,5, 7 mM) solutions of 
in pyridine/HCl buffer (pH 4.6, 0.6 ml) containing GAD (0.1 mg) were prepared. A 
reference solution was also prepared containing enzyme (0.1 mg) in buffer solution 
(0.6 ml). These solutions were incubated at 37 °C and assayed for enzyme activity 
using the method given below at t=15 s, 45 min 15 s, 2 h 15 s, 4 h 15 s, 7 h 15s  after 
the addition of the enzyme.
Modified Assay for for kinetic studies of GAD activity
The assay was carried out by adding a portion of the preincubation solution (60 1^) to 
the assay mixture (this dilution quenches the inactivation reaction). The assay mixture 
has an initial volume of 1.5 ml and contains 88% 18 mM (2S)-glutamic acid (in 0.1 M 
pyridine/HCl buffer solution, pH 4.6), 10% (2S)-[1-^"^C]-glutamic acid (5 \lC\ in 2.3 ml), 
and 2% buffer solution. At t=5, 10,15, 20,25 min after the addition of the preincubation 
solution, aliquots (200 |liI) are removed and added to 6 M H 2SO4 (200 p,l), which stops 
the conversion of (2S)-glutamic acid to GABA. After 30 min, scintillation fluid is added 
to each vial and the sample is counted for the amount of residual radioactivity.
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Incubation of (2RS)-[U-^'*C]-serlne O-sulphate with GAD
(2RS)-[U-^'^C]-Serlne O-sulphate solution (10 mM) in 0,1 M pyridine/HCl buffer at pH
4.6 was prepared. An aliquot (400 |xl) of this solution was added to GAD (1,1 mg) in the 
side arm of a Warburg apparatus. The main body of the Warburg apparatus contained 
barium hydroxide solution (10 ml). The side arm was added to the main body and 
incubated at 37 °C for 24 h. Aliquots of the inactivated enzyme solution, and the barium 
hydroxide solution were removed and checked for the amount of radioactivity present 
compared to the initial amount in the (2RS)-[U-^'^C]-serine O-sulphate solution and the 
background level of radioactivity in the barium hydroxide solution. It was found that the 
amount of radioactivity in the inactivated solution was less than in the starting solution, 
but a corresponding Increase in the barium hydroxide solution was not discovered.
NMR experiments with GAD 
(2R)-Serine O-sulphate incubation with GAD
(2R)-Serine O-sulphate (50 mg, 0.226 mmol) was added to 0.1 M pyridine/DCI buffer 
(pD 4.2, 1 ml), GAD was added (2.54 mg, =50 units) and the solution incubated at 37 
°C. Proton and carbon NMR spectra were obtained at t=0, 17, 32.5, 113 h and 
compared. It was found that no exchange or formation of new products had occurred.
(2S)-Serine O-suiphate Incubation with GAD
(2S)-Serine O-sulphate (5 mM in 0.1 M pyridine/DCI buffer, pD 4.2) was added to GAD 
(0.1 mg, approx 4 units) and the solution incubated at 37 °C. Proton NMR spectra were 
obtained at t= 0, 60, 120, 180, 240, 300, 510, 1795, 4410 min and compared. It was 
found that no exchange or rearrangement of the carbon skeleton had occurred.
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(2R)-Aspartic acid incubation with GAD
(2R)-Aspartic acid (50 mg, 0.37 mmol) was dissolved in pyridine/DCI buffer (pD 4.25,
0.1 M, 4 ml). An aliquot (0.7 ml) was put into an NMR tube and GAD was added (50 
units). The proton and carbon NMR spectra were obtained at t=0 min. The solution was 
incubated at 37 °C for one month and a proton NMR spectrum was obtained at weekly 
intervals. No exchange had taken place.
(2R)-Giutamic acid incubation with GAD
(2R)-Glutamic acid (50 mg, 0.34 mmol) was dissolved in pyridine/DCI buffer (pD 4.39,
0.1 M, 4 ml). An aliquot (0.7 ml) was put into an NMR tube and GAD was added (50 
units). The proton and carbon NMR spectra were obtained at t=0 min. The solution was 
incubated at 37 °C for one month and a proton NMR spectrum was obtained at weekly 
intervals. No exchange had taken place.
Incubation of (2S)-homocysteic acid with GAD
GAD (2.5 mg) was dissolved in 0.1 M pyridine/HCl buffer pH 4.6. To this was added 54 
mM (2S)-homocysteic acid (100 p,l). The solution was incubated at 37 °C overnight. 
The solution was concentrated to dryness in vacuo, and proton and carbon NMR 
spectra obtained. Ôh (200 MHz, DaO/pyridine buffer) 2.0 (2 H, m, 2  Ctla), 2.8 3.2 (4H, m, 
1 and 3 CHa’s); ôc (100 MHz, DaO/pyridine buffer/dioxane) 23.23 (2 GHg), 39.07, 48.71 
(1 and 3 GHa’s).
Incubation of (2R)-homocysteic acid with GAD
The incubation was carried out in an identical manner to that for (2S)-homocysteic 
acid. Inspection of the proton NMR spectrum showed that no reaction had occurred.
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Incubation of (2S)-homocysteic acid and (2S)-glutamic acid with GAD
A solution containing (2S)-glutamic acid (34 mM) and (2 S)-homocysteic acid (34 mM) 
was prepared in 0.1 M pyridine/DCI buffer, pL 4.6. GAD (0 .2  mg) was added to an 
aliquot of the above solution (700 jxl) and the solution shaken. The solution was 
incubated at 37 °C for several days. The reaction progress was followed by proton 
NMR spectroscopy.
Ultra-violet/visible studies of the GAD reactions 
Inactivation reaction of GAD with (2R)-serine O-suiphate
GAD (5 mg) and (2R)-serine O-sulphate (19.6 mg, 0.88 mmol) were added to 0.1 M 
pyridine/HCl buffer, pH 4.6. The mixture was incubated at 37 °C for 7 h. Solutions 
containing NADH (150 mM) and either alcohol dehydrogenase (0.1-0.2 mg) or lactate 
dehydrogenase (0.1-0.2 mg) in 100 mM potassium phosphate buffer at pH 7.0 were 
prepared and equilibrated to 37 °C prior to the experiment. Aliquots (10 |o,l) of the GAD 
solution were added to the alcohol dehydrogenase solution and the lactate 
dehydrogenase solution in duplicate. Any change in absorption at 340 nm was noted.
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Studies with serine hydroxy methyl transferase (SHMT)
Preparation of SHMT
E. coU  and cytosolic SHMT were obtained from Verne Sctiirch (Virginia 
Commonwealth University) in the form of the enzyme-gîycine-5-formaldehyde 
tetrahydrofolic acid ternary complex, this needed regeneration to regain enzyme 
activity. Half (about 25 mg enzyme) of each of the powders were dissolved in 20 mM 
potassium phosphate buffer (1 .5 ml) at pH 7.0, containing 5 mM mercaptoethanol and 
20 mM (2S)-serine and dialysed overnight against 1 litre of the same buffer at 4 °C, the 
enzyme solutions were dialysed for a further 8 h at 4 °C against 1 litre 20 mM 
potassium phosphate at pH 7.0 containing 5 mM mercaptoethanol. The enzyme 
solutions were diluted to 2 ml with H2O, half was frozen (12.5 mg enzyme) and the 
remainder was lyophllised and then frozen.
SHMT assay
(2S,3S)“Threonlne aldolase actlvity^^®
SHMT (10 jxl) was added to a 1 ml cuvette containing (2S,3S)-threonine (1.33 mg, 10 
mM), dithiothreitol (0.15 mg,1 mM), PLP (2.65 |xg, 10 |xM), NADH (0.21 mg, 0.3 mM) 
and yeast alcohol dehydrogenase (35 units) which had been equilibrated at 30 °C. 
The amount of enzyme activity was determined by monitoring the decrease in 
absorbance at 340 nm due to the oxidation of NADH (X^ax 340 nm, e 6220 dm  ^ moL  ^
cm'^). One unit of enzyme activity is defined as the amount of enzyme required to 
convert one micromole of (2S,3S)-threonine to acetaldehyde and glycine per minute.
uv assay
The provided mixture of glycine and 5-formaldehyde-tetrahydrofolic acid was dissolved 
in 20 mM potassium phosphate buffer pH 7.0 (1 ml) containing 5 mM mercaptoethanol.
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A portion of this solution (20 jil) was added to a 0.5 mg/ml solution of the enzyme. A uv 
spectrum was then obtained. '■s
SHMT incubations 
Cytosolic SHMT
1. In deuterium oxide (185).
The freeze dried solid from the cytosolic SHMT enzyme preparation (approx 12.5 mg 
enzyme) was dissolved in 0 2 0 (1  ml), a small portion was removed and its activity was 
determined to be approx 2 unit/mg. The remaining enzyme solution was diluted with 
D2O to 5 ml, and the pH of this solution was checked and found to be 7.19.
2-Aminomalonate (6 mg, 44.1 i^mol) was added in two equal aliquots at t=0 and t=5 
min and the solution incubated at 37 °C for 15 min. The protein was denatured by the 
addition of ethanol (5 ml), and removed by centrifugation. The solution was 
concentrated to dryness in vacuo and rewashed with water/ethanol until no further 
precipitation occurred. The final solution was concentrated once more to yield a solid 
(6.96 mg) containing glycine and no aminomalonate as judged by tic and proton NMR 
spectroscopy. The solid was dissolved in water and purified by preparative tic 
(9 rOH:NH3:H2 0  26:6:5), 15 mg of solid was obtained but there was some 
contamination with cellulose. It was assumed that this sample contained glycine (6  mg,
0.0789 mmol). The glycine/cellulose mixture was suspended in 2 M sodium hydroxide 
solution and residual cellulose removed. Freshly prepared camphanoyl chloride (25 
mg, 0.118 mmol) was dissolved in toluene. The two solutions were mixed and shaken 
for 15 min and stirred vigorously for 2  h. The organic layer was separated and 
discarded. The pH of the aqueous layer was adjusted to 2 with 5 M HCI, and extracted 
with dichloromethane (3x10  ml), these washings were combined, dried (MgS0 4 ), and 
concentrated to dryness in vacuo. Ôh (400 MHz, CDCI3) 0.9-1.15 (QHa camphanic acid |
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and camphanamide), 1.65-2.5 (CHa camphanic acid and camphanamide), 4.03 (br d, 
CH of monodeuteriated glycine camphanamide) and 7.0 (NH); Ôq (60 MHz, CDCI3) 4.2 
(CD of monodeuteriated glycine camphanamide); m/z (El) 256 (M+, 25%) and 210 
(100, [AfCOaH-H]^).
2, In protium oxide (187).
The frozen aqueous solution from the c. SHMT enzyme preparation (approx 12.5 mg 
enzyme) was defrosted and a small portion was removed and its activity determined to 
be approx 2 unit/mg. The remaining enzyme solution was diluted with H2O (5 ml). The 
pH was determined and adjusted to 7.0. Freshly prepared deuteriated aminomalonate 
was added in two aliquots of 50 p.1, the first at t=0, and the second at t=5 min. The 
solution was incubated at 37 °C for 15 min, the protein was denatured, the product 
purified and converted into the camphanamide derivative (16 mg solid isolated). §h 
(400 MHz, CDCI3) 0.9-1.15 (CH3 camphanic acid and camphanamide), 1.65-2.6 (CH2 
camphanic acid and camphanamide), 4.24 (br d, C H  of monodeuteriated glycine 
camphanamide) and 7.0 (NH); 89 (60 MHz, CDCI3) 3.99 (CD of monodeuteriated 
glycine camphanamide); m/z (El) 257 (10%, [AffH]+), 239 ([M-OH]^ 30) and 210 {[M- 
C0 2 H]+, 60).
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Hydroxymethyltransferase is, in fact, a Stereospecific Process. N.R. 
Thomas, J.E. Rose, D. Gani, J. Chem. Soc, Chem. Commun., 1991, 908.
2 . Regiospecific Deuteriation of Chiral 3-isopropyl-2,5-dimethoxy-3,6- 
dihydropyrazines in the Stereospecific Synthesis of a-Deuteriated a- Amino 
Acids. J.E. Rose, P.D. Leeson, D. Gani, J. Chem. Soc., Perkin Trans.1, 1992, 
1563.
3. Mechanisms and Stereochemistry of the Activation of (2S)- and (2R)-Serine O  
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